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Chapter 1 Introduction
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Knee OsteOarthritis
Just over 200 years ago, for the first time since Hippocrates, medicine started to aban-
don the idea all arthritic diseases could be contributed to gout1. In 1805, one of the 
first physicians to describe osteoarthritis,  John Haygarth, described very accurately the 
burden of osteoarthritis, greatly lowering quality of life, without shortening the lifespan 
of the patient, already urging his colleagues for awareness of this disease2:
“There is one distressful circumstance which distinguishes this disease. It has no intermis-
sion, and but slight remissions. For during the remainder of the patient’s life, the nodes 
gradually enlarge, impeding more and more the motion of the limb. These nodes, in their 
gradual progress, sadly embitter the comforts of life; but I know of no instance in which they 
seemed to shorten its duration. The first patient whom I saw in this disease lived to about 93 
years of age. The faithful picture drawn from nature is here exhibited to excite the compas-
sion and exertion of my professional brethren to prevent, if possible, so distressful a malady 
at its commencement.”
John Haygarth, 1805
Since then, the extent of the burden osteoarthritis has only increased and seems to 
continue doing so3 4. Large epidemiological studies show osteoarthritis to be a very 
common disease, leading to substantial morbidity, physical and psychological disability 
and a considerable economic burden5 6. The Global Burden of Disease Study reported a 
higher burden than expected from previous studies and estimates that osteoarthritis 
accounts for 6.8% of Disability Adjusted Life Years (DALY’s) worldwide7. The World Health 
Organization (WHO) reports estimates of 9.6% for men and 18.0% for women aged over 
60 years for symptomatic osteoarthritis. With an estimated 80% of all patients having 
limitations in movement and 25% experiencing limitations in daily life, osteoarthritis is 
considered one of the top ten most disabling diseases in developed countries8.
The interphalangeal joints of the hand are the most commonly affected joints in 
osteoarthritis, but very often asymptomatic. Knee osteoarthritis, the second most 
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commonly affected joint, is much more often symptomatic, making the impact of knee 
osteoarthritis the highest in this area of rheumatic diseases9. Knee osteoarthritis preva-
lence rates vary between 2.8% and 4.8% for all ages, are higher in women and highest 
around patients’ 50th life year5. Knee osteoarthritis is characterized by knee pain, morn-
ing stiffness and functional limitation and is considered to be a degenerative disease, 
caused by both mechanical and metabolic factors10 11.
Therapeutic options for knee osteoarthritis remain limited, most interventions aim 
to control symptoms and keep disability to a minimum9. Non-surgical management of 
knee osteoarthritis largely consists of pain control, exercise and weight management, 
intra-articular corticosteroids and biomechanical interventions, all contributing to 
managing the disease, more than actually curing it12. Naturally, only surgery removes 
the disease completely, but is however only applicable to a subset of patients meeting 
the criteria for major surgery. Moreover, studies show that large beneficial effects of total 
knee replacement in knee osteoarthritis are only to be expected in those patients with 
advanced osteoarthritis13.
When confronted with a disease causing high morbidity and limited therapeutic 
options, the highest benefits are to be expected from primary prevention. In order for 
primary prevention to be successful, risk factors need to be identified and a distinction 
needs to be made between modifiable and non-modifiable risk factors. The main risk 
factors for the development of knee osteoarthritis are ageing, obesity, female gender, 
knee injury in the past and heredity9 10. Self-evidently, ageing, female gender and he-
redity are non-modifiable risk factors. Modifying knee injury in the past would require 
prevention of the risk factor in the first place. This would require prevention programs at 
very young age. The only modifiable risk factor in a middle-aged population, at high risk 
for developing knee osteoarthritis, seems to be obesity. A large study investigating the 
relationship between obesity and osteoarthritis found odds ratios of 6.2 for unilateral 
knee osteoarthritis and 18.0 for bilateral knee osteoarthritis for obese women aged 45-
64 compared to women of the same age with a normal BMI14. Consequently, in literature 
many recommendations are made about prevention of knee osteoarthritis through 
modifying obesity15. In 1992 already, results from The Framingham Study suggested the 
design of a preventive trial in knee osteoarthritis and estimated that a reduction in body 
weight of approximately 5.1 kg could lead to a substantial decrease in incidence, espe-
cially in a high risk population16. Unfortunately, available evidence on the prevention of 
clinical knee osteoarthritis through weight loss is still very scarce17-19. A few studies were 
designed to evaluate the preventive effect on intermediate outcome measures of knee 
osteoarthritis, such as cartilage thickness or knee pain20 21. These studies did find indica-
tions of a preventive effect as suggested by The Framingham Study. However, in order 
to study the prevention of clinical knee osteoarthritis, a large, randomized controlled 
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trial is needed with long follow-up, conducted in a high-risk population, with outcome 
measures that combine clinical and radiographic data16-19.
OVerweight anD OBesity
Similar to osteoarthritis, obesity is an ancient problem with which physicians have been 
struggling for a long time. As early as the fifth century B.C. Hippocrates realized diet and 
exercise to be key factors in health and recommended moderation:
“If we could give every individual the right amount of nourishment and exercise, not too 
little and not too much, we would have found the safest way to health.”
Hippocrates, fifth century B.C.
Of course, in modern times the problem of overweight and obesity has reached 
enormous proportions. In 2005, 23.2% of the world’s population was overweight and 
9.8% was obese. It was estimated that in 2030 these figures can be as high as 38% and 
20%, respectively22. This problem is highest in developed countries, leading to a variety 
of comorbidities such as cardiovascular diseases, malignancies, osteoarthritis, diabetes 
and many more23. In the United States, already over 20% of all healthcare expenditures 
is spent on obesity and obesity-related diseases24.
In order to modify obesity as a risk factor for knee osteoarthritis, an effective inter-
vention is needed that is capable of inducing a clinically significant amount of weight 
loss in large groups of overweight and obese individuals. The amount of 5 kg of weight 
loss estimated by The Framingham Study as sufficient to substantially decrease the 
odds of developing knee osteoarthritis, matches the amount of weight loss which is 
needed to improve cardiovascular risk factors, as estimated by a number of studies25-27. 
Consequently, when attempting to prevent knee osteoarthritis by promoting weight 
loss, physical health will be improved in general also. Moreover, the two key ingredients 
of weight loss, diet and exercise, have been separately associated with improvement 
of health outcomes as well, regardless of actual decrease in body weight28-30. When at-
tempting to achieve a decrease in body weight however, the combination of these two 
factors has been proven to be most effective25 28 29 31.
Over the last few decades, numerous weight loss trials in overweight and obese 
patients have been conducted25 31. These trials are often confronted with a number of 
difficulties when attempting to achieve a clinically significant amount of weight loss 
in large groups of overweight and obese individuals. One of the often encountered 
problems is that of dropout. Naturally, in every clinical trial there is a proportion of par-
ticipants that drops out of the study earlier than planned. However, in weight loss trials 
dropout rates are often among the highest of clinical trials, reporting a mean dropout 
of 40% in the first twelve months in obesity trials32. Factors that have been associated 
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with high dropout rates are: strict, intensive diet and exercise schemes, female gender, 
young age, poor lifestyle habits, long studies and poor initial response to treatment32 33. 
Low dropout rates are always preferable, but when high dropout rates are unavoidable, 
complex statistic techniques are needed to account for missing data34. Unfortunately, 
these techniques are not yet always applied, some even using very outdated techniques 
such as ‘last observation carried forward’34. As a result, study results cannot properly be 
translated to clinical practice. Another common problem encountered in many weight 
loss trials is the fact that weight lost during an intervention is often quickly regained 
afterwards35. Many trials end follow-up of their participants at the same moment the 
intervention ends, failing to observe the long-term effects of the intervention after it 
ended. When attempting to modify a risk factor of a slowly progressing disease such as 
osteoarthritis, naturally an intervention is needed that can achieve long-term behavioral 
changes, leading to sustainable weight loss.
the PrOOF stuDy
In 2005, the PROOF study (PRevention of knee Osteoarthritis in Overweight Females) 
was launched. This trial was designed to be the first randomized controlled trial in the 
prevention of clinical and radiographic knee osteoarthritis. Naturally, a weight loss 
intervention was designed. To meet recommendations from literature, the weight loss 
intervention was tailor-made, meaning no predefined scheme of diet and exercise was 
determined. Instead, a dietician, or lifestyle coach, trained in motivational interview-
ing, made in dialogue with each participant an individual plan regarding both diet and 
exercise, aimed at achieving a clinically significant amount of weight loss and moreover, 
aimed at maintaining their lower body weight. It was expected this approach would 
lead to lower dropout rates than comparable weight loss interventions, prescribing a 
strict diet and exercise scheme. Moreover, motivational interviewing is aimed especially 
at promoting long-term, sustainable behavioral changes36. In addition to being random-
ized to this lifestyle intervention or to a control group, participants were randomized 
to oral glucosamine sulfate or placebo. At the time of commencement of the PROOF 
study, in addition to recommendations on weight loss, there were recommendations 
in literature regarding the effect of pharmacological substances when designing a trial 
aimed at preventing knee osteoarthritis37. Glucosamine had shown promising beneficial 
effects in patients with established knee osteoarthritis, side effects similar to placebo 
and findings from studies suggest greater effects in earlier stages of the disease, making 
a preventive effect plausible38 39.
Individuals at high-risk of developing knee osteoarthritis were the population of main 
interest. Incidence of knee osteoarthritis spikes at the age of fifty, more in women than 
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in men. Therefore, only women aged 50 - 60 without knee osteoarthritis were included. 
The glucosamine intervention lasted for 2.5 years. The tailor-made character of the 
lifestyle intervention resulted in a duration that was different for each individual, but 
was maximized at 2.5 years. During this period, every six months biometrical data was 
collected, questionnaires were completed and radiographic data was collected. In order 
to evaluate long-term intervention effects, measurements and questionnaires were 
repeated 4 years after the end of the intervention, resulting in a total follow-up time 
of 6.5 years. Primary outcome of the PROOF Study was incidence of knee osteoarthritis 
after 2.5 years. The main outcome of interest after 6.5 years was knee osteoarthritis, 
assessed by ACR (American College of Rheumatology) criteria, using both clinical and 
radiographic data40.
In conclusion, the high burden of knee osteoarthritis can best be addressed by 
prevention. Prevention of knee osteoarthritis could be achieved by weight loss in a 
high-risk population. Women from the age of 50 with overweight or obesity are those 
individuals most at risk of developing knee osteoarthritis. The PROOF Study was the 
first randomized controlled trial in the prevention of knee osteoarthritis, incorporating 
recommendations from literature to induce long-term behavioral changes in order to in-
duce a clinically significant amount of weight loss, which in turn could lead to decreased 
odds of developing knee osteoarthritis. Additionally, the PROOF Study investigated the 
preventive effect of oral glucosamine sulfate on incident knee osteoarthritis.
aims anD Outline OF this thesis
The main aims of this thesis are to describe:
1. The effectiveness of a tailor-made lifestyle intervention in achieving a clinically 
significant amount of weight loss in middle-aged, overweight women
2. The effect of this achieved weight loss on the incidence of knee osteoarthritis
3. The long-term intervention effects of the PROOF study on both health outcomes and 
incident knee osteoarthritis
Chapter 2 reports on the effectiveness of the lifestyle intervention of the PROOF Study 
in achieving a clinically significant amount of weight loss, during the first 2.5 year in 
which the intervention took place. All body weight data collected in this first period 
was used in a secondary analysis, in which particular patterns of weight change over 
time were studied, as described in Chapter 3. Both Chapter 4 and Chapter 5 report 
on the effect of weight loss on measures of knee osteoarthritis. The first of these two 
chapters evaluates the effect of a moderate amount of weight loss on the development 
of clinical knee osteoarthritis. The second chapter describes the effect of particular 
weight change trajectories, as identified in Chapter 3, on knee osteoarthritis features 
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assessed by MRI. Chapter 6 and Chapter 7 report on the long-term effects of the PROOF 
study, the first chapter reporting on the health and lifestyle of participants, the second 
chapter reporting on the long-term effects on incident knee osteoarthritis. Lastly, in 
Chapter 8, particular patterns of long-term change in physical activity during and after 
the intervention were studied, using the same technique as in Chapter 3. Chapter 9 
covers the discussion of the main findings in this thesis and reports on implications for 
clinical practice and future research.
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aBstraCt
introduction
Weight loss interventions have been studied extensively, but methodological limita-
tions negatively affecting applicability in everyday clinical practice are a very common 
problem in these studies. Despite the fact that obesity is treated mostly in a primary 
care setting, studies that investigate weight loss interventions in a primary care setting 
are scarce. Our objective was to assess the effectiveness of a tailor-made weight loss 
intervention in achieving a clinically significant weight loss in overweight (BMI ≥ 27) 
women aged 50 – 60 years in a primary care setting.
methods
As part of a randomized controlled trial on the effects of a tailor-made weight loss inter-
vention and oral glucosamine sulfate on the incidence of osteoarthritis of the knee in 
407 overweight women aged 50 – 60 years, we analyzed the effectiveness of the weight 
loss intervention in achieving clinically relevant weight loss.
results
At baseline, the mean body weight for all participants was 88.7 ± 13.2 kg, and the mean 
BMI was 32.4 ± 4.3 kg/m². At 6 months, the percentage of participants that lost 5 kg or 
5% of their baseline body weight was 11.6% in the intervention group, versus 5.5% in 
the control group (p=0.04). At 6 months, the mean weight gain was 0.9 kg in the control 
group, versus -0.9 kg in the intervention group (p<0.001). At 12 months, the mean 
weight gain was 0.6 kg and -0.6 kg respectively (p=0.01). At 30 months of follow-up, no 
significant differences were found between both groups.
Conclusions
This weight loss intervention, which, at short notice, is easily applicable in everyday 
clinical practice, is effective in achieving clinically significant weight loss in overweight 
women aged 50 – 60 over a 12 month period. Magnitude of the effect is comparable to 
that achieved in many other, more intensive weight loss interventions.
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intrODuCtiOn
Numerous studies have investigated the health benefits of weight loss in obese individu-
als. 1-3  A systematic review of long-term weight loss interventions reported that, besides 
surgical interventions, dietary and lifestyle therapy as well as drug therapy have the 
potential to provide modest weight loss and may improve cardiovascular risk factors.4 
However, drop-out rates were as high as 31-64% and only two of the 44 eligible studies 
presented intention to treat results.1 5 The other 42 studies based their conclusions on 
per protocol results, which lead to overestimation of the effects and hence, makes the 
results less applicable in everyday clinical practice.4 Besides, because of high drop-out 
rates, all other studies based their outcomes only on ‘study-completers’, or used methods 
such as ‘last observation carried forward’ or ‘baseline observation carried forward’ meth-
ods. This may overestimate the total weight loss because study completers may have 
lost more weight than participants who quit the intervention earlier.4 Because of these 
limitations, these studies have shown that particular interventions, when completed, 
have the potential to result in clinical relevant weight loss, but have failed to investigate 
whether an intervention would be applicable in everyday clinical practice.4
In the past year, there have been some trials published reporting on weight loss 
interventions in a primary care setting. A weight loss intervention study by Wadden et 
al.6, for example, included counselling with pharmacotherapy, while the study by Appel 
et al.7 tested an intervention which was delivered by care providers other than primary 
care providers. The latter solely played a supporting role.
The majority of weight loss trials conducted in the last few decades used a pre-defined 
scheme of dieting, exercise or psychological treatment to apply to all participants, re-
gardless of their age, sex, baseline body mass index (BMI), etc.8 However, a systematic 
review reported that the most effective way to promote weight loss in large groups of 
overweight and obese individuals is to offer a ‘tailor-made’ intervention with diet and 
exercise. This could reduce the high drop-out rates.9
Motivational Interviewing, a method of consulting patients based on Self Determi-
nation Theory, claims to be effective especially in promoting long-term weight loss 
maintenance.10 A systematic review clearly stated motivational interviewing as being 
superior in lowering BMI compared to traditional methods of consulting.11
The purpose of the present study was to analyze whether a tailor-made weight loss 
intervention with diet and exercise, based on motivational interviewing, would be effec-
tive in achieving 5 kg or 5% of baseline body weight in a group of overweight women in 
a primary care setting. Several studies found this amount of weight loss to be associated 
with health benefits, including improvement of cardiovascular risk factors and reduced 
risk of incident diabetes and hypertension.1-3 Douketis et al. reported that this amount 
of weight loss improves lipid levels and glycemic and blood pressure control, especially 
22
in people with cardiovascular risk factors.4 Our expectation was that by offering a tailor-
made intervention, instead of dictating the participants on the quantity and quality of 
their diet and exercises, our drop-out rates would be much lower than in comparable 
studies.
methODs
PrOOF study
The intervention we studied was part of a randomized controlled trial that investigated 
the preventive effect of a weight reduction program and oral glucosamine sulfate versus 
placebo on the development of knee osteoarthritis, in a 2x2 factorial design in over-
weight women, called the PROOF Study (ISRCTN 42823086).12 This trial was approved 
by the local Medical Ethical Committee of Erasmus University Rotterdam and all par-
ticipants provided written informed consent. The PROOF Study was open labelled for 
the tailor-made intervention to reduce weight, and double blinded for the intervention 
with crystalline glucosamine sulfate. For the present study, all data was derived from 
the complete dataset of the PROOF Study. Only the data concerning the tailor-made 
intervention to reduce body weight was used.
recruitment
A detailed description of the recruitment and measurements of the PROOF study can be 
found elsewhere12. In short, 50 general practitioners recruited participants, by sending 
an information letter to all women between 50 and 60 years registered at their practice. 
All interested women with a self-reported BMI ≥ 27 received additional information by 
mail. Subsequently these women were checked for inclusion criteria by phone. Inclusion 
criteria were: female gender, age 50 to 60 years, overweight (BMI ≥ 27 ), free of knee 
osteoarthritis according to the ACR criteria13, free of contraindications to MRI, free of 
rheumatic diseases, and not using oral glucosamine during the past six months. There-
after all eligible women were invited to the research center for physical examination 
and X-rays as well as MRI scans of both knees. Exclusion criteria were: already consulted 
a physician, a physical therapist or an alternative health provider for knee pain possibly 
indicating osteoarthritis of the knee, presence of radiologic signs indicating knee osteo-
arthritis (Kellgren-Lawrence index of 2 or more), not being able to communicate in the 
Dutch language, presence of severely disabling co-morbidity. Figure 1 shows the study 
selection process.
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intervention
The PROOF Study conducted a weight loss intervention and an intervention with 
glucosamine versus placebo. Since our study is only concerned with the weight loss 
intervention, the intervention with glucosamine versus placebo will not be described in 
detail here. The relevant intervention consists of an individual tailor-made intervention 
to reduce weight, which has been constructed in cooperation with the Dutch Society of 
Dieticians. As said, literature suggests the focus of any weight loss intervention should 
be on changing food patterns and habits in physical activity. The Health Council of the 
Netherlands also emphasizes the importance of these components.14
To make the intervention easily applicable in everyday clinical practice, all participants 
were given the opportunity to visit a dietician and a physical therapist nearby their 
home address. All dieticians were trained in Motivational Interviewing.11 At baseline, the 
participant discussed nutritional habits and physical activity patterns with a dietician. 
Based on the goal setting theory of Strecher15 and the specific implement technique16, 
they agreed on the intentions. Subsequently, the dietician composed the individual 
tailor-made strategy to accomplish these goals. Primarily, a tailor-made advice was given 
for a low fat or a low calorie diet, or both, as well as for physical activity. During the first 
month the participant had an appointment with the dietician once in every two weeks; 
during the consecutive period the frequency of appointments was determined in dia-
logue by the dietician and the participant. These appointments were used to evaluate 
 
50 general practitioners contacted all women between 50 
and 60 years registered at their practice (6691 women) 
3094 women (46%) returned the reply-
card to the research institute 
1358 women (44%) were 
not interested 
1736 women (56%) were 
interested 
847 women (49%) were 
excluded (reported BMI 
was below 27 kg/m2 
889 women (51%) with 
BMI ≥ 27 kg/m² were send 
additional information 
After screening on all in- and exclusion criteria by phone, 407 
women (46%) were eligible and were invited for baseline 
measurements 
Figure 1 Study selection process
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the plan, and if indicated, to adjust the plan. The total duration of these sessions was 
limited to a total of four hours per year. No limit was set on the total period during which 
they were under treatment.
Besides, the participants in the intervention group were given the opportunity to 
participate in physical activity classes. In these classes (groups of 12-16 persons) they 
tried a broad range of different low-intensive sport activities under the supervision of 
a physical therapist, such as Nordic walking, volleyball, bowling, salsa dancing, tai chi, 
softball, belly dance, modern dance. The aim of these lessons was to regain pleasure in 
physical activity and to find an activity which they could maintain for themselves for 
long-term continuation. Twenty group activities, one lesson of one hour weekly, were 
spread over a period of half a year. Because participants in every group were recruited 
per general practice and lived in the same neighborhood, continuation of activities 
together was stimulated in case they were interested. Both the dietician appointments 
and the physical activity lessons were free of cost to the participants in the intervention 
group.
The participants in the control group did not receive this active (i.e. initiated by the 
research group) intervention to reduce body weight, but were free to undertake any 
actions to lose weight at their own initiative.
Physical examination
At baseline and after two and a half years of follow-up, physical examination was per-
formed at the research center to measure body weight, body height, blood pressure, 
abdominal circumference and skin folds. Fat percentage was calculated using the fol-
lowing formula: body fat percentage = (0.730 * BMI) + (0.548 * triceps skin fold) + (0.270 
* age) – 5.9. According to Lean et al., this is the most reliable method of assessing body 
fat percentage based on simple anthropometric measurements in women.17 Skin folds 
were measured using The Harpenden Skinfold Caliper HSK-BI. BMI was calculated as 
height in meters divided by the body weight in kilograms squared. Additionally, serum 
samples were taken to measure serum HbA1C and total cholesterol.
Questionnaire
At baseline, the participants filled out a questionnaire to record characteristics such 
as smoking status, educational level, co morbidity, menopausal status, quality of life, 
social participation, physical activity level and nutritional habits. Every sixth month the 
participant was visited by the research assistant to fill out a shorter questionnaire to 
determine compliance to the interventions, physical activity level, nutritional habits, 
co-interventions, medical consumption and quality of life. In addition, body weight was 
measured during these visits.
25
1
2
3
4
5
6
7
8
9
10
11
Quality of life was measured using the EQ-5D Euroqol questionnaire, which has been 
thoroughly validated.18 Physical activity level was measured using the validated SQUASH 
questionnaire.19 20 Intensity scores of Ainsworth were used to calculate the activity score 
of the participants.21-23 To calculate the total activity score, each physical activity in Ain-
sworth’s compendium received an intensity score ranging from 1 to 9.19 These intensity 
scores were based on the Metabolic Equivalent Tasks (MET’s), which are the ratios of 
a person’s metabolic rate while performing the activity and their metabolic rate while 
seated and resting.21 22 Total activity scores were calculated by multiplying total minutes 
of activity per week and the intensity score. The sum of all activity scores formed the 
total score.20 Nutritional habits were assessed with a validated questionnaire24, which we 
adjusted to meet our study requirements.
assessment of compliance to the intervention
Dieticians kept record of participant’s body weight and gave them two scores each visit; 
one to indicate to what extent they had reached their set goals concerning physical 
activity, the other to indicate to what extent they had reached their set goals concerning 
nutritional habits.
Physical therapists solely recorded presence of participants during the physical activ-
ity classes.
statistical analyses
Analysis was performed using SPSS PASW statistics version 17.0 (SPSS Inc., Chicago, IL). 
Baseline characteristics were presented using descriptive statistics as mean ± standard 
deviation (SD). Body weight data was presented as mean ± standard error of the mean. 
The primary objective was to assess the number of participants that lost ≥5 kg or 5% of 
their baseline body weight. Secondary objectives were to evaluate differences between 
the intervention and the control group in fat percentage, BMI, quality of life, physical 
activity level and nutritional habits. All results presented are intention-to-treat results.
The relationship between assignment to the intervention group and chance of suc-
cess, which was defined as losing 5 kg or 5% of baseline body weight, was calculated 
using Generalized Estimating Equations (GEE), taking into account the correlation of re-
peated measurements within one participant. This analysis is the most reliable, because 
it does not require imputation and, moreover, it does not take only the completers into 
account, but all measurements of the complete dataset. Furthermore, this analysis is 
widely recommended in literature 25 26. All covariates, which included physical activity 
level, nutritional habits and quality of life, were tested for being mediators of the inter-
vention effect using Sobel’s test.27 28 Also, following the recommendations by Kraemer 
et al.29, all baseline characteristics were tested for being moderators of the intervention 
effect, using the GEE analysis.
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Group differences at set times were analyzed using 2-tailed independent t-tests for 
scale variables, and 2-tailed chi-squared tests for categorical variables. For categorical 
variables, significance was calculated with Fisher’s exact test. For each outcome multiple 
linear or binary logistic regression models were conducted to identify what the inter-
vention effect on each outcome was. Also, logistic regression was used to determine 
which variables were correlated with the primary outcome (≥5 kg or 5% of baseline 
body weight reduction). In all analyses, a 5% significance level for testing was used.
Since data were derived from a RCT on the preventive effects of a diet and exercise 
program on the development of knee osteoarthritis, the corresponding power calcula-
tion was done on incidence figures, rather than on weight loss. In retrospect, we calcu-
lated a power of more than 80% to detect a significant difference between both groups 
in losing ≥5 kg or % of their baseline body weight.
results
Participants
Of the 6691 women who were contacted by their general practitioners, 3094 women 
(46%) returned the reply-card to the research institute, of which 1736 women (56% of 
the repliers) were interested in participating. 847 women (49% of interested women) 
were excluded because calculated BMI, based on reported body weight and height, was 
below 27.0. 889 women (51% of interested women) with BMI of 27.0 or higher were 
sent additional study information. After screening on all inclusion criteria by phone, 407 
women (46%) were eligible and were invited for baseline measurements and random-
ized to either the intervention or the control group. Of these participants, 70% were 
postmenopausal at baseline, 93% were of European or North-American origin. Mean 
age was 55.7 (SD=3.2) and mean baseline BMI was 32.36 (SD=4.29). table 1 shows all 
baseline characteristics. There were no significant differences between the intervention 
group and the control group.
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Participation rates
Since no pre-defined scheme of dieting or exercising was presented, but instead par-
ticipants decided together with the dietician on their diet, exercise pattern and goals, 
the participation rates vary widely. Of the 203 participants randomized to the interven-
tion, 181(89.2%) went at least once to the dietician. 50.8% of the participants had 6 
appointments or more. The mean period between the first and the last visit was 36.3 
table 1 Baseline characteristics1
Control group Intervention group
Age, years 55.7 ± 3.2 55.7 ± 3.2
Body weight, kg 89.2 ± 13.6 88.2 ± 12.9
Body Mass Index, kg/m² 32.5 ± 4.5 32.2 ± 4.1
Fat %2 44 ± 5.5 44 ± 5.1
Abdominal circumference, cm 106 ± 10 105 ± 9
Approximate body weight 1 year ago, kg 87 ± 15 86 ± 15
Approximate body weight around 40th year, kg 76 ± 12 74 ± 14
Smoking status Non smoker 77% 87%
Smoker 23% 13%
Education level Low 35% 32%
Mid-low 45% 51%
Mid-high 17% 16%
High 3% 2%
Co morbidity3 34% 35%
Menopausal status4 Premenopausal 29% 31%
Quality of Life (Dutch Euroqol EQ-5D) .89 ± .13 .89 ± .13
Range: 0-1 16
Social participation5 9.00 ± 2.18 9.10 ± 2.06
Ethnicity European/North American 92.6% 94.2%
South American 1.1% 1.2%
African .6% .6%
Asian 1.1% 1.8%
Other 4.5% 2.3%
SQUASH score17 7094 ± 3817 6525 ± 3608
Blood HbA1C, % 5.8 ± .7 5.8 ± .8
Blood total cholesterol, mmol/L 6.1 ± 1.2 6.0 ± 1.1
[1] All variables except age, weight, BMI, fat percentage, abdominal circumference, blood glucose and cho-
lesterol were self-reported.
2 Fat percentage calculated with formula by Lean et al. 15
3 Co morbidity defined as ≥1 condition currently under treatment.
4 Postmenopausal defined as ≥ 1 year since last menstruation.
5 Social participation defined as hours per week spent on paid/voluntary/household work or studying.
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weeks (SD=31.4). 50.8% of the participant was less than half a year under treatment 
by a dietician, and 22.0% was under treatment for more than a year. Mean weight loss 
from first to last consult recorded by the dieticians was 1.89 kg (SD=3.93). Of these 203 
participants, 79% attended at least one physical activity lesson. 57% of the participants 
attended 7 classes or more. Mean attended lessons were 8 (SD 6).
weight loss
After randomization, body weight was recorded at 6 months for 371 participants (91.1%), 
at 12 months for 368 participants (90.4%) and at 30 months for 361 participants (88.7%). 
At 6 months, mean change (± standard error (SE)) from baseline in body weight was 0.9 
± 0.3 kg in the control group, and -0.9 ± 0.3 kg in the intervention group (p<0.001). At 
12 months, the mean body weight change was 0.6 ± 0.4 in the control group, and -0.6 
± 0.4 in the intervention group (p=0.014). At 18, 24 and at 30 months, there were no 
significant differences between both groups. Figure 2 shows all weight change data.
Primary objective
table 2 shows the percentages of participants who lost body weight or retained their 
baseline body weight, and the percentages of participants who lost ≥5 kg or ≥ 5% of 
their baseline body weight. At 6 months, significantly more people in the intervention 
group lost weight or retained their baseline body weight (58.2% vs. 37.4%, p<0.001) 
and there was a higher percentage of people in the intervention group who lost ≥5 kg 
or ≥ 5% of their baseline body weight (11.6% vs. 5.5%, p=0.042). At 12 months, only the 
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Figure 2 Mean body weight change in kilograms (95% CI) compared to baseline body weight according 
to randomized group.
29
1
2
3
4
5
6
7
8
9
10
11
percentage of participants who lost weight or retained their baseline body weight was 
significantly higher in the intervention group (51.9% vs. 39.2%, p=0.016). No significant 
difference was seen in the percentage of participants who lost ≥5 kg or ≥ 5% of their 
baseline body weight. At 18, 24 and at 30 months, there were no significant differences 
for both outcomes. The overall intervention effect on the primary outcome of losing 
≥5 kg or ≥ 5% of baseline body weight, taking into account all measurements, was not 
significant (OR 1.12, 95% CI 0.70-1.80).
secondary objectives
Secondary objectives were to evaluate differences between the intervention and the 
control group in fat percentage, BMI, quality of life, physical activity level, the percent-
age of participants who measure up to the Dutch Physical Activity Guideline30 and   
nutritional habits.
In the overall study population, fat percentage declined from 43.5% to 42.6% respec-
tively (p<0.001) from baseline to 2.5 years of follow-up. There was no significant differ-
ence between both groups in decline in fat percentage. For BMI, the same pattern is 
found as in body weight change; at 6 months, BMI change in the intervention group was 
-0.3 against 0.3 in the control group (p<0.001) and at 12 months, BMI change was -0.2 
against 0.3, respectively (p=0.007). With binary regression analysis, we have identified 
baseline BMI to be a positive predictor of the chance of losing 5 kg or 5% of baseline 
body weight (OR 1.08; 95% CI 1.02 – 1.15), although no interaction of this effect and 
the intervention effect was found. There were no significant differences between both 
groups in quality of life at any of the time points. At 6 months the change in physical ac-
table 2 Primary objective achievement among randomized groups
Criterion All Intervention group Control group Exact Sig. (2-tailed)
Criterion Intervention vs. 
control group
No. of participants (%)
≤ baseline body weight
6 months 178/371 (48) 110/189 (58) 68/182 (37) <0.001
1 year 168/368 (46) 97/187 (52) 71/181 (39) 0.02
2.5 year 169/361 (47) 95/184 (52) 74/177 (42) 0.07
Lost ≥5 kg or ≥5% of baseline body weight
6 months 40/371 (10.8) 28/189 (14.8) 12/182 (6.3) 0.012
1 year 55/368 (14.9) 35/187 (18.7) 20/181 (11.0) 0.027
2.5 year 63/361 (17.5) 27/184 (14.7) 36/177(20.3) 0.10
Figures presented as number of participants who comply to criterion/total participants at that time (per-
centage of total). Exact significance calculated with Chi-squared tests and Fisher’s exact test.
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tivity compared to baseline, measured with the SQUASH questionnaire, was significantly 
higher in the intervention group. Change of score was 117.3 (1.8% of baseline score) 
in the intervention group against -682.7 (9.6% of baseline score) in the control group 
(p=0.03). The percentage of participants who complied with the Dutch Physical Activity 
Guideline, was higher at 6 months in the intervention group (58.5% against 46.1% in 
the control group, p=0.019); not at 12 and 30 months. Regarding nutritional habits, the 
amount of snacks consumed at 6 months was significantly lower in the intervention 
group. Participants in the intervention group consumed on average 7.0 snacks per week, 
against 8.1 in the control group (p=0.034). The other secondary objective measurements 
at other measurement times in the follow-up showed no significant differences between 
both groups. Change in serum HbA1C and total cholesterol also showed no significant 
difference between both groups. No significant differences were found at 2.5 years of 
follow-up. table 3 summarizes the results of primary and secondary objectives.
None of the covariates were identified as being mediators of the intervention effect. In 
addition, the GEE analysis showed that none of the baseline characteristics were identi-
fied as being moderators of the intervention effect on weight loss. Also, it was found that 
after controlling for various covariates, the odds of losing 5 kg or 5% of baseline weight 
was not affected by any of the covariates, such as age, smoking status, educational level 
or ethnicity.
table 3 Differences between both groups at set times for primary and secondary outcome measures
6 months 12 months 2.5 years
Percentage of participants who lost ≥5 kg or ≥5% of 
baseline body weight
8.5%* 7.7% -5.6%
Body weight change compared to baseline body weight, kg -1.8*** -1.3* -0.5
Change in fat percentage n.m. n.m. 0.2
Change in body mass index, kg/m² -0.1*** -0.2** -0.4
Change in quality of life, Dutch Euroqol EQ-5D n.m. n.m. 0.2%
Change in physical activity, SQUASH-score17 800* 600 392
Percentage  of participants that comply to Dutch 
Guideline28
12%* -2% -0.3%
Snacks eaten per week, no. -1.1* -0.5 -0.2
Figures represent the difference between the intervention group and the control group. Differences which 
were not significantly different from 0 are not shown.  *P<0.05. **P<0.01. ***P<0.001. n.m. not measured
31
1
2
3
4
5
6
7
8
9
10
11
DisCussiOn
In this effectiveness study, a tailor-made intervention to reduce body weight was proven 
to be effective in short term. After 6 months, the percentage of participants who lost 5 
kg or 5% or more of their baseline body weight was twice as large in the intervention 
group compared to the control group. This amount of weight loss has been associated 
with improvement in cardiovascular risk factors by numerous studies.1-4 In addition, 
mean weight loss, reduction in BMI, increase in physical activity and reduction in snacks 
consumed per week was significantly greater in the intervention group at 6 months. 
At 12 months, the difference between both groups in the primary objective slightly 
declined. Still, the weight loss and reduction in BMI were significantly greater in the 
intervention group at this point. The intervention proved to have no long-term effect; 
after 2.5 years of follow-up, no significant differences between both groups were found.
In contrast to other weight loss intervention studies, we did not dictate the partici-
pants how and to what extent they should exercise and diet. Instead, we offered them 
the possibility of attending physical activity lessons and dietician appointments, in or-
der to reach, in dialogue, an individual tailor-made scheme.4 This approach was chosen 
to minimize the drop-out rates, in order to obtain results which are more applicable 
to everyday clinical practice than results from many other weight loss intervention 
studies.4 Our drop-out rates of 9.4% at one year of follow-up and 11.1% at 2.5 years of 
follow-up were considerably lower than the mean drop-out rates of many comparable 
intervention studies.4 It is a very pragmatic approach, much more accessible and easier 
to prescribe to large groups than most weight loss interventions with stricter diet and 
exercise schemes.4 Moreover, this approach was recommended in literature as being 
superior to more traditional methods.9 The inevitable consequence of this method is 
that the duration of the intervention itself, the dietician appointments and physical 
activity lessons, is subject to great variation. In our study, we have seen that only 22% of 
the participants were under treatment by a dietician for more than a year. Furthermore, 
51% of the participants quit seeing a dietician within half a year from baseline. Results in 
primary and secondary objectives reflected this pattern; the largest intervention effect 
is seen at 6 months of follow-up, at 12 months of follow-up there is still a small interven-
tion effect observable, but after this intervention effects are levelled out. Weight loss 
only seems to occur during the intervention, despite the fact this intervention was 
designed to promote long-term weight loss maintenance.
One of the reasons that may have caused underestimation of the intervention effect is 
the fact that in our control group also a substantial amount of weight loss has occurred. 
This could have been caused by the recruiting process. Since the participants were re-
cruited for participation in the PROOF Study, the participants who were randomized to 
the control group had already received information regarding the increased risk of knee 
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arthritis, due to their overweight. This information could have motivated a substantial 
proportion of the people randomized to the control group to lose weight at their own 
initiative. Another explanation as to why weight loss maintenance has occurred in such 
small rates is the limitation imposed on dieting by insurance companies. Just four hours 
per year was reimbursed. Participants who wished to visit the dietician for more than 
four hours in one year, had to pay for this themselves. Also, in this intervention the par-
ticipants were offered a maximum of 20 physical activity lessons, assuming this would 
be enough to stimulate the participants to continue physical activities themselves after 
seizure of the lessons. A final factor that could have contributed to an underestimation 
of the intervention effect is the mean baseline body weight and BMI of our participants. 
We have identified baseline BMI to be a positive predictor of the chance of losing 5 kg or 
5% of baseline body weight. The higher the baseline BMI is, the higher the chance of suc-
cess is, an effect also found in many other studies.31 In comparison to other weight loss 
studies, the baseline BMI and baseline body weight of our participants is relatively low.4
Very few trials were designed to test the effectiveness of weight loss interventions, 
rather than the efficacy.4 The facilities used in the present trial are already available in 
everyday clinical practice. Besides, few trials were conducted in a primary care setting.32 
Moreover, most studies dictated a very restrictive diet and exercise scheme, whereas our 
study let the participants decide on their scheme themselves.4 Nevertheless, the amount 
of weight loss occurred in the first year of follow-up in our pragmatic weight reduction 
intervention was similar to the amount of weight loss achieved in many efficacy studies.4
This trial has several limitations. Firstly, the participants got the opportunity to attend 
only 20 exercise lessons for free. Secondly, due to the inclusion criteria of the PROOF 
study, the results are only applicable to women aged 50-60, without knee complaints. 
Thirdly, the well-established relationship between weight loss and improvement of car-
diovascular risk factors was not confirmed in our study. Literature suggests a follow-up 
time of at least four years to examine any effect on these factors.4 Therefore effects might 
be found, when prolonging follow-up. The fact that both the dietician appointments 
and the physical activity lessons were free of cost to the participants in the intervention 
group could have caused an overestimation of the intervention effect. However, during 
the trial, insurance covered the costs for the dietician appointments, also for the partici-
pants in the control group, in case they decided to visit a dietician on their own initiative.
Since the objective of this study was not to show superiority of our intervention to 
traditional pre-defined interventions, but to assess the effectiveness of the intervention 
in itself, we did not compare our tailor-made weight loss intervention to a traditional 
pre-defined intervention. Therefore, from this study, it cannot be determined whether 
this intervention is more effective in achieving clinically significant weight loss than a 
traditional intervention. Several strengths of this trial are the low drop-out rates, the 
design which makes this intervention easily applicable in everyday clinical practice, the 
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intention-to-treat data, which make a much more valid estimate of the intervention 
effect in everyday clinical practice than per protocol analyses and, finally, our design 
including motivational interviewing as a basis for promoting adherence, as has been 
recommended.9 31
In conclusion, despite the fact that the diet and exercise schemes in our study are 
less restrictive than in most weight loss interventions, our tailor-made intervention to 
reduce body weight is effective to induce clinically significant weight loss in one year 
in an amount which is comparable to that achieved in most other weight loss trials.4 
This effect is not overestimated, since our drop-out rates were relatively low, and we 
conducted an intention-to-treat analysis. Since the facilities for this intervention are 
already accessible and it is easy to prescribe to large groups, this intervention could 
be a realistic option to implement in primary care. In future research, long-term weight 
loss maintenance, which has occurred marginally in our study, might be achieved by 
prolonging the intervention or follow-up time, offering more physical activity lessons 
and dieting consults, and by designing a more representative control group. Also, the 
use of electronically delivered interventions, such as internet and telephone counselling 
could help to increase participation rates.33 Additional studies are needed to provide 
general practitioners with an effective tool to achieve especially long-term weight loss 
maintenance in overweight women.
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aBstraCt
introduction
Weight loss interventions often present small mean weight changes over time, despite 
the fact that a substantial proportion of the participants lost more weight. This effect 
is often leveled out by the substantial proportion of participants who gained weight 
during the trial. The aim of this study is to identify and describe distinct subgroups of 
participants with different weight change trajectories during and after a weight loss 
intervention.
methods
We used data from a weight loss intervention that was part of a randomized controlled 
trial on the preventive effect of a tailor-made weight loss intervention and oral glucos-
amine sulfate on the incidence of osteoarthritis of the knee in 407 overweight women 
aged 50 – 60 years. Latent class growth analysis (LCGA) was used to identify subgroups 
of participant with different weight change trajectories over time.
results
LCGA revealed three latent classes of participants, one large group (n=298) with very 
small weight changes over time close to zero, and two smaller groups (n=48), of which 
one represents participants who steadily gained weight over time, while the other repre-
sents participants who steadily lost weight over time. Participants that had relatively low 
body weight around their 40th year of life, and that gained weight in the year preceding 
the study, were most likely to be assigned to the group that lost weight.
Conclusions
Participants with a low body weight at their 40th year of life, with a high baseline body 
weight, and who gained weight in the year preceding the study, were the most likely to 
be assigned to the subgroup that lost weight. It seems weight loss that occurred during 
this weight loss intervention was mostly recently gained weight.
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intrODuCtiOn
Numerous studies on weight loss interventions have proved efficacy of interventions 
that consist of diet and exercise.1  Longitudinal trajectories of weight data within such 
trials often show high heterogeneity, making the results hard to interpret.
When assessing mean body weight changes, often the overall mean of the study 
population is relatively low1, despite the fact that a substantial proportion of partici-
pants did lose weight. This is often leveled out by the proportion of participants that 
gained weight during the study. As a solution to this problem, studies often present the 
proportion of people who lost 5% of their baseline weight, an amount of weight loss 
which has been associated with clinically significant improvement in cardiovascular risk 
factors, including lipid levels, glycemic and blood pressure control and reduced risk of 
incident diabetes and hypertension.1-4 This way, a distinction is made between partici-
pants who lost a clinically significant amount of weight, and participants who did not 
or even gained weight. However, there is no distinction between participants who re-
mained stable or who gained weight this way, despite the fact this could have important 
clinical consequences. In addition, in many weight loss intervention trials participants 
that lost 5% of their baseline weight at the end of the follow-up period were considered 
to be compliant, regardless of their weight changes preceding the end of the follow-up 
period. This way, participants with widely varying weight changes are not distinguished 
from participants who steadily lost weight during the entire follow-up period.5 6
In a study aiming to identify patterns of weight loss strategies in a sample of 197 women, 
using latent class analysis, Lanza et al. classified participants into four subgroups based 
on self-reported strategies they had used.7 With this approach, variation within groups 
is smaller than between groups.8 This method yields more reliable results than simply 
choosing subgroups based on self-selected parameters, because this methods allows 
for testing the reliability of different models based on objective parameters.8 Literature 
refers to this method as a ‘person-centered’ approach, instead of a ‘variable-centered’ 
approach, which means the focus is on relationships among individuals, instead of how 
variables are related to one another.8
Identifying subgroups of participants with different longitudinal trajectories of body 
weight changes during weight loss interventions would be useful to identify patients 
who are likely to benefit the most from a particular intervention. This way, a tailor-made 
strategy could be offered to overweight and obese patients prone to certain trajectories. 
Therefore, the present study aimed to identify distinct subgroups of participants with 
different longitudinal trajectories of body weight changes during and after a weight re-
duction intervention, using latent class growth analysis (LCGA), and to describe relations 
between participant’s characteristics, compliance to the intervention and subgroup 
assignment.
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methODs
study design and aim
The present study used data from the PROOF Study (ISRCTN 42823086), a randomized 
controlled trial that investigated in a 2x2 factorial design the preventive effect of a 
weight reduction program and oral glucosamine sulfate versus placebo on the develop-
ment of knee osteoarthritis in 407 overweight women.9 For this study, only the weight 
change data were used, the data regarding knee osteoarthritis were disregarded. The 
follow-up time was 2.5 years; participants’ body weight was recorded every 6 months. 
Because the aim of the present study is solely to identify distinct subgroups of a 
population, undergoing a weight loss intervention, and to describe them, details on 
the aforementioned study will not be presented here. Obviously, these are published 
elsewhere.9 10 To describe the different subgroups, we tested for significant differences 
between the subgroups in baseline characteristics, as measured in the PROOF Study. 
Also, we determined the intervention effect on the outcome of assignment to one of the 
subgroups. Finally, we tested whether baseline characteristics or certain aspects of the 
intervention had an effect on the outcome, assignment to one of the subgroups.
statistical analyses
To identify distinct subgroups of participants with different longitudinal trajectories, 
latent class growth analysis (LCGA) was used. This analysis is capable to identify ho-
mogeneous subgroups in a larger heterogeneous population.8 11   As recommended in 
literature, several indices of how well the fit of the model was, were used: the Bayesian 
Information Criterion (BIC), the Vuong-Lo-Mendell-Rubin Likelihood Ratio Test (LRT) 
and entropy indices.8 12 Improvements of fit of the models were assessed for two to six 
trajectory classes. Each model was tested with linear, quadratic and cubic trajectories. 
In addition to the fit of the model, the usefulness of the latent classes was assessed. 
Especially, the shape of the trajectories of the different latent classes and the number of 
participants in each class were evaluated in order to identify the most optimal model.12
Characteristics of participants and body weight data in each latent class were 
presented as means ± standard deviation (SD). Analysis of variance was used to test 
whether significant differences existed between the groups. Bonferroni and Fisher’s 
least significant difference post hoc tests were used to reveal between which particular 
groups significant differences existed. The intervention effect on the probability of 
assignment to one of the latent classes was determined using univariate multinomial 
regression analysis. Multivariate multinomial regression analysis was used first to test 
the effect of the baseline characteristics of the participants on the primary outcome, 
that is, probability of assignment to one of the latent classes, and second to test the 
effect of characteristics of the intervention, that is, the period of time they were under 
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treatment by the dietician and the amount of goals they met, on the outcome. In the 
first regression analysis, we adjusted for the intervention effect, as determined in the 
univariate multinomial regression analysis mentioned previously, because the aim was 
to determine the effect of the baseline characteristics in itself. In addition, we tested if 
any of the baseline characteristics showed a significant interaction with the intervention 
effect, using multivariate multinomial regression analysis, to identify success factors that 
increased the odds to benefit from the intervention. The second analysis solely included 
participants that were assigned to the intervention group, because the aim here was to 
determine the effect of certain aspects of the intervention.
Mplus version 6.12 (sixth edition; Muthén and Muthén, Los Angeles, CA, USA) (1998-
2010) was used for the LCGA. SPSS PASW statistics version 17.0 (SPSS Inc., Chicago, IL, 
USA) was used for description of characteristics, testing differences and multinomial 
regression analyses. A significance level of 0.05 was used in all analyses.
results
three group linear model
After evaluating the BIC, LRT, and entropy scores of the models, two models showed the 
best fit. The first model was a three-group linear model; the second one was a five-group 
quadratic model. The BIC value of the latter was lower (10,550.628 vs. 10,260.052), and 
the LRT was more significant (P = 0.09 vs. P = 0.003), which represents a better fit. In 
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Fig. 1. Mean weight changes during and after the weight loss intervention. Figures presented as mean 
body weight in kilograms and error bars present 95% confidence intervals. CI, confidence interval.
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addition, entropy indices showed the five-group model to be the most reliable (0.897 vs. 
0.875). However, in the five-group model, two groups consisted each of 10 participants. 
These two groups had very similar weight change trajectories over time. Our goal was 
to determine subgroups with different weight change trajectories over time. Therefore, 
the three-group linear model, which yielded three distinguishable groups, was chosen 
as the most optimal model. For all participants, the probability of belonging to their sub-
group was 88% or higher, suggesting the allocation of the majority of the participants 
was done correctly. Figure 1 shows the mean weight change trajectories of the three 
subgroups.
The largest subgroup (n = 298, 73.2%) represented participants who were classified as 
‘‘steadies’’ because their weight changes were minimal (0.6 ± 3.4 kg over 30 months) and 
the slope of this trajectory was close to zero. Participants in the second class (n = 48, 
11.8%) were classified as ‘‘gainers’’ because their weight changes were mostly positive 
(7.2 = 4.1 kg over 30 months) and the slope of this trajectory was positive. Participants 
in the third class (n = 48, 11.8%) were classified as ‘‘losers’’ because their weight changes 
were mostly negative (-7.7 ± 6.3 kg over 30 months) and the slope of this trajectory 
was negative. The three groups were significantly different from each other, regarding 
weight change data on 6, 12, 18, 24, and 30 months, on a significance level of P < 0.001.
The intervention effect is estimated by the odds ratio (OR) of 0.4 (95% CI: 0.2, 0.7) for 
becoming a ‘‘gainer’’ over a ‘‘steady’’. This OR represents that participants in the interven-
tion group, compared with participants in the control group, were less likely to become 
a ‘‘gainer’’ than to become a ‘‘steady’’. The OR for becoming a ‘‘loser’’ against becoming a 
‘‘steady’’ was 1.2 (95% CI: 0.7, 2.3) for the intervention group compared with the control 
group. These results are not shown in tables.
Baseline characteristics
The first multivariate multinomial regression analysis (table 1) showed that participants 
with a high baseline body weight were significantly more likely to become a ‘‘loser’’ than 
to become a ‘‘steady’’. In addition, there is a trend (P 5 0.07) that participants who gained 
more weight in the year preceding baseline measurements, are more likely to become 
a ‘‘loser’’ than to become a ‘‘steady’’. Also, the participants who gained more weight in 
the year preceding baseline measurements were significantly less likely to become a 
‘‘gainer’’ than to become a ‘‘steady’’. Participants that had a high reported body weight 
around their 40th year of age were significantly less likely to become a ‘‘loser’’ than of 
becoming a ‘‘steady’’. There were no significant differences found between the three 
groups in the remaining baseline characteristics, such as age, ethnicity, and educational 
level. Therefore, we did not adjust for these characteristics. No interactions of any of the 
baseline characteristics and the intervention effect were found.
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intervention characteristics
The second multivariate multinomial regression showed that participants who were 
under treatment by a dietician for a longer period of time were significantly more likely 
to become a ‘‘loser’’ than to become a ‘‘steady’’. In addition, participants who met more of 
their goals set by their dietician were significantly more likely to become a ‘‘loser’’ than to 
become a ‘‘steady’’. table 2 shows the ORs acquired with this analysis.
DisCussiOn
In this study we classified 407 overweight women who entered a weight reduction 
trial into three different subgroups based on their weight changes during and after the 
weight reduction intervention, using an objective method of classifying participants into 
a number of groups. LCGA revealed three distinct subgroups of individuals. We found 
that most participants remained relatively stable over time, and there were two smaller 
groups of which one represented participants who steadily gained weight over time, 
while the other represented participants who steadily lost weight over time. Addition-
ally, we found a significant intervention effect lowering the odds of becoming “a gainer”, 
when assigned to the intervention group. When controlling for the intervention effect, 
participants with higher baseline weight and with a lower body weight around their 40th 
year of age were more likely to become “a loser” than to become “a steady”. In addition, 
there is a trend (p=0.07) that participants who gained more weight in the year preceding 
table 1 Odds ratios from multinomial regression analysis for effects of baseline characteristics on latent 
class membership, “steadies” was used as reference class. Adjustment for the intervention effect was ap-
plied.
Losers Gainers
Or 95 % Ci Or 95 % Ci
Baseline weight, kg 1.06 1.02-1.09 1.00 0.96-1.04
Weight change in year preceding baseline, kg 1.06 1.00-1.13 0.90 0.85-0.95
Reported body weight around 40th year, kg 0.96 0.92-1.00 1.00 0.96-1.04
table 2 Odds ratios from multinomial regression analysis for effects of intervention characteristics on la-
tent class membership, “steadies” is used as reference class.
Losers Gainers
Or 95 % Ci Or 95 % Ci
Period under treatment, months 1.06 1.01-1.12 0.90 0.79-1.04
Percentage of achieved goals in dietician’s 
treatment, scale 0-100%
1.02 1.01-1.04 0.99 0.97-1.01
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baseline measurements, are more likely to become “a loser” than to become “a steady”. 
These participants, who gained weight in the year preceding baseline measurements, 
were less likely to become “a gainer” than to become “a steady”. Most ORs are very close 
to 1.0. This is a consequence of the independent variables in the model, being linear. 
This means the OR of, for instance, baseline weight in Table 2 represents the change in 
odds of a 1-kg increase in baseline weight.
In short, the participants who had low body weight around their 40th year of age, 
who gained weight in the year preceding baseline measurements, and who had a high 
baseline weight were most likely to become “losers”. It therefore seems to be that the 
weight loss recorded during the trial mostly is recently gained weight. In future research, 
the developments of body weight changes in the years preceding the study should be 
better assessed, to correctly understand the interaction between these developments 
and the intervention effect, instead of simply asking participants whether they are cur-
rently on a diet or not, which is customary in weight loss trials.6
To our knowledge, this is the first study to apply latent class analysis to weight data 
from a weight loss intervention trial. One previous study investigated latent classes 
of weight loss strategies among women, but based their subgroups on strategies the 
participants used.7 We based our subgroups on the actual weight changes in reaction 
to the intervention, to identify subgroups of patients who are likely to benefit from 
an intervention such as described in this study. When a general practitioner would 
have a guideline of which intervention is likely to be effective in which subgroups of 
patients, a tailor-made advice could be given to each patient after assessing a number of 
characteristics. In this study, we solely found predictors of success, independent of the 
intervention effect. No interactions of predictors and the intervention effect were found.
This study solely evaluates the effect of a weight loss intervention on weight changes. 
In addition, subgroups of people that change their nutritional habits or that change 
their physical activity patterns would be useful too, because either one of these can be 
a specific goal. Therefore, in addition to the analysis done in the present study, LCGA 
should be used to recognize patterns in change in nutritional habits or physical activity 
as well.
In conclusion, LCGA is a useful approach to assess weight loss data in weight loss inter-
vention trials, because it makes it possible to identify patients who are likely to benefit 
from a particular intervention. In this study, we identified three distinct subgroups of 
participants with different weight change trajectories during and after a weight loss 
intervention. Using this model, we found out that a certain amount of the weight loss 
that occurred during this weight loss intervention was in fact recently put on weight. 
Success factors that increased the probability to benefit from the intervention were not 
found, but predictors of success, independent of the intervention effect, were identified. 
More studies are needed to externally validate these findings.
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aBstraCt
Objective
The present study evaluated the effect of a moderate amount of weight loss on the 
incidence of knee osteoarthritis (OA) in middle-aged, overweight and obese women, 
without clinical and radiological knee OA at baseline.
methods
A total of 353 women (87%) with follow-up data available were selected from the PROOF 
study (ISRCTN 42823086), which evaluated the preventive effect of a diet and exercise 
intervention and of oral glucosamine sulfate on the incidence of knee osteoarthritis. As 
an exploratory proof of concept analysis, incidence of knee OA was compared between 
women who reached the clinically relevant weight loss (WL) target of 5 kg or 5% of body 
weight after 30 months and those who did not reach this target (N-WL).
results
The WL group showed a significantly lower incidence of knee OA according to the pri-
mary outcome measure, composed of knee OA according to ACR criteria (clinical and 
radiographic), K&L grades and joint space narrowing ≥ 1.0 mm (15% vs. 20%; OR 0.5, 95% 
CI 0.3 – 0.9). Moreover, the weight loss also positively affected several health measures, 
such as blood glucose level, fat percentage and blood pressure.
Conclusion
A reduction ≥ 5 kg or 5% of body weight over a 30 month period reduces the risk for the 
onset of radiographic knee OA in middle-aged, overweight and obese women. Due to 
the slow progression of the disease, a longer follow-up period will be necessary before 
the number of prevented cases of knee OA by moderate weight loss becomes clinically 
more relevant.
significance and innovations
For the first time, the preventive effect of a moderate amount of weight loss (5 kg or 5% 
of body weight) on incident knee osteoarthritis has been studied.
This study serves as a proof of concept that a moderate amount of weight loss can, in 
fact, prevent incident knee osteoarthritis in a high-risk population of overweight and 
obese women.
This paper contributes to preventive studies in osteoarthritis, which are lacking, espe-
cially in a primary care setting.
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intrODuCtiOn
The worldwide prevalence of obesity nearly doubled between 1980 and 2008 1. Accord-
ing to the most recent estimations by the World Health Organization, 35% of all adults 
are overweight (BMI ≥ 25 kg/m2) and more than 12% is obese (BMI ≥ 30 kg/m2) 1. A high 
BMI is a strong risk factor for the onset of knee osteoarthritis (OA) 2-4 and has been associ-
ated with the incidence of both clinical 5-7 and structural features 8-13 of knee OA. Given 
the high medical costs, productivity costs, morbidity and disability associated with knee 
OA, there is an increasing need for preventive measures.14
In trials among subjects with and without established knee OA, weight loss was shown 
to have advantageous structure modifying, systemic and clinical effects 15-21. In a system-
atic review on the effects of weight loss on knee OA patients, a weight loss of at least 
5% body weight was indicated for symptomatic relief 22. Losing 5 kg or 5% body weight 
has also been indicated as minimal weight loss for a positive and clinically relevant ef-
fect on the cardiovascular risk profile, including significant reduction of blood pressure 
and improved glucose tolerance 23. In subjects without knee OA but with overweight or 
obesity, and hence at high risk for developing knee OA, the preventive effect of such a 
clinically relevant weight reduction has never been studied. In the Framingham Study it 
has been estimated that moderate weight loss (± 5 kg) could reduce the onset of knee 
OA in overweight and obese subjects 24 25.
Recently, the first preventive trial in OA research, the PROOF study (PRevention of 
knee Osteoarthritis in Overweight Females)26, was undertaken. In this randomized clini-
cal trial among middle-aged women with a BMI ≥ 27 kg/m2 without knee OA at baseline, 
the effects of a diet and exercise program on incidence of knee OA over 2.5 years was 
studied. The diet and exercise program did show favorable effects on body weight fig-
ures in the intervention group during the first year of the intervention and indications 
of a preventive effect among subjects compliant to the intervention were found26. The 
objective of the diet and exercise intervention was a structural weight reduction of 5 kg 
or 5% of baseline body weight.
The primary objective of the present study is to evaluate the effects of a clinically rel-
evant reduction in body weight (≥ 5 kg or 5%), irrespective of the original interventions, 
on the incidence of clinical and radiological knee OA after 2.5 years in middle-aged 
overweight and obese women.
Patients anD methODs
For this study we used data from the PROOF study (ISRCTN 42823086). A full descrip-
tion of the study protocol can be found elsewhere26.   In short, this 2.5 year follow-up 
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study aimed to evaluate the preventive effect of a diet and exercise program and oral 
glucosamine sulfate (double-blind, placebo controlled) on the onset of knee OA in a 
2x2 factorial design. Study protocol was approved by the Medical Ethical Committee of 
Erasmus MC. This manuscript was prepared according to the STROBE statement.27 For 
the present study, the predefined hypothesis was tested, stating that losing 5 kg or 5% 
of baseline body weight had a preventive effect on knee OA.
Fifty general practitioners in the area of Rotterdam, the Netherlands, contacted all 
women aged between 50 and 60 years registered at their practice. All women that 
returned the reply-card, reported a BMI ≥ 27 kg/m2, and were interested in participation, 
were sent additional information. One week later, inclusion criteria were screened by 
phone. Inclusion criteria were: age between 50 and 60 years, BMI ≥ 27 kg/m2, free of ACR 
criteria 28, no contra-indications for MRI, no rheumatic diseases, not using a walking aid, 
not under treatment for knee complaints, mastering the Dutch language, and not using 
oral glucosamine during the past 6 months. Here, ACR criteria concerned the clinical cri-
teria only, since screening at this stage was done by phone. All other references to ACR 
criteria in the present paper refer to those measured with clinical and radiographic data. 
All women eligible and willing to participate were invited to visit the research institute 
for informed consent procedure and baseline measurements. The period of recruitment 
ran from July 2006 until May 2009.
At baseline, body weight and height, waist circumference, and blood pressure 
were measured. Skin folds of the triceps were measured and used to calculate fat 
percentage using the formula by Lean et al 29, that was defined as the most reliable 
method based on simple anthropometric measurements in women (fat percentage = 
[0.73xBMI]+[0.548*triceps skin fold]+[0.27xage]-5.9). A blood sample was taken to as-
sess total blood cholesterol and HbA1c concentration and Heberden’s nodes on both 
hands were assessed. A standardized semi-flexed PA radiograph of both knees was taken 
according to the MTP protocol 30. All subjects filled in a questionnaire that included 
questions on knee complaints, number of days with knee pain, past knee injuries, and 
postmenopausal status. Knee complaints were defined as having any knee pain in the 
past 12 months. All measurements were repeated after 2.5 years of follow-up.
All tibiofemoral compartments of all knees were scored for knee OA by a researcher 
blinded for clinical outcomes (baseline and follow-up images at once with known se-
quence), using Kellgren & Lawrence (K&L) criteria 31 (kappa 0.6). Also, alignment of the 
knee was assessed and varus alignment was defined as having an angle of less than 178 
degrees on the baseline radiograph. Minimal joint space width (intraclass correlation 
0.67-0.76) was measured digitally on each radiograph in each tibiofemoral compart-
ment by two blinded researchers independently, according to the method of Lequesne 
32. Scores with a difference between both readers ≥ 2.0 mm were re-evaluated by both 
readers at a consensus meeting. Joint space narrowing (JSN) was calculated for each 
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tibiofemoral compartment by subtracting the mean score of both assessors at baseline 
from the mean score at follow-up.
For the analyses, all subjects with the primary outcome measure and follow-up data 
on body weight available were selected. Baseline characteristics were tested for signifi-
cant difference between WL and N-WL group using independent t-test (linear measures) 
and Chi2 test (dichotomous measures). Using Generalized Estimating Equations (GEE), 
which takes into account the association between knees within subjects, incidence of 
knee OA in subjects that reached the weight loss (WL) target of 5 kg or 5% body weight 
reduction at 2.5 years was compared to subjects that did not fulfil the target (N-WL). 
The predefined primary outcome measure was the incidence of knee OA, defined as 
incidence of either K&L ≥ 2 or ACR criteria (clinical + radiographic) or JSN ≥1.0 mm in 
the medial or lateral tibiofemoral compartment. A JSN of 1.0 mm was chosen as cut-off 
point, because the population concerned is a population without knee OA and there-
fore, with healthy cartilage thickness. We hypothesized that less than 1.0 mm would be 
of questionable clinical interest in this population. Since initial screening was done by 
phone, we anticipated a proportion of participants would meet the criteria of one of 
the components of the primary outcome measure at baseline. These participants would 
be included in the analysis, defining development of knee OA during the follow-up 
period as meeting the criteria of one of the other components of the primary outcome 
measure. As a sensitivity analysis, we also analyzed differences between WL and N-WL 
for the separate items of the primary outcome measure. For these analyses, participants 
that met criteria of that specific outcome measure at baseline, were excluded. All GEE 
analyses were adjusted for the randomized groups of the initial PROOF study and their 
interaction, K&L grade at baseline (0 vs. ≥ 1) ; since it was shown to be related to the 
incidence of knee OA26, and those factors that were significantly different between WL 
and N-WL groups at baseline. Results from these analyses were presented in odds ratios 
(ORs) with 95% confidence intervals (CI). Baseline differences between WL and N-WL 
groups were tested using Student’s t-tests for continuous variables and Pearson Chi-
square test for categorical variables. To evaluate the magnitude of the changes in clinical 
outcomes after a weight reduction of 5 kg or 5% body weight, changes over the 2.5 year 
follow-up period on total cholesterol, HbA1c level, fat percentage, waist circumference 
and blood pressure between WL and N-WL were assessed using Student’s t-tests. All 
statistical analyses were performed using performed using SPSS 20.0 (Chicago, IL) with 
a p-value < 0.05 regarded as statistically significant.
52
results
After 2.5 years, the primary outcome measure and follow-up data on body weight was 
available for 353 women (87 %). The reasons the remaining 54 participants were lost to 
follow up were as follows: one was unattainable, one had no radiograph at baseline, 9 
had no radiograph at follow-up, 38 were unwilling and dropped-out during follow-up, 
2 dropped-out due to side effects of the glucosamine, one had no questionnaire data 
at follow-up, two died during the course of the study. The participants that were lost 
to follow up had a slightly lower BMI (32.3 ± 4.1 vs. 33.1 ± 5.0) and more often had a 
history of knee injury (14 % vs. 6%). Both of these differences were significant differences 
(p<0.05). The other variables showed no significant differences between the participants 
that were lost to follow up and those that completed the study. From these women, 61 
subjects (17%) fulfilled the weight loss target of 5 kg or 5% body weight. This group was 
defined as the ‘weight loss group’, which we compared to the other 292 participants, 
called the ‘non weight loss group’. Baseline characteristics of both groups are presented 
in table 1.
As expected, there was a proportion of participants with knee OA at baseline, due to the 
initial screening by phone. 3.9% of the participants met ACR criteria at baseline and 6.6% 
had K&L grade 2 or higher. As described in the methods section, these participants were 
not excluded from the analysis. However, as a sensitivity analyses, these participants 
table 1. Baseline characteristics (mean ± st.dev.).
Non weight loss group Weight loss group p-values
N – subjects 292 61
Age (yr) 55.8 ± 3.2 55.5 ± 3.2 0.42
BMI (kg/m2) 32.0 ± 4.1 33.4 ± 4.3 <0.01
Postmenopausal status (yes) 69% 73% 0.33
Heberden’s nodes (in ≥ 1 finger) 28% 25% 0.58
N – knees 584 122
K&L grade 0 52% 43% 0.11
K&L grade ≥ 1 48% 57%
History of knee injury (yes) 12% 21% 0.01
Knee OA symptoms* (yes) 31% 33% 0.75
Varus alignment** (yes) 39% 43% 0.36
* Knee OA symptoms defined as having knee pain in the last 12 months.
** Varus alignment of the knee defined as an angle of less than 178 degrees on the baseline radiograph.
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were excluded from the analyses with the separate components of the primary outcome 
measure as outcome measure.
At baseline, the mean BMI (p = 0.01) and the number of knees with an injury in the 
past (p = 0.01) were significantly higher in the WL group. Hence, the analyses were ad-
ditionally adjusted for these variables. The weight change in the WL group over the 2.5 
years of follow-up was -9.9 ± 5.7 kg on average, ranging from -4.2 kg to -24.7 kg. In the 
N-WL group, subjects gained 1.8 ± 4.0 kg on average, ranging from -4.8 to +21.2 kg. 
Mean change in BMI was -3.6 kg/m2 in the WL group and +0.7 kg/m2 in the N-WL group.
Incidence figures of knee OA according to the primary outcome and the separate 
items and corresponding ORs for the WL group relative to the N-WL group are presented 
in table 2. Incidence according to the primary outcome measure was 20% in N-WL and 
15% in the WL group (OR 0.50; 95% CI 0.27 – 0.93). Also the difference in incidence of K& 
L ≥ 2 between N-WL (6%) and the WL-group (3%) showed to be statistically significant 
(OR 0.28; 95% CI 0.08 – 0.90). The other outcome measures showed no significant differ-
ence between both groups.
Subjects in the WL group had a significant reduction of HbA1c level (-1.4 vs 0.4 mmol/
mol, P=0.03), fat percentage (-4.7 vs -0.1%, P<0.01), waist circumference (-7.3 vs 1.5 cm, 
table 2. Incidence of knee OA for weight loss and non-weight loss groups.
Outcome Group Incidence Adjusted Odds Ratio**
(95% CI)
Knee OA* WL group 18/122 (15%) (0.27-0.93)
(primary outcome 
measure)
WL group 18/122 (15%) (0.27-0.93)
N-WL group 117/584 (20%) 1
K&L ≥ 2 WL group 3/118 (3%) 0.27 (0.08-0.90)
N-WL group 33/545 (6 %) 1
ACR criteria WL group 6/122 (5%) 0.34
(0.09-1.32)
N-WL group 41/584 (7 %) 1
Medial JSN WL group 6/122 (5%) 0.65
(0.26-1.67)
N-WL group 34/583 (6%) 1
Lateral JSN WL group 7/122 (6%) 0.74
(0.32-1.70)
N-WL group 40/583 (7%) 1
WL group: weight loss group (≥5 kg or 5% weight loss). N-WL group: non weight loss group (<5 kg or 5% 
weight loss). K&L: Kellgren & Lawrence criteria. JSN: joint space narrowing (≥1.0 mm). *Defined as incidence 
of K&L ≥ 2 or the ACR criteria(clinical and radiographic) or JSN ≥1.0 mm. **Analyses adjusted for random-
ized groups of PROOF study and their interaction, K&L grade and BMI at baseline, and past injury. N-WL 
group served as reference group.
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P<0.01) and systolic (-5.3 vs 0.2 mmHg, P=0.04) and diastolic (-7.9 vs -2.8 mmHg, P<0.01) 
blood pressure over the 2.5 year follow-up compared to subjects in the N-WL group.
DisCussiOn
For the first time, the preventive effect of moderate weight reduction on incident knee 
OA in a high risk group of middle-aged women with a BMI ≥ 27 kg/m2 has been studied. 
Previously, one study reported a preventive effect of weight loss on cartilage thickness 
of the knee18. However, this was an observational study without validated clinical or 
radiological osteoarthritis outcomes, making the results less applicable in clinical 
practice. Recently, a study reported on the preventive effect of an intensive diet and 
exercise program on knee pain and showed evidence of a preventive effect of a weight 
loss intervention on knee pain.33 However, knee OA figures were not presented, since no 
radiographs were taken.  Moreover, the present study reports on an effect of moderate 
weight loss, which makes it more applicable in primary care.
The intention to treat analysis of the original PROOF study showed no significant main 
effects of the diet-and-exercise program or the glucosamine vs placebo intervention on 
incidence of knee osteoarthritis over 2.5 years. The present study, as a proof of concept, 
shows that a clinically relevant weight reduction of 5 kg or 5% body weight or more 
leads to significantly less incident cases of knee OA in overweight and obese women.
The PROOF study used a combined outcome measure of radiographic and clinical 
knee OA features in order to make a preventive randomized trial feasible over a relative 
short follow-up time26. In the N-WL group, 6% of all knees had incident radiographic 
knee OA (K&L ≥ 2) over the follow-up period. This annual incidence of 2,4% is at the 
high end of the range found in population based cohorts using the same criterion, such 
as the Framingham Study (2% in women) 34, the Rotterdam Study (1.4% in men and 
women with a BMI > 27.5 kg/m2), the Chingford Women’s Study (2,3% in women aged 
45-64) 35, and the Road Study (3,6% in women aged 50-59) 36. Only the latter reported 
higher incidence numbers than in our study, but these were calculated on a subject level 
rather than knee level. On a subject level, an annual incidence of 4% was found in the 
N-WL group. Incidence of clinical knee OA (clinical + radiographic) found in the present 
study (2.8% in N-WL group) was higher than numbers reported in other studies (1% in 
women of the Framingham Study 34 and 0.3% in middle-aged women 37). This might be 
explained by the fact that our study was conducted in overweight and obese subjects, 
who are at higher risk for the onset of knee OA than normal weight individuals 2 3.
There is an obvious overlap between incidence of JSN and incidence of K&L ≥ 2, given 
the fact that JSN is part of the definition of K&L ≥ 2. Nevertheless, we did not find a similar 
association between weight loss and incident JSN like we found for the incidence of K&L 
55
1
2
3
4
5
6
7
8
9
10
11
≥ 2. In addition to JSN, K&L ≥ 2 requires definite osteophytes in the tibiofemoral joint. 
Previously, surplus fat mass has been linked to osteophyte formation, possibly through 
circulating leptin levels 38. Since circulating leptin level decrease after weight loss 38, it 
could be supposed that a clinically relevant weight loss would lead to less osteophyte 
formation. Less osteophyte formation could explain why we did find an effect of weight 
loss on incidence of K&L ≥ 2, which was not found for JSN.
At baseline, the WL group had a significantly higher BMI and reported a higher num-
ber of knees with a history of knee injury. The first was to be expected since a high 
BMI is a predictor for greater weight loss 39 40. Probably, the higher prevalence of knees 
with a history of injury in the WL group was also linked through BMI; baseline BMI was 
significantly higher in subjects with a previously injured knee than in subjects without 
and a history of injury showed to have a non-significant effect on all outcome measures 
when adjusted for BMI at baseline (data not shown). Perhaps the former injury led to a 
less active lifestyle and hence, a higher body weight.
Besides effects on the onset of knee OA, moderate weight loss also positively affected 
several health measures, such as blood glucose level, fat percentage, waist circumfer-
ence and blood pressure. Positive alterations in these features have been linked to lower 
risk of diabetes mellitus type 2, cardiovascular morbidity and mortality 41. However, the 
magnitude of the changes found was not high enough to reduce the 10-year risk of 
fatal cardiovascular disease 41. Maintenance of the body weight in the WL group over 
a prolonged period will possibly lead to greater reductions in these health measures. 
Other limitations of this study include the observational design, making the results less 
applicable in clinical practice, since the intervention effect of the original randomized 
controlled trial was adjusted for in the analyses, making this article a ‘proof of concept’. 
In addition, a limitation of this study is that solely an association is found between sig-
nificant weight loss and the development of knee OA. This does not necessarily mean 
a causal relation between these two variables exists. Confounding factors could distort 
this association. For example, a secondary analysis on data derived from the PROOF 
study, showed, among other things, that participants with a relatively low body weight 
around their fortieth life year, were more likely to lose weight during the study.42 This 
could mean that the group that lost 5 kg or 5% of their body weight is, in fact, a group of 
participants with an overall healthier lifestyle, which could account for the better health 
outcomes. However, the changes in health outcomes were measured during the period 
in which the participants lost weight. It is not expected that their blood pressure and 
HbA1c would lower spontaneously.
In conclusion, a reduction of ≥ 5 kg or 5% of body weight over a 30 month period is 
associated with a reduced risk for the onset of (radiographic) knee OA in middle-aged, 
overweight and obese women. Also, several health measures were positively altered af-
ter this moderate weight loss. Due to the slow progress of the disease, a longer follow-up 
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period will be necessary before the number of prevented cases of knee OA by moderate 
weight loss becomes clinically relevant.
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aBstraCt
Objective
To evaluate the effects of weight change on progression of magnetic resonance imag-
ing (MRI) features of knee osteoarthritis (OA) in overweight and obese women without 
clinical and radiographic knee OA.
methods
Women with available outcome (83%) were selected from the PROOF study (ISRCTN 
42823086) and classified with latent class growth analysis into a group with steady 
weight (n = 254), a group that gained weight (n = 38) and a group that lost weight 
(n = 44) over 2.5 years follow-up. Baseline and follow-up MRIs were scored with MRI 
Osteoarthritis Knee Score (MOAKS) to assess progression of bone marrow lesions 
(BMLs), cartilage defects, osteophytes, meniscal abnormalities and meniscal extrusion 
in the tibiofemoral and patellofemoral joint. Associations between weight change and 
MRI progression were performed on knee level using adjusted Generalized Estimating 
Equations.
results
640 knees from 336 women with mean age 55.7±3.2 years and mean BMI 32.3±4.1 
kg/m2 were analyzed. Baseline prevalence ranged from 11% for osteophytes to 65% for 
meniscal abnormalities. Progression ranged from 6% for osteophytes to 27% for menis-
cal abnormalities and 30% for cartilage defects. Despite a mean weight reduction of 9.0 
± 7.2kg in the weight loss group and an 8.2 ± 3.6kg increase in the weight gain group, 
there were no significant effects of the weight change subgroups on the progression of 
MOAKS features.
Conclusion
In overweight and obese middle-aged women without knee OA, prevalence of MOAKS 
features was high. Neither weight loss nor weight gain did affect progression of the 
features over 2.5 years.
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intrODuCtiOn
The epidemic of obesity is one of the most important health problems worldwide1. As 
described by the World Health Organization, the global prevalence of obesity has nearly 
doubled since 1980. In 2014, 11% of men and 15% of women aged 18 years and older 
were classified as obese (BMI ≥ 30 kg/m2) and 39% of adults as overweighed (BMI ≥ 
25 kg/m2 )2. They are established risk factors for incident clinical and radiographic knee 
osteoarthritis (OA)3-5 and there is evidence that BMI is associated with progression of 
clinical knee OA6. High prevalence of knee OA has important negative health, social and 
economic consequences7. As important modifiable risk factors for knee OA, overweight 
and obesity are key targets in knee OA management and prevention8.
As the symptomatic treatment of first choice, weight reduction can reduce pain and 
physical disability in overweight persons with knee OA9, but beneficial effects on struc-
tural OA have not been identified10-13. It is important to know whether instead weight 
loss as a preventive measurement in overweighed subjects without knee OA has benefi-
cial effects on articular structures. Evidence from existing studies is limited and studies 
have evaluated in particular cartilage or its biochemical composition14 15. The effects of 
substantial weight loss in high-risk populations on other OA MRI features, such as bone 
marrow lesions (BMLs), osteophytes and meniscal damages, have not been assessed yet.
A common method to assess weight loss is the percentage weight change over time 
relative to baseline. Weight loss of ≥ 10% is recommended to use in OA research, in 
order to provide significant pain reductions16. A disadvantage of this is that subjects 
with fluctuations in BMI during follow-up are not distinguished from those with steady 
weight loss. Subjects could have lost 10% of their baseline weight at the end of follow-
up, regardless of weight changes preceding this period. A summary measure which 
takes into account weight changes over time would be more appropriate. Latent Class 
Growth Analysis (LCGA) can provide such a summary measure with the use of objective 
parameters to classify participants in subgroups17. Recently, this method successfully 
identified three latent classes of participants within the PROOF Study, a preventive RCT 
among overweight and obese middle-aged women free of clinical knee OA18 19. The 
latent classes represented three subgroups with different weight changes over time, 
with higher inter-group variability than intra-group variability19. Using the assignment 
to these groups as summary measure, less information is lost in contrast to using the 
weight change at the end of the follow-up time. This method might give us more de-
tailed information about the effect of weight change on MRI features. 
The aim of the present study was to compare 2.5 years changes in different OA MRI 
features using three distinct weight change subgroups among middle-aged overweight 
and obese women without clinical and radiographic knee OA.
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Patients anD methODs
study design, setting and population
For the present study, we used data from the PROOF study (Prevention of knee Osteoar-
thritis in Overweight Females, ISRCTN 42823086). The description of the trial design and 
first results have been published previously18 20. In short, this 2.5 year follow-up study 
evaluated the preventive effects of a diet and exercise program and of oral crystalline 
glucosamine sulfate (double-blind and placebo-controlled) on the development of knee 
OA in a 2x2 factorial design. All women aged between 50 and 60 years and with a BMI ≥ 
27 kg/m2 were contacted by their general practitioner (GP). They had to be free of knee 
OA according to the clinical criteria of the American College of Rheumatology (ACR)21. 
They had to master the Dutch language and had to be free of major co-morbidities, free 
of inflammatory rheumatic diseases, not under treatment of a physical therapist or GP 
for knee complaints, not using walking aids, not using oral glucosamine for the last 6 
months and free of contraindications for MRI.  The description of the diet and exercise 
program, aimed to achieve weight loss in the intervention group, has been presented 
elsewhere20. The Institutional Review Board of Erasmus MC University Medical Center 
Rotterdam approved the study. All participants gave written informed consent prior to 
baseline measurements. We used three weight change subgroups, identified previously 
with LCGA using six-monthly weight data19. By using the mean over these time points as 
a summary measure, participants with highly fluctuating weight changes around zero  
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Fig. 1. Mean weight changes during and after the weight loss intervention. Figures presented as mean 
body weight in kilograms and error bars present 95% confidence intervals. CI, confidence intervals. Figure 
from de Vos et al., with approval of the authors19.
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were treated similarly to participants who remained steady around zero. The women 
were classified into a subgroup of relatively unchanged weight participants (‘steadies’), 
a subgroup representing subjects who steadily gained weight (‘gainers’) and a subgroup 
of women who steadily lost weight over time (‘losers’) (Figure 1)19.
Clinical and radiographic assessment
At baseline all subjects filled in a questionnaire to record demographics, self-reported 
body weight around their 40th year of age, history of knee injury of age and mild knee 
symptoms (defined as having knee pain in the last 12 months). Baseline body weight 
and height were assessed with a standardized physical examination by a research as-
sistant at the research center. Posterior-anterior radiographs of both knees were taken 
using the semi-flexed standing metatarsophalangeal (MTP) view22. The Kellgren and 
Lawrence (K&L) classification23 and the medial anatomical knee alignment angle were 
assessed on all knee radiographs24. Varus alignment was defined as an angle <182° 25. 
All measurements were repeated after 2.5 years of follow-up, body weight was recorded 
every six months.
mri assessment
An MRI of both knees was made at baseline and 2.5 years on a 1.5 Tesla scanner (Siemens 
or GE Healthcare). The MRI protocol included coronal and sagittal non-fat suppressed 
proton density weighted sequences (slice thickness 3.0 mm/slice gap 0.3 mm), a coronal 
T2 weighted Spectral Presaturation by Inversion Recovery (SPIR) sequence (slice thick-
ness 5.0 mm/slice gap 0.5 mm), an axial dual spin-echo sequence (slice thickness 4.5mm/
slice gap 0.5 mm), and a sagittal 3D water selective (WATS) sequence with fat saturation 
(slice thickness 1.5 mm). Baseline and follow-up MRIs were scored at once (sequence 
known) by two trained and blinded researchers (JR human movement scientist, PvdP 
radiology trainee) using the semi-quantitative MRI Osteoarthritis Knee Score (MOAKS)26. 
The following OA-features were evaluated: bone marrow lesions (BMLs), cartilage de-
fects, osteophytes, meniscal abnormalities and meniscal extrusion. We defined meniscal 
abnormalities, separately from meniscus extrusion, as meniscal morphologic abnormali-
ties (tears, maceration, hypertrophy and cysts) and (degenerative) signal abnormalities. 
For the purpose of adequate implementation of MOAKS, an extensive training for the 
two researchers was organized under supervision of an experienced musculoskeletal 
radiologist (EO: 10 years of experience with musculoskeletal MRI in clinical and research 
settings)27. The change of the individual features over 2.5 years was scored using the 
recently proposed definitions for longitudinal evaluation of MOAKS, in which the 
average prevalence adjusted bias adjusted kappa (PABAK) values per feature showed 
‘substantial’ to ‘nearly perfect’ agreement (range 0.77 – 0.88, observed agreement 89% 
- 94%)27. Appendix table 1 shows the definitions of change, which we applied to the 
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present study27. We summed the subregional change scores into an overall score per 
feature and dichotomized this into progression versus no progression (change score ≥ 1 
= progression, change score < 1 = no progression).
Outcome measures
The primary outcome measure was defined as the progression over 2.5 years of the fol-
lowing OA MRI features: BMLs, cartilage defects, osteophytes, meniscal abnormalities 
and meniscal extrusion. BMLs, cartilage defects and osteophytes were assessed in the 
tibiofemoral (TF) and patellofemoral (PF) joint separately. Meniscal abnormalities and 
meniscal extrusion were assessed for the medial and lateral meniscus together. The 
secondary outcome measure was defined as the progression over 2.5 years of BMLs, 
cartilage defects and osteophytes in the medial and lateral TF joint separately and the 
progression of meniscal abnormalities and meniscal extrusions for the medial and lat-
eral meniscus separately.
statistical analysis
Participants with available body weight data and available MRI of one or both knees 
at baseline and 2.5 years were included. Knees with K&L ≥ 2 were excluded and the 
analyses were performed on knee level. Descriptive data were presented as mean ± 
standard deviation (SD) or as numbers (percentages). First, unadjusted associations 
between the weight change subgroups and the primary outcome were analyzed with 
binomial logistic regression using generalized estimating equations (GEE), which takes 
the association between knees within subjects into account. The subgroup of ‘steadies’ 
was defined as reference group. Next, the associations were adjusted for baseline BMI, 
injury and mild knee symptoms, covariates which are likely to affect both weight change 
and MRI feature progression. In addition, for each MRI feature outcome, adjustment was 
made for the presence of that MRI feature at baseline. Also, the analyses were adjusted 
for K&L classification (0 vs. 1) and performed irrespective of the original trial interven-
tions of the PROOF study and therefore adjusted for the randomization groups. Results 
from the GEE analyses were presented in odds ratios (ORs) with 95% confidence inter-
vals (CI). As an explorative analysis, we evaluated the progression rates within the three 
weight change subgroups for the medial and lateral TF joint and the medial and lateral 
meniscus separately. Analyses were performed with SPSS 21.0 (Chicago, IL). P values less 
than 0.05 were considered statistically significant.
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results
Characteristics of the study population
71 of 407 (17%) women were not available for current analyses. The main reason was no 
further time available or interest in the study (47 women, 66%). 12 women (17%) had 
K&L ≥ 2 in both knees. Other reasons (17%) were claustrophobia (3 women), unattain-
ability (6 women) and insufficient MRI quality (1 woman). Two persons deceased during 
follow-up. Additionally, 34 unilateral knees were excluded for analysis due to baseline 
K&L ≥ 2 (n = 28), a recent severe knee trauma (n = 2) or the inability or unwillingness 
to continue MRI scanning of the second knee (n = 4). This resulted in the analysis of 
640 knees of 336 women. Comparison of the baseline characteristics between included 
and non-included knees showed a significant higher prevalence of K&L score 1  (98/170 
(58%) vs. 300/640 (47%), p = 0.01), varus alignment (83/170 (48%) vs 240/636 (38%), p = 
0.01), meniscus extrusion (96/143 (67%) vs 317/637 (50%), p = < 0.001), PF osteophytes 
(30/142 (21%) vs 73/639 (11%), p = 0.02) and TF osteophytes (49/144 (34%) vs 95/639 
(15%), p = < 0.001) in knees that were excluded. With LCGA, 254 of 336 women were 
classified as ‘steadies’, 38 women as ‘gainers’ and 44 as ‘losers’19. The weight change in the 
‘steadies’ was minimal with 0.1 ± 4.0 kg weight gain. Weight change in the ‘gainers’ was 
8.2 ± 3.6 kg weight gain, in the ’losers’ this was 9.0 ± 7.2 kg weight loss. These changes 
were significantly different between groups (p < 0.001). table 1 shows the distribution 
and means of baseline characteristics among the subgroups. Mean age was 55.7 ± 3.2 
table 1. Baseline characteristics (mean ± SD) of the study participants.
All Steadies Gainers Losers
N - subjects 336 254 38 44
Age (years) 55.7 ± 3.2 55.8 ± 3.3 55.0 ± 2.8 55.6 ± 2.9
BMI (kg/m²) 32.3 ± 4.1 32.0 ± 4.0 31.7 ± 3.8 34.0 ± 4.3
BMI (kg/m2) at age 40 years (self-
reported)
27.3 ± 4.1 27.3 ± 4.1 27.7 ± 3.3 27.1 ± 4.2
DEP control + placebo 82 (25%) 62 (24%) 13 (34%) 10 (23%)
DEP control + glucosamine 79 (24%) 59 (23%) 12 (32%) 8 (18%)
DEP intervention + placebo 84 (25%) 63 (25%) 7 (18%) 14 (32%)
DEP intervention + glucosamine\ 88 (26%) 70 (28%) 6 (16%) 12 (27%)
N - knees 640 488 70 82
K&L grade 0 340 (53%) 259 (53%) 39 (56%) 42 (51%)
K&L grade 1 300 (47%) 229 (47%) 31 (44%) 40 (49%)
Varus alignment (yes) 240 (38%) 171 (35%) 35 (50%) 34 (41%)
Mild knee symptoms* (yes) 189 (30%) 142 (29%) 17 (24%) 30 (37%)
History of knee injury (yes) 79 (12%) 53 (11%) 11 (16%) 15 (18%)
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years, mean BMI was 32.3 ± 4.1 kg/m2 and mean BMI at 40 year of age was 27.3 ± 4.1 kg/
m2. Of the 640 knees, 30% were classified as having ‘mild knee symptoms’. K&L 1 was 
present in 47% of the knees. Prevalence of OA MRI features ranged from 11% for PF os-
teophytes to 65% for meniscal pathologies. For BMLs and cartilage defects, prevalence 
was higher in the PF joint than in the TF joint.
effect of weight change subgroups on progression of Oa mri features in the tF 
and PF  joint and the meniscus
Progression rates of the OA MRI features for the TF, PF joint and meniscus with corre-
sponding ORs for the weight change subgroups are presented in table 2. Progression 
ranged from 6% in the ‘steadies’ for PF osteophytes, to 30% in the ‘gainers’ for PF cartilage 
defects. There was no significant effect of weight loss compared to stable weight on the 
progression of any of the different OA MRI features. Also, the effect of weight gain did 
not differ significantly from stable weight.
table 1. Baseline characteristics (mean ± SD) of the study participants. (continued)
All Steadies Gainers Losers
BMLs
TF joint 198 (31%) 155 (32%) 15 (21%) 28 (34%)
PF joint 315 (49%) 242 (50%) 35 (50%) 38 (46%)
Cartilage defects
TF joint 251 (39%) 201 (41%) 15 (21%) 35 (43%)
PF joint 370 (58%) 291 (60%) 41 (59%) 38 (46%)
Osteophytes
TF joint 95 (15%) 76 (16%) 8 (11%) 11 (13%)
PF joint 73 (11%) 55 (11%) 3 (4%) 15 (18%)
Meniscal pathologies
Medial and/or lateral 413 (65%) 323(66%) 44 (63%) 46 (56%)
Meniscal extrusions
Medial and/or lateral 317 (50%) 244 (50%) 32 (46%) 41 (50%)
BMI = body mass index; DEP = Diet and Exercise Program;  K&L = Kellgren and Lawrence classification;  TF = 
tibiofemoral; PF = patellofemoral; * Mild knee symptoms defined as having knee pain in the last 12 months.
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table 2. Progression of OA MRI features of the tibiofemoral (TFJ) and patellofemoral joint (PFJ) over 30 
months for the weight change subgroups. Subjects with steady weight (‘steadies’) were used as reference.
Group N (%) OR 95% CI aOR* 95% CI
Bone marrow lesions and cysts
TFJ Steadies (n = 488) 61 (13) 1 Reference 1 Reference
Gainers (n = 70) 7 (10) 0.78 0.35 – 1.70 0.88 0.40 – 1.96
Losers (n = 82) 10 (12) 0.98 0.47 – 2.07 0.93 0.43 – 2.02
PFJ Steadies 102 (21) 1 Reference 1 Reference
Gainers 20 (29) 1.55 0.84 – 2.87 1.63 0.90 – 2.97
Losers 18 (22) 1.11 0.60 – 2.07 1.04 0.56 – 1.95
Cartilage defects
TFJ Steadies 58 (12) 1 Reference 1 Reference
Gainers 6 (9) 0.69 0.29 – 1.60 0.81 0.33 – 1.96
Losers 8 (10) 0.84 0.39 – 1.82 0.73 0.35 – 1.53
PFJ Steadies 108 (22) 1 Reference 10 Reference
Gainers 21 (30) 1.50 0.85 – 2.67 1.63 0.92 – 2.91
Losers 14 (17) 0.74 0.42 - 1.29 0.76 0.43 – 1.35
Osteophytes
TFJ Steadies 53 (11) 1 Reference 1 Reference
Gainers 9 (13) 1.20 0.54 – 2.68 1.41 0.65 – 3.07
Losers 11 (13) 1.31 0.54 – 3.15 1.14 0.47 – 2.79
PFJ Steadies 28 (6) 1 Reference 1 Reference
Gainers 5 (7) 1.29 0.48 – 3.46 1.65 0.58 – 4.74
Losers 8 (10) 1.81 0.74 – 4.45 1.14 0.37 – 3.44
Meniscal abnormalities
Medial and/or 
lateral
Steadies 132 (27) 1 Reference 1 Reference
Gainers 19 (27) 1.00 0.54 – 1.83 1.00 0.54 – 1.84
Losers 20 (24) 0.92 0.48 – 1.76 0.91 0.47 – 1.74
Meniscal extrusions
Medial and/or 
lateral
Steadies 84 (17) 1 Reference 1 Reference
Gainers 12 (17) 0.98 0.50 – 1.92 0.98 0.49 – 1.96
Losers 10 (12) 0.67 0.32 – 1.39 0.71 0.33 – 1.50
N = number of knees with progression; aOR = adjusted odds ratio. Adjustments are made for baseline body 
mass index (kg/m2), mild knee symptoms, injury, Kellgren & Lawrence score (0 vs. 1), presence of MRI feature 
at baseline and randomized groups of the PROOF study.
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explorative analysis
table 3 presents the progression rates for the weight change subgroups in the medial 
and lateral TF joint and the medial and lateral meniscus. Progression rates ranged from 
4% for lateral meniscal extrusion to 21% for medial meniscal pathologies. Overall, pro-
gression rates were highest in the medial TF joint and medial meniscus. Since absolute 
progression numbers per weight change group were low, no further analysis was per-
formed to assess the effect of weight change on progression of medial and lateral MRI 
features.
DisCussiOn
summary
Three weight change subgroups within a high-risk group of middle-aged overweight 
and obese women without clinical and radiographic knee OA were analyzed for the 
effects on the progression of different OA MRI features. This study showed that weight 
change over 2.5 years, either gain or loss, did not have a statistically significant effect on 
the 2.5 years progression of different OA MRI features.
table 3. Progression of OA MRI features for the three weight change subgroups in the medial and lateral 
tibiofemoral (TF) joint and for the medial and lateral meniscus over 30 months
All Steadies Gainers Losers
N knees 640 488 70 82
Progression BMLs
Medial TF joint (%) 51 (8) 39 (8) 4(6) 8 (10)
Lateral TF joint (%) 37 (5) 29 (6) 3 (4) 5 (6)
Progression cartilage defects
Medial TF joint (%) 48 (6) 40 (8) 4 (6) 4 (5)
Lateral TF joint (%) 33 (5) 26 (5) 2 (3) 5 (6)
Progression osteophytes
Medial TF joint (%) 62 (10) 47 (10) 7 (10) 8 (10)
Lateral TF joint (%) 24 (5) 16 (3) 3 (4) 5 (6)
Progression meniscal pathologies
Medial 132 (21) 101 (21) 17 (24) 14 (17)
Lateral 67 (9) 56 (11) 4 (6) 7 (9)
Progression meniscal extrusions
Medial 92 (14) 73 (15) 12 (17) 7 (9)
Lateral 21 (4) 14 (3) 3 (4) 4 (5)
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Context and comparison with existing literature
Although the women in the present study were free of clinical and radiographic knee 
OA, there was a substantial amount of baseline OA MRI features. High prevalence of 
structural features are also seen in other studies that evaluated high-risk populations28-31. 
In our study, a high prevalence of cartilage defects (39% in TF and 58% in PF) and menis-
cal lesions (65% abnormalities and 50% extrusions) was found, which might be due to 
the overweight and obese participants (mean BMI 32.1kg/m2). The association between 
BMI and prevalence and severity of cartilage and meniscal lesions in pre-radiographic 
subjects have previously been shown by data of the OAI32-34. In addition, we also found a 
considerable amount of BMLs (prevalence of 31% in the TF joint and 49% in the PF joint). 
This might be related to the high prevalence of malalignment (38% varus alignment), 
as there is evidence for the association between increased mechanical loading by knee 
malalignment and incidence and progression of BMLs35. The prevalence and progres-
sion rates of cartilage defects and BMLs in the present study were the highest in the PF 
joint. Although the TF joint is the joint most studied in OA research, the importance of 
the PF joint in OA research has already been shown in the early ’90s36 and more recently 
by the Framingham Osteoarthritis study 37. When assessing the medial and lateral com-
partment separately, more progression was found in the medial compartment. This is 
likely attributable to varus malalignment and differences in load distribution; the high-
est compressive loads during daily activity are transmitted to the medial compartments 
of the knee38 39.
With the use of LCGA, we were able to classify individuals into groups based on 
individual response patterns over time, yielding more reliable results than choosing 
subgroups based on self-selected groups17 19. Although estimated as the most appro-
priate method, no significant effects of weight change were found, neither of weight 
loss nor of weight gain. The ‘steadies’ were intuitively chosen as reference group. When 
the ‘gainers’ were the reference, results did nog change, except for the progression of 
cartilage defects in the PF joint, showing a significant difference between ‘losers’ and 
‘gainers’ (aOR 0.47, 95% CI 0.22 – 0.98, p-value 0.04). Due to the large number of analyses 
performed (16 tests), the probability of a type-I-error was increased and a Bonferroni 
correction resulted in a non-significant p-value. On the other hand, PF joint cartilage 
damage has been found to be associated with quadriceps weakness40. The women that 
reduced weight were possibly more active, resulting in increased quadriceps strength 
and less cartilage progression.
The absence of a preventive effect of weight loss might be due to the study popu-
lation, which was overweight or obese for many years as demonstrated by the self-
reported weight data at age 40. Since the ‘losers’ had a mean BMI of 27.1 ± 4.2 kg/m2 
at age 40, high weight exposure time was at least ± 15 years. The effect of prolonged 
exposure to high BMI on development of knee OA has been previously described41. The 
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authors found that the risk on midlife knee OA was mostly influenced by the duration 
of exposure to high weight during adult life. The association between BMI and midlife 
knee OA in women was already detectable around adolescence. Although we found a 
mean weight loss of 9.0 ± 7.2 kg in the ‘losers’, they might be well beyond the possibil-
ity of minimizing the articular damage by weight loss and disease processes might be 
ongoing. Weight loss can be helpful to prevent or reduce joint pain, but the prevention 
of structural knee OA might be more effective when weight loss is initiated at young 
adulthood or adolescence.
Studies that found preventive effects of weight loss on articular cartilage did not use 
LCGA to obtain objective weight change subgroups, but used a pre-defined percentage 
of weight loss as cut-off to generate two groups14 15. Besides, when the biochemical 
composition of the cartilage was assessed no conclusions could be drawn about later 
development of structural cartilage defects15. In previous data of the PROOF study, the 
effect of weight loss on radiographic knee OA was evaluated42. Also in this study the 
authors did not use LCGA. The authors suggested that a weight reduction of ≥ 5 kg or 
≥ 5% body weight reduced the risk on incidence of Kellgren & Lawrence (K&L) grade ≥ 
2 over 30 months. However, this result should be interpreted with caution as absolute 
numbers were low, which reduced statistical power. Moreover, no differences were 
found for the incidence of the clinical and radiographic ACR criteria nor for joint space 
narrowing (JSN).
Although counterintuitive, no significant detrimental effects were found of 2.5 years 
weight gain. This might be due to the high prevalence of baseline MRI features, leaving 
little room for more progression. However, it might be well possible that within a longer 
follow-up time, detrimental effects could have been found, which is also suggested 
when comparing our results with a recent study of the Osteoarthritis Initiative34. Weight 
gain over 4-years follow-up (mean 15.2% +/- 7.8%) in an overweighed population was 
associated with increased progression of cartilage, meniscal and bone marrow lesions 
compared to stable weight.
strengths and limitations
This study assessed weight changes on multiple OA MRI features in women without 
clinical and radiographic knee OA. Up to now, weight loss studies have mainly focused 
on cartilage 14 15. Weight gain has been studied on different structures, but as far as we 
know, osteophytes have never been included34. Also, this is the first study in OA research 
that used LCGA to obtain distinct and most objectively acquired subgroups of weight 
change in relation to structural progression.
This study has also some imitations. The lack of effect of weight loss and gain might 
be due to the small samples in these groups, reducing statistical power. Only in the 
case of PF cartilage defects and meniscal abnormalities, the ‘gainers’ and ‘losers showed 
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opposite effects, with higher ORs for ‘gainers’ and lower for ‘losers’. Larger studies are 
necessary to draw definite conclusions about these results.
Secondly, when using LCGA, the different subgroups have to fit well to the observed 
data.  One might argue whether the obtained subgroups are representative of the dif-
ferent weight change trajectories. However, the subgroups were obtained from a model 
with high goodness of fit indices19. Also, the participants had a probability of belonging 
to their particular subgroup of 90% or higher, which suggests that classification of the 
majority of the participants was correct.
Further, the original MOAKS scoring system has been developed for the assessment 
of disease status and the definition for change over time was not described in the 
original paper. We applied a recently proposed definition for the longitudinal change 
of the different MOAKS features, but it has not been validated yet against clinical and 
other structural outcomes27. However, it is the only available definition for longitudinal 
changes in MOAKS scores.
Certain grades of the structural features of MOAKS reflect a wide range of severity. For 
instance, grade 2 for size and thickness of cartilage loss is defined as 10-75% loss of the 
subregion26. As a result, within-grade progression may remain unnoticed when using 
the proposed progression definitions of MOAKS features.
Furthermore, our data showed that the prevalence of K&L 1, varus alignment ,  menis-
cus extrusion, PF osteophytes and TF osteophytes was higher in the in the knees that 
were excluded from analyses, partly due to the exclusion of knees with K&L ≥ 2. Less 
healthy knees might benefit less from the original trial interventions, but since we cor-
rected for these interventions, results will not have been influenced much.
Conclusion and implications
A high prevalence of OA MRI features is found in a high-risk group of middle-aged 
women, without clinical and radiographic knee OA. Neither 2.5 years weight loss nor 
weight gain influenced progression of different OA MRI features. The lack of a preventive 
effect of weight loss suggests that damage to the articular structures in this particular 
population is beyond salvation of weight loss. No detrimental effects of weight gain 
on progression of MRI features was found, which warrants further research with longer 
follow-up. The lack of any preventive effect of weight loss on MRI structures is concern-
ing and emphasizes the importance of weight control throughout entire life, which may 
constitute a more effective primary prevention measurement for knee OA.
Key messages
There is a high prevalence of OA MRI features in overweight and obese middle-aged 
women without clinical and radiographic knee OA.
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Weight change at middle-age, either gain or loss, did not change progression of OA 
MRI features over a follow-up of 2.5 years.
75
1
2
3
4
5
6
7
8
9
10
11
reFerenCes
 1. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007; 29: 1-5.
 2. WHO. Global status report on noncommunicable diseases, 2014.
 3. Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older 
adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010; 18(1): 24-33.
 4. Reijman M, Pols HA, Bergink AP, et al. Body mass index associated with onset and progression of 
osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007; 66(2): 
158-62.
 5. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its 
risk factors. Ann Intern Med 2000; 133(8): 635-46.
 6. Bastick AN, Runhaar J, Belo JN, et al. Prognostic factors for progression of clinical osteoarthritis of 
the knee: a systematic review of observational studies. Arthritis Res Ther 2015; 17: 152.
 7. Lehnert T, Sonntag D, Konnopka A, et al. Economic costs of overweight and obesity. Best Pract Res 
Clin Endocrinol Metab 2013; 27(2): 105-15.
 8. Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 2015.
 9. Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed 
with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007; 66(4): 433-
9.
 10. Messier SP, Loeser RF, Miller GD, et al. Exercise and dietary weight loss in overweight and obese 
older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis 
Rheum 2004; 50(5): 1501-10.
 11. Hunter DJ, Beavers DP, Eckstein F, et al. The Intensive Diet and Exercise for Arthritis (IDEA) trial: 
18-month radiographic and MRI outcomes. Osteoarthritis Cartilage 2015; 23(7): 1090-8.
 12. Henriksen M, Christensen R, Hunter DJ, et al. Structural changes in the knee during weight loss 
maintenance after a significant weight loss in obese patients with osteoarthritis: a report of 
secondary outcome analyses from a randomized controlled trial. Osteoarthritis Cartilage 2014; 
22(5): 639-46.
 13. Gudbergsen H, Boesen M, Christensen R, et al. Changes in bone marrow lesions in response to 
weight-loss in obese knee osteoarthritis patients: a prospective cohort study. BMC Musculoskelet 
Disord 2013; 14: 106.
 14. Anandacoomarasamy A, Leibman S, Smith G, et al. Weight loss in obese people has structure-
modifying effects on medial but not on lateral knee articular cartilage. Ann Rheum Dis 2012; 
71(1): 26-32.
 15. Serebrakian AT, Poulos T, Liebl H, et al. Weight loss over 48 months is associated with reduced 
progression of cartilage T2 relaxation time values: Data from the osteoarthritis initiative. J Magn 
Reson Imaging 2015; 41(5): 1272-80.
 16. Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: evidence, hypotheses 
and horizons - a scoping review. Obes Rev 2014; 15(7): 578-86.
 17. Jung T, Wickrama KAS. An Introduction to Latent Class Growth Analysis and Growth Mixture 
Modeling. Social and Personality Psychology Compass 2008; 2(1): 302-17.
 18. Runhaar J, van Middelkoop M, Reijman M, et al. Prevention of knee osteoarthritis in overweight 
females; the first preventive randomized controlled trial in osteoarthritis. Am J Med 2015.
 19. de Vos BC, Runhaar J, Verkleij SP, et al. Latent class growth analysis successfully identified sub-
groups of participants during a weight loss intervention trial. J Clin Epidemiol 2014; 67(8): 947-51.
76
 20. de Vos BC, Runhaar J, Bierma-Zeinstra SM. Effectiveness of a tailor-made weight loss intervention 
in primary care. Eur J Nutr 2014; 53(1): 95-104.
 21. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of 
osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria 
Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29(8): 1039-49.
 22. Buckland-Wright JC, Wolfe F, Ward RJ, et al. Substantial superiority of semiflexed (MTP) views 
in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing ex-
tended, semiflexed (MTP), and schuss views. J Rheumatol 1999; 26(12): 2664-74.
 23. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16(4): 
494-502.
 24. Kraus VB, Vail TP, Worrell T, et al. A comparative assessment of alignment angle of the knee by 
radiographic and physical examination methods. Arthritis Rheum 2005; 52(6): 1730-5.
 25. Brouwer GM, van Tol AW, Bergink AP, et al. Association between valgus and varus alignment and 
the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum 
2007; 56(4): 1204-11.
 26. Hunter DJ, Guermazi A, Lo GH, et al. Evolution of semi-quantitative whole joint assessment of 
knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthritis Cartilage 2011; 19(8): 990-1002.
 27. Runhaar J, Schiphof D, van Meer B, et al. How to define subregional osteoarthritis progression 
using semi-quantitative MRI Osteoarthritis Knee Score (MOAKS). Osteoarthritis Cartilage 2014; 
22(10): 1533-6.
 28. Sharma L, Chmiel JS, Almagor O, et al. Significance of preradiographic magnetic resonance imag-
ing lesions in persons at increased risk of knee osteoarthritis. Arthritis Rheumatol 2014; 66(7): 
1811-9.
 29. Javaid MK, Lynch JA, Tolstykh I, et al. Pre-radiographic MRI findings are associated with onset of 
knee symptoms: the most study. Osteoarthritis Cartilage 2010; 18(3): 323-8.
 30. Englund M, Guermazi A, Gale D, et al. Incidental meniscal findings on knee MRI in middle-aged 
and elderly persons. N Engl J Med 2008; 359(11): 1108-15.
 31. Guermazi A, Niu J, Hayashi D, et al. Prevalence of abnormalities in knees detected by MRI in adults 
without knee osteoarthritis: population based observational study (Framingham Osteoarthritis 
Study). Bmj 2012; 345: e5339.
 32. Laberge MA, Baum T, Virayavanich W, et al. Obesity increases the prevalence and severity of focal 
knee abnormalities diagnosed using 3T MRI in middle-aged subjects--data from the Osteoarthri-
tis Initiative. Skeletal Radiol 2012; 41(6): 633-41.
 33. Baum T, Joseph GB, Nardo L, et al. Correlation of magnetic resonance imaging-based knee carti-
lage T2 measurements and focal knee lesions with body mass index: thirty-six-month followup 
data from a longitudinal, observational multicenter study. Arthritis Care Res (Hoboken) 2013; 
65(1): 23-33.
 34. Bucknor MD, Nardo L, Joseph GB, et al. Association of cartilage degeneration with four year 
weight gain--3T MRI data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2015; 23(4): 
525-31.
 35. Hayashi D, Englund M, Roemer FW, et al. Knee malalignment is associated with an increased risk 
for incident and enlarging bone marrow lesions in the more loaded compartments: the MOST 
study. Osteoarthritis Cartilage 2012; 20(11): 1227-33.
 36. McAlindon TE, Snow S, Cooper C, et al. Radiographic patterns of osteoarthritis of the knee joint in 
the community: the importance of the patellofemoral joint. Ann Rheum Dis 1992; 51(7): 844-9.
77
1
2
3
4
5
6
7
8
9
10
11
 37. Stefanik JJ, Niu J, Gross KD, et al. Using magnetic resonance imaging to determine the compart-
mental prevalence of knee joint structural damage. Osteoarthritis Cartilage 2013; 21(5): 695-9.
 38. Morrison JB. The mechanics of the knee joint in relation to normal walking. J Biomech 1970; 3(1): 
51-61.
 39. Mundermann A, Dyrby CO, D’Lima DD, et al. In vivo knee loading characteristics during activities 
of daily living as measured by an instrumented total knee replacement. J Orthop Res 2008; 26(9): 
1167-72.
 40. Stefanik JJ, Guermazi A, Zhu Y, et al. Quadriceps weakness, patella alta, and structural features of 
patellofemoral osteoarthritis. Arthritis Care Res (Hoboken) 2011; 63(10): 1391-7.
 41. Wills AK, Black S, Cooper R, et al. Life course body mass index and risk of knee osteoarthritis at the 
age of 53 years: evidence from the 1946 British birth cohort study. Ann Rheum Dis 2012; 71(5): 
655-60.
 42. Runhaar J, de Vos BC, van Middelkoop M, et al. Moderate weight loss prevents incident knee 
osteoarthritis in overweight and obese females. Arthritis Care Res (Hoboken) 2016.

12
3
4
5
6
7
8
9
10
11
Chapter 6  The long-term effects of a 
randomized, controlled, tailor-made 
weight loss intervention in primary 
care on the health and lifestyle of 
overweight and obese women.
Bastiaan C. de Vos
Jos Runhaar
Marienke van Middelkoop
Marjolein Krul
Sita M.A. Bierma-Zeinstra
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Am J Clin Nutr. 2016 Jul;104(1):33-40. doi: 10.3945/
ajcn.116.133512. Epub 2016 Jun 15.
80
aBstraCt
Background
Maintenance of weight loss after a diet and exercise intervention is often low. Moreover, 
short follow-up periods and high attrition rates often impede translation of study results 
to clinical practice.
Objectives
The present study evaluated the long-term effectivity of a randomized, tailor-made 
lifestyle intervention, consisting of diet and exercise, on the health and lifestyle of over-
weight, middle-aged women in primary care.
Design
The intervention was part of a randomized controlled trial on the prevention of knee 
osteoarthritis (PROOF Study, ISRCTN 42823086). The intervention lasted for 2.5 years 
and consisted of visits to the dietician and participation in physical activity classes, 
supervised by a physiotherapist. The outcome of main interest of the present study was 
weight change in kilograms 6-7 years after randomization. Additionally, the intervention 
effect on change in physical activity was investigated.
results
After six months, weight loss was significantly higher in the intervention group (adjusted 
difference 1.34 kg, 95% CI: 0.46, 2.22). Over time, this difference decreased and became 
non-significant after 24 months. Per protocol analyses showed similar results. After six 
months, change in physical activity was significantly higher in the intervention group 
(15.2%, 95% CI: 28.6, 1.7). Over time, this difference increased up to 29.8% (95% CI: 2.3, 
57.2) after 6.6 years of follow-up. Per protocol analyses showed no significant differences 
in change in physical activity.
Conclusions
A long lasting intervention effect on change in physical activity was found, which in-
creased over time. For weight change, smaller differences were found, which decreased 
over time. In future research, greater intervention effects on weight change are expected 
when higher compliance rates can be reached. The present study provides important 
recommendations for future research.
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intrODuCtiOn
In medicine, the elaborately investigated subject of weight loss in overweight and obese 
people often is accompanied by the reporting of a multitude of limitations and chal-
lenges. Reviews report the current lack of long-term trials, making the true effects of 
weight loss interventions hard to determine 1-3. It is generally expected that a substantial 
portion of the study population often afterwards regains the weight, which was lost dur-
ing the intervention 2 4. It was therefore recommended to extend the follow-up time, in 
order to ensure that the proportion of participants that regained their lost weight after 
the intervention ended is taken into account 3 5 6. In addition, high attrition rates are very 
often encountered in weight loss intervention studies 1 2 7. Consequently, the methods 
used for handling missing data are diverse and seen as an important cause of bias 8-10.
Several reviews have identified specialized interventions, such as bariatric surgery or 
pharmacologic therapy, as the most effective methods in achieving a significant amount 
of weight loss 2 11. However, when attempting to address the worldwide problem over-
weight has become, an intervention needs to be large-scale applicable to the general 
population 12. Primary care is therefore regarded as an optimal setting for the prevention 
and management of overweight and obesity 13 14.
Interventions available for the general population in primary care settings mostly 
consist of a combination of diet and exercise 1 2 7. It has been shown that in order to 
achieve a clinically significant amount of weight loss over a relatively short period of 
time, intensive and restrictive diet and exercise schemes are most effective 7 11. However, 
more recently it has been suggested that a less restrictive and intensive intervention, 
making use of higher autonomous motivation, self-efficacy and flexible eating restraint, 
contribute to better maintenance of diet and exercise outcomes in the long term 15. 
Motivational interviewing is a method widely used by a variety of health care workers, 
which particularly focusses on obtaining long-term, sustainable changes in behavioral 
patterns 16 17. Based on manipulating intrinsic motivational patterns, motivational inter-
viewing is identified as an effective method to contribute to long term maintenance of 
behavioral changes and, in particular, long term maintenance of weight loss and physi-
cal activity 15. Moreover, it is recommended to tailor an intervention to specific targets 
per person, in contrast to dictating a strict, predetermined regime 15.
Efforts in determining whether diet or exercise contributes most to the success of 
weight loss interventions, often lead to inconclusive results 18 19. However, literature 
suggests that separate components of weight loss interventions, especially physical 
exercise, can in itself induce improvement of health outcomes without affecting actual 
body weight 1. Therefore, when attempting to improve the health of overweight and 
obese people, improved dietary habits or heightened physical activity can be goals in 
itself too.
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The objective of the present study was to evaluate the long-term effectiveness of a 
tailor-made weight loss intervention, consisting of diet and exercise, based on motiva-
tional interviewing, on the health and lifestyle of overweight and obese women.
methODs
PrOOF study
The present study evaluates the long-term effectiveness of a weight loss intervention 
that was part of a randomized controlled trial on the prevention of knee osteoarthritis 
(OA) 20. The short-term effectiveness has been published elsewhere 21. The PROOF study 
(Prevention of knee Osteoarthritis in Overweight Females), ISRCTN 42823086 (Interna-
tional Standard Randomized Controlled Trial Number) received approval from the Medi-
cal Ethics Committee of Erasmus University Medical Centre Rotterdam in 2005 and all 
participants provided informed consent. The preventive effects of a weight loss program 
and of oral glucosamine sulfate versus placebo on the incidence of knee osteoarthritis 
were investigated in a 2 x 2 factorial design with a follow-up time of 6.6 years. 1:1 block 
randomization was used, using block size 20 and for the weight loss intervention, the 
PROOF study was open labelled. A detailed description of the methods of the weight 
loss intervention has been published elsewhere 21. Below, methods will be described 
concisely. The present study focusses on the effectiveness of the diet and exercise in-
tervention on health and lifestyle. No effects of glucosamine on these outcomes were 
expected or detected. Therefore, the glucosamine intervention will be disregarded in 
the present manuscript. This manuscript has been prepared according to the CONSORT 
Statement guidelines 22.
recruitment
All women between 50 and 60 years registered at the 50 general practitioners who 
cooperated with the study, received an information letter about the PROOF study and 
a reply card. All interested women with a self-reported body mass index (BMI) of 27 or 
higher received additional information about the purpose and the setting of the study. 
Inclusion criteria were: female gender, age 50-60 years, overweight (BMI ≥ 27), free of 
knee osteoarthritis according to the clinical American College of Rheumatology (ACR) 
criteria 23, free of contraindications to MRI, free of rheumatic diseases and not using oral 
glucosamine during the past six months. Exclusion criteria were: already consulted a 
physician, a physiotherapist or an alternative health provider for knee pain possibly in-
dicating knee osteoarthritis, presence of radiologic signs indicating knee osteoarthritis 
(Kellgren Lawrence index 2 or more), not being able to communicate in the Dutch lan-
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guage and presence of severely disabling comorbidity. Recruitment took place between 
July 2006 and May 2009. Figure 1 shows the selection process.
 
50 general practitioners contacted all women between 50 
and 60 years registered at their practice (6691 women) 
3094 women (46%) returned the reply-
card to the research institute 
1358 women (44%) were 
not interested 
1736 women (56%) were 
interested 
847 women (49%) were 
excluded (reported BMI 
was below 27 kg/m2 
889 women (51%) with 
BMI ≥ 27 kg/m² were send 
additional information 
After screening on all in- and exclusion criteria by phone, 407 
women (46%) were eligible and were invited for baseline 
measurements 
Randomization 
Diet and exercise 
intervention 
Control group 
 
17 women lost to follow-up 
after 2.5 years (15 
unwilling, 1 unattainable, 1 
died) 
24 women lost to follow-up 
after 2.5 years (21 
unwilling, 2 side-effects, 1 
died 
In total, 73 women lost to 
follow-up after 6.7 years 
(63 unwilling, 5 
unattainable, 1 side-
effects, 4 died) 
In total, 87 women lost to 
follow-up after 6.7 years 
(79 unwilling, 5 
unattainable, 2 side-
effects, 1 died) 
Figure 1 Flowchart of recruitment process
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intervention
As stated above, details on the diet and exercise intervention are published elsewhere 
21. In short, participants in the intervention group met with a dietician. After evaluating 
the current nutritional and physical activity habits, in mutual agreement goals were set, 
using motivational interviewing 16. These goals were individually tailored and concerned 
both diet and physical activity. The first three appointments were biweekly, after that 
the frequency of visits was determined by mutual agreement.
These meetings were limited to a total duration of four hours per calendar year. 
Additionally, participants were invited to attend 20 weekly physical activity classes, 
supervised by a physiotherapist. These classes served as an exploration of low-intensive 
sport activities, in order to find a sport the participants could enjoy and maintain until 
after the intervention. The dietician, the physiotherapist and the facilities to engage in 
sports were available close to the participants’ homes, in order to make the intervention 
more approachable and to stimulate mutual involvement between participants living in 
the same neighborhood. The dietician and physiotherapist sessions were free of charge 
for the participants. The intervention lasted for 2.5 years.
The participants in the control group did not receive an intervention, but were free to 
undertake any health promoting activities at their own initiative.
Questionnaires and measurements
At baseline, all participants filled out an extensive questionnaire recording baseline 
characteristics. For the first 2.5 years, all participants were home visited every six months 
by a research assistant to fill in a shorter questionnaire to assess compliance to the diet 
and exercise, physical activity level, nutritional habits, co-interventions, menopausal 
status, comorbidities and quality of life. Additionally, body weight was measured dur-
ing these visits. In addition, skin folds were measured at baseline and after 2.5 years of 
follow-up. After 6.6 years, participants were visited once more for measurements and 
a questionnaire. In all questionnaires, quality of life was measured using the validated 
EQ-5D Euroqol questionnaire24 and physical activity was measured using the validated 
SQUASH questionnaire 25 26. Nutritional habits were measured using an adapted version 
of a validated questionnaire 27. Fat percentage was calculated with the formula by Lean 
et al 28. The physiotherapists kept record of attendance to the classes and the dieticians 
kept record of frequency of meetings and of the percentage of set goals the participants 
met, regarding both diet and exercise.
Outcome measures
For the present analysis, the outcome of main interest was weight change in kilograms, 
relative to participants’ baseline body weight, 6-7 years after randomization. Addition-
ally, the proportion of participants that lost 5 kg or 5% of their baseline body weight 
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was examined. Evidence has shown this amount of weight loss to be associated with 
improvement of several health outcomes, including cardiovascular risk factors, glucose 
tolerability and hypertension 2 29-31. Secondary outcomes were change in physical activ-
ity, change in nutritional habits, change in fat percentage and change in quality of life. 
These outcome measures were presented as percentage change relative to baseline 
measurement. Since the questionnaire used for nutritional habits did not allow calculat-
ing a total caloric intake, separate components of this questionnaire were investigated, 
focusing mostly on snacks eaten per week.
statistical analyses
At set times, unadjusted differences in weight change between both groups were tested 
using 2-tailed independent t tests. Differences in categorical outcome measures were cal-
culated using Fisher’s exact test. A linear mixed model estimated by restricted maximum 
likelihood was fitted to estimate adjusted differences in continuous outcomes between 
randomized groups. This method takes all available data into account instead of only 
cases that completed the study 8 9 32. The model included time in months as a random 
effect and a time by treatment interaction. This model was also used to test all baseline 
characteristics for confounding. Adjusted effect sizes (Cohen’s d) were calculated by 
dividing the adjusted difference in mean between both groups by the pooled standard 
deviation 33. The same analyses were performed for the predefined per-protocol analy-
sis. For categorical outcome measures, Generalized Estimating Equations were used to 
estimate differences between randomized groups and to test for confounding. These 
models also included time in months and a time by treatment interaction.
Beforehand, it was clear that compliance would be difficult to determine, as a result 
of the tailor-made strategy, which included individually tailored goals. Therefore, we 
chose to determine a cutoff value in number of appointments with the dietician and 
number of attended physical activity classes at the point where dichotomizing resulted 
in the largest difference in effect on weight loss between the two resulting groups. This 
approach resulted in a definition of compliance of attendance of ≥ 6 dietician visits 
and ≥ 7 physical activity classes.  For the per protocol analyses, these participants were 
compared to all participants in the control group.
In order to characterize the participants that completed the study and to compare 
them to the participants that did not complete the study, logistic regression analysis 
was used to identify factors that increased the likelihood to complete the follow-up time 
of 6.6 years. First, univariate logistic regression analysis was used to identify possible fac-
tors. All baseline characteristics were tested respectively. Second, multivariate logistic 
regression analysis was used, including all factors with a P-value < 0.1 in the univariate 
regression analyses, to identify factors with a significant association with completing the 
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follow-up time of 6.6 years. These factors were presented as odds ratios (OR) with 95% 
confidence intervals (CI).
A ≤5% significance level for testing was used for all analyses. Descriptive analyses 
were performed using SPSS PASW statistics version 21 (SPSS Inc., Chicago, IL). All other 
analyses were performed using R Statistical Software version 3.2.3 (R Foundation for 
Statistical Computing, Vienna, Austria).34
results
A detailed description of the selection process is published elsewhere 21. In short, 6691 
women were contacted by their general practitioners, of which eventually 407 were 
randomized. Figure 1 shows the selection process. Of the randomized women, 35% was 
overweight (BMI 25 – 29.9 kg/m²), while 6% met class III obesity (BMI ≥ 40 kg/m²). Mean 
age was 55.7 years and mean BMI was 32.4 kg/m². Baseline characteristics per random-
ized group are presented in table 1. Smoking status was the only variable that showed a 
significant difference between the randomized groups (23% in the control group versus 
table 1 Baseline characteristics in Mean (SD) or proportion among randomized groups
Control group Intervention group
(n=204) (n=203)
Obesity (kg/m²)
BMI 25-29.9 33% 36%
BMI 30-34.9 42% 44%
BMI 35-39.9 18% 15%
BMI ≥ 40 7% 5%
Age (years) 55.7 (3.2) 55.7 (3.2)
Body weight (kg) 89.2 (13.6) 88.2 (12.9)
BMI (kg/m²) 32.5 (4.5) 32.2 (4.1)
Fat percentage (%)¹ 43.9 (5.5) 43.6 (5.0)
Abdominal circumference (cm) 106.3 (9.8) 105.5 (9.4)
Approximate body weight one year before study (kg) 86.3 (14.6) 85.7 (14.5)
Approximate body weight around 40th year of age (kg) 75.7 (11.8) 74.4 (13.5)
Ethnicity
European/North American 93% 94%
South American 1% 1%
African 1% 1%
Asian 1% 1%
Other 5% 2%
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13% in the intervention group, p=0.014). However, smoking status had no association 
with any of the outcome measures, so no adjustment was performed. All other baseline 
characteristics showed no significant difference between the groups, so no adjustment 
for confounders was made in the linear mixed model.
Follow-up
After 2.5 years, 10.1% of the participants were lost to follow-up. After 6.6 years, 247 
participants (60.7%) agreed to additional measurements and questionnaire. Reasons 
for lost to follow-up are mentioned in Figure 1. No significant difference in attrition 
rate was found between the randomized groups. In univariate analyses, nine baseline 
characteristics were associated with completing the follow-up time of 6.6 years. The 
majority of these associations were in favor of the completers. On average, this group 
had a lower incidence of hypertension, lower baseline body weight and BMI, lower fat 
percentage, lower proportion of participants with an active smoking status, higher 
social participation, higher physical activity level, lower blood HbA1c, but higher blood 
table 1 Baseline characteristics in Mean (SD) or proportion among randomized groups (continued)
Control group Intervention group
(n=204) (n=203)
Educational level
Low 35% 32%
Medium 62% 66%
High 3% 2%
Postmenopausal status² 71% 69%
Comorbidity³ 34% 34%
Active smoking status 23% 13%4
Quality of life (range 0-1) 5 0.89 (0.1) 0.89 (0.1)
Social participation6 9.0 (2.2) 9.1 (2.1)
Physical activity  7 7136 (3785) 6556 (3522)
Blood HbA1C (mmol/L) 5.8 (0.7) 5.8 (0.8)
Blood total cholesterol (mmol/L) 6.1 (1.2) 6.0 (1.1)
Snacks consumed per week 10.0 (0.8) 9.4 (0.8)
Hypertension8 74.3% 68.4%
1 Fat percentage calculated with formula by Lean et al. (28)
2 Postmenopausal status defined as ≥ one year since last menstruation
3 Comorbidity defined as ≥1 condition currently under treatment
4 P=0.014 (Fisher’s exact test)
5 Quality of life measured with validated Dutch Euroqol questionnaire(24)
6 Social participation defined as hours per week spent on paid/voluntary/household work or studying
7 Physical activity measured with validated SQUASH questionnaire(25, 26)
8 Hypertension defined as a systolic blood pressure > 130 mmHg or a diastolic blood pressure > 90 mmHg
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total cholesterol. In addition, more participants in the group completers were compliant 
to the diet and exercise intervention. In a multivariate analysis, hypertension, HbA1c 
and blood total cholesterol were associated with completing the follow-up time. Re-
spectively, odds ratios and 95% confidence intervals for these variables were: 0.61 (0.37, 
0.99), 0.72 (0.52, 0.99), 1.25 (1.03, 1.52).
Compliance rates
As a result of the study design, which described a tailor-made weight loss intervention, 
the participation rates of visits to the dietician and attendance to the physical activity 
classes varied widely. 11% of participants randomized to the intervention, never visited 
the dietician, while 51% visited the dietician at least six times. 21% of the participants 
randomized to the intervention, did not attend any of the physical activity classes. 57% 
of these participants attended at least seven classes. 32% of the participants in the 
intervention group complied with both criteria and were considered compliant to the 
intervention.
intervention effects
After 6.6 years of follow-up, 51% of all women with available follow-up data had a 
body weight below their baseline body weight, while 19% were 5 kg or 5% below their 
baseline body weight. The intervention group lost significantly more weight than the 
control group at six and twelve months of follow-up. Thereafter, no significant unad-
justed differences were found between both groups, although a trend was seen that 
in the long term, the intervention group, on average, maintained a body weight below 
their baseline weight, whereas the control group, on average, exceeded their baseline 
weight. The proportion of participants that lost 5 kg or 5% of their baseline body weight 
was significantly different between both groups only at six months of follow-up, in favor 
of the intervention group. Figure 2 shows the trajectories of weight loss over time for 
both groups and the proportions of participants that reached the 5 kg/5 % goal. Physical 
activity was significantly higher in the intervention group than in the control group at 
all of the measurement time points, except at 12 months after randomization. Figure 3 
shows the change in physical activity over time for the randomized groups. Adjusted 
differences at set times showed a decreasing intervention effect over time on weight 
change, a significant difference in losing 5 kg or 5% baseline weight in favor of the 
intervention group before 24 months, but in favor of the control group after 24 months. 
An increasing intervention effect over time was found on change in physical activity. 
table 2 shows the adjusted differences in weight change over time. table 3 shows the 
adjusted differences in physical activity over time.
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Figure 2 Weight change presented as means ± SEM, proportion of participants that lost 5 kg or 5% base-
line weight presented in percentages, n= 407
* Significant unadjusted difference in weight change and in proportion of participants that lost 5 kg or 5% 
baseline weight (P<0.05), calculated using Student’s T-test and Fisher’s exact test, respectively
† Significant difference in weight change only (P<0.05), calculated using Student’s T-test
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Figure 3 Change in physical activity from baseline, measured using SQUASH questionnaire, presented as 
means ± SEM, n = 407
* Significant unadjusted difference at set time point: P<0.05, calculated using Fisher’s exact test
† No significant difference, but trend: P<0.1, calculated using Fisher’s exact test
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table 2 Estimated differences in weight change between randomized groups at set times
Weight change (kg) Proportion that lost 5 kg or 5% (%)
Difference 95% CI Effect size1 OR 95% CI Effect size1
intention to treat analysis
6 months 1.34 0.46, 2.22 0.22 2.10 1.30, 3.35 0.22
12 months 1.22 0.35, 2.09 0.20 1.62 1.14, 2.31 0.20
18 months 1.11 0.22, 1.99 0.18 1.26 0.96, 1.65 0.13
24 months 0.99 0.07, 1.91 0.16 0.98 0.75, 1.27 -0.01
30 months 0.87 -0.10, 1.84 0.13 0.76 0.54, 1.06 -0.12
80 months -0.11 -2.00, 1.77 -0.01 0.59 0.37, 0.92 -0.21
Per protocol analysis
6 months 2.18 0.93, 3.43 0.25 3.90 2.19, 6.89 0.34
12 months 2.08 0.85, 3.31 0.24 2.70 1.77, 4.14 0.34
18 months 1.98 0.73, 3.23 0.23 1.87 1.34, 2.60 0.28
24 months 1.88 0.58, 3.18 0.22 1.29 0.92, 1.83 0.11
30 months 1.78 0.40, 3.16 0.19 0.90 0.57, 1.42 -0.04
80 months 0.95 -1.76, 3.66 0.06 0.62 0.34, 0.87 -0.14
1Effect size presented as Cohen’s D: adjusted mean difference divided by the pooled standard deviation.
Differences in weight change were estimated using a linear mixed model with treatment, time in months 
and a treatment by time interaction as independent variables. Odds ratios were calculated with General-
ized Estimating Equations with the same independent variables.
table 3 Estimated differences in physical activity between randomized groups at set times
Change in physical activity1 (%)
Difference 95% CI Effect size2
intention to treat analysis
6 months 15.15 1.65, 28.64 0.16
12 months 16.33 2.83, 29.84 0.17
18 months 17.52 3.70, 31.33 0.19
24 months 18.70 4.30, 33.10 0.19
30 months 19.89 4.66, 35.11 0.19
80 months 29.76 2.32, 57.19 0.19
Per protocol analysis
6 months 6.20 7.83, 20.24 0.06
12 months 6.84 6.80, 20.48 0.07
18 months 7.48 5.94, 20.90 0.08
24 months 8.11 5.28, 21.50 0.09
30 months 8.75 4.80, 22.30 0.09
80 months 14.05 6.40, 34.51 0.12
1 Measured using the SQUASH questionnaire (25, 26), in percentage change relative to baseline measure-
ment
2Effect size presented as Cohen’s D: adjusted mean difference divided by the pooled standard deviation.
Differences were estimated using a linear mixed model with treatment, time in months and a treatment by 
time interaction as independent variables.
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Per protocol analyses showed greater effects on weight change over time, but the 
changes in physical activity were not significant in the per protocol analyses. None of 
the other outcome measures showed significant differences between the randomized 
groups.
DisCussiOn
The present study provides evidence that a tailor-made weight loss intervention con-
tributes to long-term behavioral changes. Physical activity was significantly higher in 
the intervention group until the end of follow-up time. Weight loss was overall higher in 
the intervention group, but no significant difference was found at the end of follow-up.
Analyses showed that the group of participants that completed the study was in fact 
a selective group with more favorable health parameters. This indicates that the group 
‘completers’ was a healthier group, making it possibly easier for them to lose weight. This 
could have resulted in overestimation of the intervention effect, especially the long-
term effect, since the time interval between 2.5 years and 6.6 years only contained these 
participants. However, the association of total cholesterol was different in direction than 
hypertension and HbA1c, making it less obvious this group was in fact significantly 
healthier than the other. Moreover, the linear mixed model was fitted using all data 
available, instead of only data from completers. Using this method, overestimation of 
the intervention effect due to the fact that the ‘completers’ might have been a healthier 
group, is less likely to have occurred.
A pragmatic approach with a tailor-made intervention was chosen for this interven-
tion, in contrast to many weight loss interventions that describe strict regimes for diet 
and exercise. This choice was made because of implementation reasons and because 
high compliance rates and low attrition rates were expected as a result of this method 
7 11. Moreover, it was expected that this approach was more likely to induce long-term 
maintenance of weight loss. Attrition rates were indeed low in the first 2.5 years. How-
ever, for the last measurement just 60.7% of the participants were available. Since very 
few to none weight loss interventions in literature present a follow-up time beyond 30 
months, we cannot compare this rate to others 3 7.
Compliance rates were comparable to those of many weight loss and lifestyle inter-
ventions 35. Seemingly, the pragmatic approach of the present study, using motivational 
interviewing and a tailor-made intervention, has not led to higher adherence to the 
intervention. A possible explanation for these disappointing figures is the fact the 
study population was already highly motivated to lose weight; at baseline, 88% of all 
participants indicated to prefer being randomized to the intervention group. Possibly 
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motivational interviewing has more success increasing compliance rates in a less moti-
vated population.
Due to ethical reasons, the control group was free to undertake any measures to re-
duce weight on their own. Naturally, all participants were informed of the higher risk of 
knee osteoarthritis due to their overweight and the possible preventive effect of weight 
loss, which was the main objective of the PROOF study. The mean weight changes over 
time in the control group were not as expected. The first 30 months mean weight change 
fluctuated, but at 2.5 and at 6.6 years, mean weight changes were close to zero. Fildes 
et al. showed that the probability of an overweight or obese person to remain stable in 
weight over time is low 36. We expected the control group to gain weight steadily over 
time. In addition, there was a substantial proportion of participants in the control group 
that reached the goal of losing 5 kg or 5% of their baseline weight, up to 22% at 6.6 years 
of follow-up. It is likely that participation in this study has influenced weight course over 
time positively in the control group and consequently caused underestimation of the 
intervention effect.
Despite the low compliance rates in the intervention group and the relatively high 
weight loss in the control group, significant differences in weight change were observ-
able and for change in physical activity, this effect lasted for the total follow-up time and 
even increased over time. The magnitude of these effects are comparable to those of 
many lifestyle interventions with considerably shorter follow-up periods 2 3 7. Moreover, 
per protocol analyses showed greater intervention effects on weight change, confirm-
ing the efficacy of the intervention. Because of the lack of weight loss studies reporting 
on a follow-up period of more than 30 months, we cannot compare this effect with other 
studies.
Regarding secondary outcome measures, only change in physical activity showed 
a significant intervention effect. It is remarkable that mean physical activity in the in-
tervention group rose 28% in the first six months pertaining to the baseline physical 
activity, before remaining quite stable at that level, while the control group remained 
quite stable until 2.5 years, before declining to –13% at 6.6 years. This shows that the 
intervention had its effect on physical activity in the first six months, which endured for 
the subsequent six years, resulting in a difference at 6.6 years which was still significant. 
Additionally, the estimated differences at set times show an increasing intervention ef-
fect over time on change in physical activity. However, in the per protocol analysis we 
did not find a significant intervention effect on physical activity level. This indicates the 
participants that were randomized to the intervention became on average more physi-
cally active, but this was not due to their visits to the dietician or the physical activity 
classes. No intervention effect was found on nutritional habits. However, only separate 
components of the questionnaire assessing nutritional habits could be assessed, since 
no total caloric intake could be calculated from the results. In conclusion, this study de-
93
1
2
3
4
5
6
7
8
9
10
11
scribes the effectiveness of a tailor-made weight loss intervention conducted in primary 
care with a follow-up period of 6.6 years. A long lasting intervention effect on change in 
physical activity was seen over this period of time. Differences in weight change were 
small, and not significant after 24 months, but the literature suggests an increase in 
physical activity alone can also improve health outcomes, without affecting actual body 
weight 1. Since this intervention was especially aimed at long-term maintenance of 
lifestyle changes, it can be considered effective and provides proof that a tailor-made 
weight loss intervention can, in fact, induce lifestyle changes which endure over a long 
period of time.
Recommendations for future research include long follow-up periods, including post-
intervention follow-up, in order to make comparison between long-term weight loss 
maintenance figures possible. In addition, motivational interviewing seems effective in 
promoting long-term behavioral changes, but careful considerations should be made 
regarding the specific approach of the intervention 13 14. In the present study, the inter-
vention effect found on physical activity could not be attributed to compliance to the 
intervention.  This warrants more research regarding the most effective approach and, 
more specifically, the most optimal setting to deliver the intervention. Unfortunately, to-
tal caloric intake could not be calculated in the present study, impeding the possibilities 
of assessing intervention effects on dietary intake and habits. Future research should 
thoroughly investigate possibilities to measure these parameters reliably. Since the 
per protocol analyses showed greater effects on weight change than the intention to 
treat analyses, it is expected that higher compliance rates could result in greater effects. 
Therefore, optimizing compliance rates should be given high priority in future studies.
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aBstraCt
Background
The present study aimed to evaluate the effect of a lifestyle intervention aimed to re-
duce body weight and of oral glucosamine sulfate on the incidence of knee OA after 6 - 7 
years in a population of middle-aged, overweight women, without knee OA at baseline.
methods and Findings
The PROOF study (PRevention of knee Osteoarthritis in Overweight Females, ISRCTN 
42823086) was a randomized controlled trial with a 2 x 2 factorial design. 407 women 
aged 50 - 60 years with a BMI of ≥27 kg/m² and free of knee osteoarthritis were ran-
domized. 477 knees from 245 participants were available after a mean follow-up time 
of 6.6 years. 19% of all knees showed incident knee OA. Both interventions showed no 
significant preventive effect on incident knee OA. Despite the fact per protocol analyses 
showed greater differences between both groups for the lifestyle intervention, signifi-
cance was not reached. A significant effect of losing ≥ 5 kg or ≥ 5% of baseline weight in 
the first 12 months on the incidence of knee OA according to the primary outcome was 
found (OR 0.10; 95% CI, 0.02-0.41).
Conclusions
No significant preventive effect on incident knee OA of either the lifestyle intervention or 
the glucosamine intervention was found. As a proof of concept, the preventive effect of 
moderate weight loss in one year on the incidence of clinical knee OA is demonstrated. 
This trial provides important insights for future studies on the prevention of knee OA, 
which are currently lacking.
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intrODuCtiOn
The association between obesity and knee osteoarthritis (OA) has been extensively 
described in literature.1 The majority of these studies have focussed on obesity as a risk 
factor or weight loss as a treatment for knee OA in individuals with obesity.1-4 Consider-
ing the increasing body of evidence stating that obesity is an important risk factor for 
knee OA, the options of primary prevention by weight loss should be investigated.5 As 
early as 1992, results from The Framingham Study suggested a preventive approach to 
knee OA by weight loss.6 Thereafter, few trials were specifically designed to study the 
preventive effect of weight loss on knee OA, despite recommendations in literature to 
design preventive trials.6-9 Recent results of trials investigating the effect of weight loss 
on intermediate outcomes, such as cartilage thickness or chronic pain, 10 11 support the 
hypothesis that weight loss can prevent the development of knee OA, as suggested by 
Felson et al. in 1992.6 Recommendations made in literature regarding the design of a trial 
investigating the preventive effect of weight loss on knee OA often include: a random-
ized design, a high-risk population of overweight, middle-aged participants without 
knee OA, a long follow-up period and clinical and radiographic outcome measures.6-9 12
In addition, recommendations have been made to study the efficacy of pharmaco-
logical substances, such as glucosamine.13 A large review found an overall significant 
beneficial effect of glucosamine on pain and function of the knee in participants with 
established knee OA.14 However, the heterogeneity of the included studies was very 
high. In fact, pooled results from high quality studies failed to show a significant effect 
of glucosamine.14 Literature suggests that in patients in an earlier stage of disease, larger 
effects could be found.15 Furthermore, glucosamine has been shown to modify disease 
progression, raising the question whether it would be more effective as a preventive in-
tervention rather than as a treatment.5 15 The above mentioned review found the safety 
of glucosamine to be equal to placebo, making a trial investigating the preventive effect 
of glucosamine on the development of knee OA feasible.14
The objective of the present study was to evaluate the long-term effectiveness of a 
tailor-made weight loss intervention, using diet and exercise, and of oral glucosamine on 
the incidence of knee OA in a high risk population of overweight, middle aged women 
without knee OA at baseline. Previously, short-term results of the trial were published, 
showing no significant preventive intervention effects on knee OA.16 17 It was hypoth-
esized that prolonging the follow-up time could possible result in greater effects. The 
present study focusses on the long-term effectiveness 6-7 years after randomization.
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methODs
In 2005, approval from the Medical Ethics Committee of Erasmus MC was obtained for 
the PROOF Study (Prevention of knee Osteoarthritis in Overweight Females, ISRCTN 
42823086). All participants provided informed consent. The present manuscript was 
prepared according to the CONSORT Statement guidelines.18 A full description of the 
study protocol has been published elsewhere.17 In short, in a 2 x 2 factorial design the 
preventive effect of both a diet and exercise program (DEP) and of oral glucosamine 
sulfate (OGS) on the incidence of knee OA was investigated. For the diet and exercise 
program, the study was open-labelled, the glucosamine intervention was double-blind 
and placebo-controlled.
recruitment and randomization
From July 2006 to May 2009, 50 general practitioners from the Erasmus MC network 
contacted all women aged 50 to 60 years registered at their practices. Additional infor-
mation was sent to all interested women with a self-reported body mass index (BMI) of 
≥27 kg/m². Inclusion and exclusion criteria were checked by telephone: age 50 to 60 
years, BMI ≥27 kg/m², free of ACR criteria for knee OA (clinical American College of Rheu-
matology criteria19), no contra-indications for MRI, no rheumatic diseases, not using a 
walking aid, not under treatment for knee complaints, mastering the Dutch language, 
and no use of oral glucosamine during the past six months. All women who were willing 
to participate and who met all inclusion criteria were invited for baseline measurements 
and randomization. For both interventions, participants were randomized 1:1 using 
block size 20 in block randomization.
measurements
At baseline, physical examination was performed by research assistants, measuring: 
body weight, body height, knee pain upon pressure at the joint margins, warmth and 
crepitations of both knees,   and Heberden’s nodes in both hands. Also, semi-flexed 
posterior-anterior knee radiographs were taken according to the metatarsophalangeal 
protocol.20 These measurements were repeated after 2.5 years of follow-up and after 
6 - 7 years of follow-up. The radiographs were scored using Kellgren & Lawrence (K&L) 
criteria.21 All radiographs were scored by a trained researcher, blinded for treatment as-
signment and clinical outcomes. Interobserver variability was determined by a second 
blinded researcher who scored a subset of 20% of the radiographs. Digitally, medial knee 
alignment was measured and varus alignment was defined as an angle of <178 degrees.
Participants filled out a questionnaire every six months for the first 2.5 years and 
one after 6 - 7 years recording number of days with knee pain, physical activity, co-
interventions and quality of life. Physical activity was measured using the validated 
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SQUASH questionnaire (Short Questionnaire to Assess Health-enhancing physical activ-
ity).22 23 Quality of life was measured using the validated EQ-5D EuroQol questionnaire.24 
In addition, participants filled in questions on knee complaints, menopausal status, 
comorbidities and filled in the Knee injury and Osteoarthritis Outcome Score (KOOS) 
questionnaire at baseline, 12 months, 2.5 years and 6 - 7 years.25 Mild knee symptoms 
were defined as having any knee pain in the past 12 months.
Participants were visited at home every six months for the first 2.5 years to measure 
body weight, to check the questionnaire for unanswered questions and to replace the 
batch of study drugs with a new one. The retrieved batch was used for objective calcula-
tion of compliance.
interventions
Both interventions are described in detail elsewhere.16 17 In short, participants random-
ized to the DEP were referred to a local dietitian, agreements were made on frequency 
of visits, and personal goals regarding nutritional patterns and physical activity were set. 
All dietitians were trained in motivational interviewing in order to tailor the intervention 
to the participant’s individual needs and possibilities.26 In addition, participants were 
invited to participate in a series of 20 weekly physical exercise classes. These 1-hour 
classes were supervised by a physiotherapist, were offered near participants’ homes and 
were conducted in small groups of 12-15 participants. The goal of these classes was to 
regain pleasure in physical exercise and to find activities suited for long-term continua-
tion. A wide variety of low-impact sports were offered. Participants in the control group 
did not receive this intervention, but were free to independently take any actions to 
improve their health.
Participants randomized to OGS were prescribed 1500 mg of oral crystalline glucos-
amine sulfate per day for 2.5 years. Participants in the control group received placebo. 
All study drugs were provided by Rottapharm Madaus. There was no involvement of Rot-
tapharm Madaus in study design, data collection or statistical analyses. All participants 
and research staff were blinded for allocation during these 2.5 years. After the interven-
tion ended, observation of participants continued for four years.
statistical analyses
Baseline characteristics were presented as means ± standard deviation (SD) for numeri-
cal variables and proportions for categorical variables. Baseline differences were tested 
using 2-tailed independent t-tests for numerical variables and Fisher’s exact test for 
categorical variables. Incidence figures on knee OA were presented per knee.
Primary outcome measure for the present study was the incidence of knee OA after 
6 - 7 years, according to the combined clinical and radiological ACR criteria. Secondary 
outcome measure was the incidence of knee OA after 6 - 7 years, defined as K&L grade 
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2 or higher. Analyses were performed on knee level. OA was considered an irreversible 
process. Therefore, all knees that met ACR criteria at 2.5 years of follow-up or at 6 - 7 years 
of follow-up were considered positive for knee OA for the primary outcome. Because 
initial screening of inclusion criteria was done by phone, it was expected there would be 
a proportion of participants that met ACR criteria or showed K&L grade ≥2 for one or two 
knees at baseline already. These knees were excluded from the analysis.
Intention to treat (ITT) analysis served as primary analysis. The intervention effect on 
the primary and secondary outcome measures was tested using Generalized Estimating 
Equations (GEE), since this method takes the correlation of both knees of one participant 
into account. Effects were reported as odds ratios (OR) with 95% confidence intervals 
(CI). First, the associations between known prognostic variables and the outcome were 
tested with univariate GEE analyses. Age, K&L grade ≥1 versus 0, varus alignment, mild 
knee symptoms, BMI, a history of knee injury, Heberden nodes and postmenopausal 
status were tested accordingly. Next, all variables with a P-value <0.2 were analysed 
using multivariate GEE analysis. All variables with a P-value <0.05 in the multivariate 
model were adjusted for in the analyses testing the intervention effects. This was done 
separately for the primary and secondary outcome measures. Additionally, all analyses 
were adjusted for follow-up duration in months, since follow-up time was not equal for 
all participants, due to the large period of recruitment (July 2006 to May 2009). Using the 
GEE model, interaction between both interventions was assessed. In case of significant 
interaction, all four groups would be assessed separately.
For the pre-defined per protocol (PP) analyses, participants that were compliant to the 
intervention were compared to the participants that were randomized to the control 
group. Compliance to the DEP intervention was defined as having visited the dietitian 
at least six times and having attended at least seven physical activity classes. Regarding 
the OGS intervention, an objective compliance calculation of ≥75% was used, which was 
assessed using the retrieved study drugs batches.
As an explanatory analysis, incident knee OA was compared between participants that 
lost 5 kg or 5% of their baseline weight at one year of follow-up and participants that 
did not meet this pre-defined goal in the first year of the study. This outcome served as 
primary outcome of the weight loss intervention and was chosen for its associations 
with improvement of cardiovascular risk factors.16 We hypothesized that achieving this 
goal in the period of one year could possibly be an easily achievable goal to recommend 
patients in primary care in the context of preventing knee OA. Adjusting for follow-up 
duration and confounding factors, as in the ITT and the PP analyses, GEE was used for 
this analysis.
To estimate the effect of the missing data, multiple imputation was performed, as 
recommended in literature.27 50 imputed datasets were used, method was set to auto-
mated selection of linear regression or predictive mean matching, maximum iterations 
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was set to 20 and a maximum of 150 parameters per variable was used. All variables 
used in the GEE, including the outcome variables, were imputed and used as predictors. 
Both baseline characteristics and follow-up data were used as auxiliary variables.
As a sensitivity analysis, a worst case scenario was explored according to literature 
recommendations.28 We hypothesized that no intervention effect at all would be the 
worst case scenario. Therefore, in all participants with missing data, the outcome was 
imputed evenly distributed over the two groups that were compared, resulting in an 
equal incidence of knee OA in both groups in all participants with missing data. The 
incidence found in the completers’ analysis was used to impute these variables. Missing 
values in covariates used in the GEE model were imputed by the average value of the 
completers. The results of the sensitivity analysis were used to check the plausibility of 
the results produced by the multiple imputation model.
All analysis were performed using IBM SPSS statistics version 21 (SPSS Inc, Chicago, IL). 
In all analysis, a P-value < 0.05 was defined as statistically significant.
results
407 women were randomized after 50 general practitioners contacted 6691 women. 
Full description of the selection process is published elsewhere.17Figure 1 shows the 
selection process and participants lost to follow-up with reasons. At baseline, knee OA 
data were available for 405 participants with 810 knees (99.5%). After 2.5 years, there 
were 356 participants for whom knee OA data was available on 712 knees (87.5%). After 
6.6 years, 260 participants supplied knee OA data on 508 knees (62.4%). At baseline, 32 
knees (4.0%) met ACR criteria and were excluded from analyses, concerning the primary 
outcome. In addition, 51 knees (6.3%) showed K&L grade ≥2 and were excluded from 
analyses, concerning the secondary outcome. As a result, knee OA data were available 
on 477 knees (58.9%) for the primary outcome measure and for the secondary outcome 
measure knee OA data on 452 knees (55.8%) was available. Attrition rates were similar 
between both randomized groups of the DEP intervention: 27% in the intervention 
group versus 31% in the control group. For the OGS intervention, attrition rates were 
higher in the placebo group: 35% versus 18% in the intervention group. Participants 
that completed the long-term follow-up had a lower baseline BMI (32.0 versus 33.0) 
and more Heberden’s nodes (18% versus 15%). Baseline knee OA incidence figures were 
similar between participants that completed the follow-up time and those that did not: 
4% versus 4% for the primary outcome and 5% versus 8% for the secondary outcome.
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table 1 shows baseline characteristics on the 508 knees from 260 participants that were 
available after complete follow-up. Mean follow-up time was 6.6 ± 0.7 years. There were 
no significant differences in baseline characteristics between both groups for both inter-
ventions. In the multivariate analysis, three baseline characteristics were associated with 
the primary outcome: BMI, K&L grade ≥1 versus 0 and mild knee symptoms. Regarding 
the secondary outcome, BMI, K&L grade ≥1 versus 0 and a history of knee injury were as-
sociated with the outcome in a multivariate model. Consequently, adjustment of these 
variables was performed in all analyses.
 
50 general practitioners contacted all women between 50 and 60 
years registered at their practice (6691 women) 
3094 women (46%) returned the reply-card to 
the research institute 
1358 women (44%) were not 
interested 
1736 women (56%) were 
interested 
847 women (49%) were 
excluded because BMI, based 
on reported body weight and 
height was  
< 27 kg/m² 
889 women (51%) with BMI ≥ 
27 kg/m² were sent additional 
information 
After screening on all in- and exclusion criteria by phone, 407 
women (46%) were eligible and were invited for baseline 
measurements 
Randomization 
DEP + placebo 
N=101 
DEP + OGS 
N=102 
Control + placebo 
N=102 
Control + OGS 
N=102 
36 women lost 
to follow-up 
after 6.6 years 
(32 unwilling, 3 
died, 1 
unattainable) 
37 lost to follow-up 
after 6.6 years (31 
unwilling, 4 
unattainable, 1 
side-effects, 1 died) 
45 lost to 
follow-up after 
6.6 years (39 
unwilling, 4 
unattainable, 2 
side-effects) 
42 lost to 
follow-up after 
6.6 years (40 
unwilling, 1 
unattainable, 1 
died) 
8 knees 
excluded (met 
ACR criteria at 
baseline) 
4 knees 
excluded (met 
ACR criteria at 
baseline) 
2 knees 
excluded (met 
ACR criteria at 
baseline) 
7 knees 
excluded (met 
ACR criteria at 
baseline) 
125 knees 
analysed in 
primary analysis 
129 knees 
analysed in 
primary analysis 
112 knees 
analysed in 
primary analysis 
111 knees 
analysed in 
primary analysis 
Figure 1 Flowchart of recruitment process
DEP: diet and exercise programme, OGS: oral glucosamine sulfate
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Compliance rates
Since the DEP intervention was tailor-made, frequency and total number of visits to the 
dietitian varied widely. Of all participants randomized to the DEP, 11% did not meet with 
their dietitian once. For 51% of all participants, six or more visits were recorded. As for 
the physical activity classes, of which 20 were offered, 43 (21%) of the participants never 
participated in these, while 116 (57%) participated in at least seven classes. Participants 
that met both above mentioned criteria, were considered compliant to the DEP inter-
vention, resulting in a compliance rate of 32%.
Regarding the compliance to the OGS intervention, 133 (65%) of all participants were 
compliant.
intervention effects
After 6.6 years, the overall incidence of knee OA according to the primary outcome was 
19%. No significant interaction between both interventions was found. Intention to 
treat analysis showed no significant difference in knee OA between randomized groups, 
table 1 Means and distribution (± st. dev) of prognostic variables.
Diet & Exercise Program Oral Glucosamine Sulfate
Control group Intervention group Placebo Glucosamine
Baseline characteristics
N - subjects 122 138 130 130
Age (yr.) 55.9 ± 3.2 55.6 ± 3.2 55.7 ± 3.2 55.8 ± 3.1
BMI (kg/m²) 32.1 ± 4.1 31.9 ± 3.9 32.4 ± 4.2 31.6 ± 3.6
Postmenopausal status 73.7% 65.4% 70.4% 68.3%
Heberden’s nodes 29.4% 27.0% 31.2% 25.0%
N - knees 238 270 253 255
ACR* 3.8% 4.5% 4.0% 4.3%
K&L**
Grade 0 49.6% 48.5% 49.4% 48.6%
Grade 1 47.0% 44.8% 44.6% 47.1%
Grade ≥ 2 3.4% 6.7% 6.0% 4.3%
Minimal JSW
Medial (mm) 4.8 ± 0.7 4.7 ± 0.8 4.7 ± 0.8 4.8 ± 0.8
Lateral (mm) 6.2 ± 1.0 6.2 ± 1.1 6.1 ± 1.1 6.2 ± 1.0
Varus alignment 44.4% 39.5% 43.0% 40.6%
Mild symptoms*** 32.4% 32.3% 32.8% 31.9%
History of knee injury 15.0% 10.9% 12.1% 13.5%
* Knee OA according to the ACR criteria. ** Kellgren and Lawrence grades. *** Mild symptoms defined as 
any pain in the concerned knee in the past 12 months.
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for both the DEP intervention (OR 0.86, 95% CI: 0.47, 1.54) and the OGS intervention (OR 
1.58, 95% CI: 0.86, 2.89). Regarding the secondary outcome, knee OA incidence was 14%, 
with also no differences between both groups for both interventions.
Per protocol analysis showed greater intervention effects for the DEP than the inten-
tion to treat analysis, though did not reach statistical significance with odds ratios of 
0.55 (95% CI: 0.23, 1.33) for the primary outcome and 0.39 (95% CI: 0.12, 1.29) for the 
secondary outcome. For the OGS intervention, effects in the PP were not consistently 
greater. The intervention effect on the primary outcome did not change significantly, 
while the intervention effect on the secondary outcome changed in direction. Odds 
ratios for the secondary outcome were 0.96 (95% CI: 0.48, 1.92) for the PP and 1.26 
(0.67, 2.39) for the ITT. All incidence numbers and odds ratios obtained from ITT and PP 
analyses are presented in table 2.
table 2 Incidence figures and odds ratios on knee OA from intention to treat and per protocol analyses
Incident knee 
OA
Incident knee 
OA intervention 
group
Incident knee 
OA control 
group
OR (adjusted)† 95% CI
intention to treat analyses
Diet and exercise program ( n=477: 254 vs 223)
ACR criteria* 19% 18% 19% 0.86 0.47-1.54
K&L grades** 15% 14% 16% 0.91 0.48-1.72
Oral glucosamine sulfate (n=477: 240 vs 237)
ACR criteria 19% 20% 17% 1.58 0.86-2.89
K&L grades 15% 15% 14% 1.26 0.67-2.39
Per protocol analyses
Diet and exercise program (n=305: 82 vs 223)
ACR criteria 18% 13% 19% 0.55 0.23-1.33
K&L grades 14% 8% 16% 0.39 0.12-1.29
Oral glucosamine sulfate (n=413: 176 vs 237)
ACR criteria 18% 19% 17% 1.64 0.86-3.14
K&L grades 13% 12% 14% 0.96 0.48-1.92
exploratory analysis††
Lost 5 kg or 5% in one year (n=477: 69 vs 408)
ACR criteria 19% 7% 21% 0.10 0.02-0.41
K&L grades 15% 6% 16% 0.28 0.08-0.94
* Knee OA according to the ACR criteria. ** Knee OA, defined as K&L grade ≥ 2. † GEE adjusted for baseline 
differences and confounding factors. †† Comparing the incidence of knee OA between participants that 
lost 5 kg or 5% of their baseline weight in the first year of follow-up versus all participants that did not lose 
this amount of body weight in the first year of follow-up. NB. Numbers are numbers of knees.
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exploratory analysis
69 participants achieved the goal of losing 5 kg or 5% of their baseline body weight after 
one year of follow-up. These participants showed a lower incidence of knee OA after 6.6 
years than participants that did not achieve this goal at one year of follow-up (7% versus 
21%). Adjusted odds ratio for the primary outcome was 0.10 (95% CI 0.02, 0.41) and 0.28 
(95% CI: 0.08, 0.94) for the secondary outcome. Table 2 shows these odds ratios.
multiple imputation
Pooled odds ratios obtained from the imputed datasets showed no significant interven-
tion effects. Incidence numbers were markedly higher than in the original data. In these 
analyses, both interventions showed greater effects in the PP analyses compared with 
the ITT analyses. The association between losing 5 kg or 5% baseline weight became 
table 3 Incidence figures and odds ratios after multiple imputation
Incident knee 
OA
Incident knee 
OA intervention 
group
Incident knee 
OA control 
group
OR (adjusted)† 95% CI
intention to treat analyses
Diet and exercise program
ACR criteria* 31% 29% 33% 0.84 0.49-1.44
K&L grades** 28% 26% 31% 0.83 0.45-1.53
Oral glucosamine sulfate
ACR criteria 31% 32% 30% 1.07 0.63-1.81
K&L grades 28% 28% 29% 0.92 0.56-1.52
Per protocol analyses
Diet and exercise program
ACR criteria 30% 22% 33% 0.57 0.27-1.22
K&L grades 27% 18% 31% 0.47 0.19-1.19
Oral glucosamine sulfate
ACR criteria 28% 25% 30% 0.81 0.44-1.51
K&L grades 25% 20% 29% 0.61 0.34-1.10
exploratory analysis††
Lost 5 kg or 5% in one year
ACR criteria 31% 22% 32% 0.54 0.23-1.31
K&L grades 28% 20% 30% 0.56 0.22-1.43
* Knee OA according to the ACR criteria. ** Knee OA, defined as K&L grade ≥ 2. †GEE adjusted for baseline 
differences and confounding factors. †† Comparing the incidence of knee OA between participants that 
lost 5 kg or 5% of their baseline weight in the first year of follow-up versus all participants that did not lose 
this amount of body weight in the first year of follow-up.
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less strong and non-significant. table 3 shows all incidence numbers and odds ratios 
obtained from the multiple imputation datasets.
sensitivity analysis
Odds ratios obtained from the worst case scenario were very similar to the completers’ 
analysis. Naturally, all effects decreased; all odds ratios moved closer to one. Regarding 
the DEP intervention, the OR for the primary outcome changed from 0.86 (0.47, 1.54) to 
0.97 (0.65, 1.45) and OR for the secondary outcome changed from 0.91 (0.48, 1.72) to 
0.95 (0.60, 1.49). Regarding the OGS intervention, OR for the primary outcome changed 
from 1.58 (0.86, 2.89) to 1.07 (0.71, 1.60) and OR for the secondary outcome changed 
from 1.26 (0.67, 2.39) to 1.03 (0.67, 1.60). None of the associations changed in direction 
and none of the confidence intervals which included one in the completers’ analysis 
table 4 Incidence figures and odds ratios after worst case scenario
Incident knee 
OA
Incident knee 
OA intervention 
group
Incident knee 
OA control 
group
OR (adjusted)† 95% CI
intention to treat analyses
Diet and exercise program
ACR criteria* 19% 19% 19% 0.97 0.65-1.45
K&L grades** 14% 14% 14% 0.95 0.60-1.49
Oral glucosamine sulfate
ACR criteria 19% 20% 18% 1.07 0.71-1.60
K&L grades 14% 15% 14% 1.03 0.67-1.60
Per protocol analyses
Diet and exercise program
ACR criteria 18% 14% 19% 0.68 0.35-1.33
K&L grades 13% 10% 14% 0.55 0.24-1.27
Oral glucosamine sulfate
ACR criteria 19% 21% 18% 1.19 0.74-1.89
K&L grades 13% 12% 13% 0.99 0.57-1.69
exploratory analysis††
Lost 5 kg or 5% in one year
ACR criteria 19% 11% 20% 0.45 0.23-0.90
K&L grades 14% 8% 15% 0.43 0.20-0.93
* Knee OA according to the ACR criteria. ** Knee OA, defined as K&L grade ≥ 2. †GEE adjusted for baseline 
differences and confounding factors. †† Comparing the incidence of knee OA between participants that 
lost 5 kg or 5% of their baseline weight in the first year of follow-up versus all participants that did not lose 
this amount of body weight in the first year of follow-up.
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became significantly different from one, or vice versa. All odds ratios obtained from the 
sensitivity analysis are presented in table 4.
DisCussiOn
The present study presents the long-term results of the first preventive randomized 
controlled trial in knee OA. Intention to treat analyses showed no significant effects of 
either the diet and exercise program or of the glucosamine sulfate on the long-term 
incidence of knee OA according to ACR criteria. Also, no effects were found on incidence 
of knee OA, defined as K&L grade ≥2. Per protocol analyses showed greater effects for 
the DEP, but significance was not reached. For OGS, effects were not uniformly larger in 
the per protocol analyses. As a proof-of-concept, the present study demonstrated the 
preventive effect of losing 5 kg or 5% of baseline body weight in the first year of the 
study on the incidence of knee OA after 6.6 years.
The primary analysis of the present study is a completers’ analysis. As a result, under- or 
overestimation of the intervention effect could have occurred. Weight loss studies often 
suffer from high dropout rates, resulting in a wide variety of methods used to handle 
missing data.27 Multiple imputation was recommended in literature as best method for 
handling missing data in obesity randomized controlled trials.27 However in the current 
study, multiple imputation led to markedly higher incidence numbers of knee OA. In the 
original data the incidence was 19% and 14% for the primary and secondary outcome, 
respectively. In the multiple imputation datasets, these incidence numbers were 31% 
and 28%. These numbers are markedly higher than the range found in population based 
cohorts.29-32 Incidence numbers found in the completers’ analyses were much more com-
parable to the incidence numbers reported in literature, giving rise to the question as 
to how reliable the multiple imputation was. When only looking at the participants with 
missing data on the outcome, the imputed incidence numbers were 50% for the primary 
and secondary outcome; more than double the incidence numbers in the completers’ 
analysis. Moreover, some of the odds ratios obtained from the multiple imputation sets 
were outside of the range of the odds ratios found in the completers’ analysis and the 
worst case analysis. For instance, in the exploratory analyses odds ratios from multiple 
imputation were closer to one than odds ratios from the worst case scenario. Since the 
worst case scenario simulated the scenario of no intervention effect at all in participants 
with missing data, this would indicate that the preventive effect of losing 5 kg or 5% 
baseline weight reversed in the participants with missing data, and actually increased 
the risk of incident knee OA. To our knowledge, an association between weight loss 
and knee OA in this direction has not been found before. Therefore, results from the 
multiple imputation model were considered unreliable. A possible explanation as to 
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why the multiple imputation model did not result in more plausible incidence rates, is 
the possibility that not all of the assumptions underlying multiple imputation were met, 
such as the missing data mechanism being random.33 Additionally, large amounts of 
missing data, especially on the outcome variable, can result in unreliable results and can 
introduce bias not present in a completers’ analysis.34
The present study pioneered in the prevention of knee OA and is to our knowledge 
the first to investigate the prevention of knee OA with incidence of knee OA as primary 
outcome.17 Results presented by trials investigating the preventive effect of weight loss 
on intermediate outcomes indicated a high possibility of a preventive effect of weight 
loss on knee OA.10 11 The present study however, failed to find a significant interven-
tion effect. Two possible mechanisms could have caused underestimation of the 
intervention effect. First, weight loss in the control group was considerably higher than 
expected, possibly caused by a high baseline motivation to participate in a diet and 
exercise programme.35 As a result, the difference in weight loss between both groups 
was smaller than expected. Second, compliance rates were lower than expected. Just 
32% of all participants randomized to the intervention group were compliant to the 
intervention. Considering these possible reasons for underestimation of the interven-
tion effect, in addition to the fact that per protocol analyses showed greater effects than 
intention to treat analyses, a true preventive effect of weight loss on incident knee OA 
should be considered, despite the lack of significant findings in the present study. For 
this reason, as a proof of concept, the exploratory analysis was undertaken, which did 
show a significant effect of losing 5 kg or 5% of baseline body weight on incident knee 
OA in the completers’ analysis. This finding is consistent with intervention effects found 
on weight loss and physical activity.35
In conclusion, no long-term effectiveness in preventing incident knee OA of the 
DEP or of the OGS was found in the present study. However, the PP effects of the DEP 
intervention were greater than the ITT effects, indicating a possibility of a significant ef-
fect, would there have been higher compliance rates and a more representative control 
group. Exploratory analyses showed an association between losing 5 kg or 5% baseline 
weight and a considerable decrease in incident knee OA. This association indicates 
that weight loss could be a successful strategy in preventing knee OA in an overweight 
population, but needs further study. For the OGS, no indications of a preventive effect 
were found. Additionally, PP analyses did not show greater effects than ITT analyses. 
However, these conclusions should be interpreted with caution, since the large amount 
of missing data resulted in high uncertainty of the results. As illustrated in the present 
study, this problem cannot always be reliably mitigated through multiple imputation.
The present study provides important insights in the possibilities of preventing knee 
OA. A follow-up time of 6.6 years seems to be sufficient to study the development in 
knee OA, given the large differences in knee OA incidence between groups in the ex-
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ploratory analyses. Future research should further investigate the preventive effect of 
weight loss on incident knee OA. Adherence rates should be of the utmost importance 
when designing trials investigating prevention of knee OA. The present study illustrates 
the large consequences of missing data, resulting in high uncertainty about the validity 
and usefulness of conclusions drawn. Additionally, higher compliance rates should be 
given high priority, in order to achieve a clinically significant amount of weight loss in a 
considerable proportion of the study population. Weight loss remains challenging in the 
present population, but this study provides proof that the concept of preventing knee 
OA through weight loss is viable.
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aBstraCt
Background
The present study aimed to identify and describe subgroups of participants with differ-
ent longitudinal evolutions of physical activity over time following a lifestyle interven-
tion.
methods
Long-term data on physical activity from the PROOF study (PRevention of knee Osteo-
arthritis in Overweight Females, ISRCTN 42823086), a randomized controlled trial on the 
prevention of knee osteoarthritis through a lifestyle intervention, was analysed using 
latent class growth analysis. Additionally, the effect of changes in physical activity on 
incident knee osteoarthritis was assessed.
results
Two groups were identified with distinctly different trajectories of change in physical 
activity over time. A group of 42 participants showed a more favourable pattern of 
change in physical activity over time than the remaining 345 participants. Low baseline 
physical activity and low social participation increased the odds to benefit from the 
lifestyle intervention, regarding their physical activity; odds ratios for one point increase 
in physical activity score or one hour per week increase in social participation were 0.50 
(95% CI: 0.27, 0.93) and 0.69 (95% CI: 0.49, 0.99) respectively.
Conclusions
A lifestyle intervention aimed to increase physical activity has highest success in par-
ticipants with low physical activity and low social participation. An increase in physical 
activity in this group may lead to an increase in pain of the knees. These findings empha-
size the need to personalize lifestyle interventions to patients’ individual characteristics.
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intrODuCtiOn
The beneficial effects of increased physical activity on health outcomes, such as car-
diovascular risk factors, have been extensively described in literature1. Physical exercise 
even proved to have beneficial effects on health outcomes without affecting actual body 
weight2. Therefore, trials investigating lifestyle interventions often record participants’ 
physical activity level3-5. A large variety of instruments is used in literature to quantify 
this measure of interest, such as accelerometers or questionnaires6-8. Questionnaires are 
often used due to their relatively low costs and general usability for participants7 9.
Many interventional and observational studies that measure physical activity report 
on the cross-sectional relationships between physical activity and various variables, 
such as body weight, pain or quality of life2 10. However, very few studies investigate the 
longitudinal evolutions of physical activity over time11. Longitudinal trials that are avail-
able often focus on change in physical activity and often aim to increase the physical 
activity of their participants10 12. Mostly, the difference in physical activity between the 
end of the study and the baseline measurement is used as outcome measure2 10 12. How-
ever, changes in physical activity in between those two measurements could provide 
additional information. For example, a steady, consistent increase in physical activity 
over time could provide other health benefits than a highly fluctuating evolution of 
physical activity with relapses over time. Therefore, it would be useful to study the lon-
gitudinal evolutions of change in physical activity over time of participants of a lifestyle 
intervention. Certain baseline characteristics could be identified that increase the odds 
to follow a favorable pattern of change over time. These findings could aid in estimating 
prognoses and in specific targeting of participants for a particular intervention. In addi-
tion, the effect of particular patterns of change over time on several outcome measures 
could be assessed.
Latent class growth analysis (LCGA) is a technique that uses an objective method to 
identify homogeneous subgroups in a heterogeneous population13. Using this method, 
subgroups can be identified which are based on objective measures, instead of choos-
ing subgroups on self-chosen criteria. When applying LCGA to longitudinal data with 
repeated measurements, these subgroups each represent a particular pattern over 
time. This method has been proven to reliably classify participants into homogeneous 
subgroups when analyzing longitudinal data14 15.
All data used in the present study was derived from the PROOF Study (PRevention of 
knee Osteoarthritis in Overweight Females, ISRCTN 42823086), a randomized controlled 
trial on the prevention of knee osteoarthritis through a lifestyle intervention16. During 
this trial, physical activity level was measured repeatedly over time. Longitudinal data 
from the above mentioned randomized controlled trial was used earlier to successfully 
classify participants in different subgroups based on their body weight changes over 
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time17. The present study aimed to identify subgroups of participants of a lifestyle 
intervention with different longitudinal evolutions of physical activity over time. Sub-
sequently, associations between baseline characteristics and different longitudinal 
evolutions could be assessed to identify success factors of becoming physically more 
active. Finally, to show how LCGA derived subgroups can be used to study the effects of 
the modeled longitudinal change, the subgroups will be used to evaluate the effects of 
longitudinal changes in physical activity on incident knee osteoarthritis.
methODs
PrOOF study
Data used for the present study was retrieved from the PROOF study16. This randomized 
controlled trial investigated the preventive effect of a lifestyle intervention and of oral 
glucosamine sulfate on the incidence of knee OA in a 2 x 2 factorial design. Methods of 
the PROOF study have been published previously and are therefore not described in 
detail in the present manuscript16. In short, 407 women, aged 50 to 60 years, with a body 
mass index of 27 kg/m2 or higher, free of clinical knee OA, were randomized to a diet and 
exercise intervention group or to the control group. Because glucosamine use was not 
expected to have any effect on physical activity and because such an effect has not been 
found in earlier studies, the glucosamine intervention was disregarded in the present 
study. The diet and exercise intervention consisted of visits to a dietician and physical 
activity classes and lasted for 2.5 years. The main outcome of interest of the PROOF study 
after 6.5 years was incidence of knee OA according to clinical and radiographic American 
College of Rheumatology (ACR) criteria18. A secondary outcome measure was incidence 
of radiographic knee OA defined as Kellgren & Lawrence grade ≥ 219.
measurements
Physical activity was measured using the SQUASH questionnaire20. The Short QUestion-
naire to ASsess Health-enhancing physical activity (SQUASH) was developed by the 
Dutch National Institute of Public Health and the Environment7. This questionnaire was 
validated and proved to be useful for assessing physical activity and for categorizing 
adults according to the Dutch physical activity guideline21. All participants (n=407) 
received a SQUASH questionnaire to measure physical activity every 6 months for the 
first 2.5 years of the study. 4 years after the end of the intervention, all participants were 
asked to fill in a SQUASH questionnaire once more.
Baseline measurements included body weight, body length, quality of life (EQ-5D 
questionnaire22), social participation, educational level and hours of paid work. Social 
participation was presented as hours per week spent on work, voluntary work or study-
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ing. Educational level was separated in low (intermediate vocational training or lower) 
and high (high vocational training or academically educated). Additionally, the propor-
tion of participants that complied with the Dutch Activity Guideline was determined (at 
least five times 30 minutes of moderately intense physical activity per week)23.
statistiCal analyses
latent class growth analysis
Change in physical activity was calculated using the difference between each SQUASH 
score at a given time point and the baseline SQUASH score for that particular partici-
pant. Subsequently, this difference was divided by the baseline score of that particular 
participant, obtaining a relative change in  SQUASH score, relative to the baseline score, 
which was used in the LCGA. Using LCGA, models with 2 to 6 trajectory classes were 
tested, using linear, quadratic and cubic transformations of time, as well as taking a fixed 
variance over time into account versus a free variance. As recommended in literature, 
a number of indices of fit were used to identify the most optimal model: entropy, the 
Bayesian Information Criterion (BIC), the Akaike Information criterion (AIC), the Vuong-
Lo-Mendell-Rubin likelihood ratio test (VLMR-LRT) and the likelihood ratio test (LRT)13. 
Additionally, the shape of the trajectories and number of participants in each class was 
taken into consideration for the final decision on the optimal model13 24.
evaluation of success factors
Unadjusted differences in baseline characteristics between the identified subgroups 
were tested using one way ANOVA tests for continuous variables and Fisher’s exact tests 
for categorical variables. If LCGA identified just two subgroups, t-tests and Fisher’s exact 
test were used. Second, relationships between baseline characteristics, that could theo-
retically be associated with changes in physical activity, and assignment to one of the 
identified groups were tested using univariate multinomial regression. Here, posterior 
class membership probabilities were used as weights, as recommended in literature25 26. 
If LCGA identified just two subgroups, logistic regression was used. In these analyses, 
interactions between all baseline characteristics and the effect of the lifestyle interven-
tion were tested additionally.
effect of longitudinal change in physical activity on osteoarthritis development
As a post-hoc exploratory analysis, the effect of the identified trajectories on knee osteo-
arthritis development was studied. For this analysis, the relationship between the dif-
ferent longitudinal trajectories of change in physical activity and incidence of knee OA 
was tested using logistic regression with incidence of knee OA as dependent variable 
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and the variable indicating the subgroups identified by LCGA as independent variable. 
These analyses were adjusted for confounding factors. All baseline variables that theo-
retically could be associated with incidence of knee OA were tested on this relationship 
using logistic regression. Baseline variables that showed a significant association with 
the incidence of knee OA and all baseline variables that differed significantly between 
the identified groups were identified as possible confounders. Additional baseline 
characteristics were tested for this purpose, namely: WOMAC pain, WOMAC function 
and WOMAC stiffness27, a history of knee injury and mild knee symptoms. Mild knee 
symptoms were defined as having any knee pain in the past 12 months. These analyses 
were performed for knee OA according to ACR criteria and K&L grades separately. To 
assess the outcome of radiographic knee OA, knee radiographs were taken according to 
the metatarsophalangeal protocol28. The scoring of these radiographs was done using 
Kellgren & Lawrence criteria19.
Mplus version 7.3 (Muthén & Muthén, Los Angeles, CA, USA) was used for the LCGA. 
SPSS software version 21 (Windows, Chicago, IL, USA) was used for the remaining analy-
ses.
results
Full details of the inclusion and the results of the PROOF study have been published 
elsewhere16 20. Of the 407 participants randomized, 390 participants had available data 
on physical activity on at least two time points and were included in the LCGA. Of these 
390 participants, all available data on physical activity was taken into account. Three 
participants clearly stood out of the rest of the participants regarding their trajectories 
of change in physical activity over time. These three participants all had a SQUASH score 
of > 5 standard deviations above the average for the study population at >80% of their 
measurements. After evaluating the individual questionnaires for these three partici-
pants, the research group decided to exclude these participants from the analysis, since 
the scores were considered impossible. Consequently, 387 participants were included in 
the final analysis.
latent class growth analysis
A cubic model with free variance and two subgroups was selected as the optimal model. 
Both the BIC and AIC were smallest of all models tested. The VLMR-LRT and the LRT 
both indicated no better fit of the data when one subgroup was added. Entropy of the 
selected model was 0.93, indicating good discriminative properties13 24. The first group 
of this model consisted of 42 participants, that showed a steep increase in change in 
physical activity up to 18 months after randomization, followed by a slight decrease un-
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til remaining stable between 2.5 years and 6.5 years after randomization, still well above 
twice their baseline score. The second group of this model consisted of 345 participants 
that showed very little changes in physical activity, relative to their baseline score. At 
each set time point, the change in physical activity was significantly higher in the first 
group. Figure 1 shows the trajectories over time for the two identified groups. When 
looking at the absolute SQUASH scores, in contrast to the change in physical activity, 
it is shown that group 1 had a remarkably lower baseline physical activity than group 
2, catches up with the latter in the first year of the study and after that, no significant 
changes between both groups are observed. Figure 2 shows these patterns.
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Figure 2 Absolute physical activity in SQUASH score over time, means ± SEM
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success factors
Several baseline characteristics differed between the two identified groups. The 
most notable differences were as follows: participants in group 1 had, on average, a 
lower baseline SQUASH score (2987 versus 7419), lower level of social participation (7.8 
versus 9.3 hours per week) and a lower educational level (98% low versus 80% low). 
table 1 shows all baseline characteristics for the two identified groups. Intervention 
group membership of the diet and exercise intervention of the original study was evenly 
distributed over the two identified groups (52% versus 50%).
The weighted analyses using the posterior class membership probabilities, showed the 
following baseline characteristics to be significantly associated with class membership: 
baseline SQUASH score, proportion of participants that complied with the Dutch Activ-
ity Guideline, quality of life, social participation, having a paid job and educational level. 
Of these variables, the baseline SQUASH score and social participation showed a sig-
nificant interaction with the lifestyle intervention effect of the original trial. Both these 
variables showed a negative correlation with the outcome of membership to group 1. 
In the intervention group, these effects were stronger than in the control group. table 2 
shows the results of these analyses. Of the tested interactions, only those with a p-value 
< 0.05 are shown.
table 1 Baseline characteristics, proportions and means (standard deviation)
Improved group (n=42) Stable group (n=345)
Lifestyle intervention (% intervention group) 52% 50%
Age (years) 55.2 (3.0) 55.8 (3.2)
Body Mass Index (kg/m²) 33.1 (5.0) 32.2 (4.1)
Baseline physical activity (SQUASH score)* 2987 (1608) 7419 (3532)
Compliance with Dutch Activity Guideline (% yes)** 31% 52%
Quality of life (EQ-5D, 0-1)** 0.85 (0.14) 0.90 (0.13)
Social participation (hours/week)* 7.8 (1.9) 9.3 (2.0)
Paid job (% yes)* 46% 75%
Educational level*
Low 98% 80%
High 2% 20%
* p < 0.002, ** P < 0.03, Dutch Activity Guideline recommending at least 5 times 30 minutes a week of mod-
erately intense physical activity, social participation defined as hours per week spent on work, voluntary 
work or studying, educational level was separated in low (intermediate vocational training or lower) and 
high (high vocational training or academically educated). Mild knee symptoms were defined as having any 
knee pain in the past 12 months.
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effect of longitudinal change in physical activity on osteoarthritis development
Participants in group 1 showed a higher chance of developing knee OA than participants 
in group 2, regarding ACR knee OA (adjusted odds ratio: 7.67, 95% CI: 1.99, 29.47). Re-
garding the secondary outcome, Kellgren & Lawrence grade ≥ 2, no significant effect of 
the identified longitudinal evolutions was found (adjusted odds ratio: 1.63, 95% CI: 0.37, 
7.25). These analyses were adjusted for all possible confounding variables, including the 
intervention effects of the original interventions (here, also the glucosamine interven-
tion effect was adjusted for). Identified baseline variables that showed a significant 
association with the outcome were: BMI, mild knee symptoms and Kellgren & Lawrence 
score. In addition to the variables that differed significantly between the identified 
groups, as presented in Table 1, these variables were considered potential confounders 
and were adjusted for.
DisCussiOn
In this study, longitudinal evolutions of change in physical activity over time during and 
after a lifestyle intervention were studied. LCGA successfully identified two subgroups, 
representing two different trajectories in change in physical activity over time. 42 of 
the 387 participants with available data showed a more advantageous evolution over 
table 2 Results of weighted univariate logistic regression analysis on improved group membership (refer-
ence group is the stable group, group 2)
Odds ratio 95% confidence 
interval
p-value
Lifestyle intervention group 1.18 0.61, 2.28 0.633
Age 0.94 0.85, 1.05 0.250
Body Mass Index 1.04 0.97, 1.12 0.265
Baseline physical activity (SQUASH score) 0.39 0.30, 0.51 <0.001
Compliance with Dutch Activity Guideline 0.42 0.21, 0.85 0.016
Quality of life (EQ-5D) 0.10 0.01, 0.80 0.031
Social participation 0.70 0.59, 0.83 <0.001
Paid job 0.28 0.14, 0.55 <0.001
Educational level (ref = low) 0.06 0.01, 0.80 0.033
SQUASH score x intervention effect 0.50 0.27, 0.93 0.027
Social participation x intervention effect 0.69 0.49, 0.99 0.041
Dutch Activity Guideline recommending at least 5 times 30 minutes a week of moderately intense physical 
activity, social participation defined as hours per week spent on work, voluntary work or studying, edu-
cational level was separated in low (intermediate vocational training or lower) and high (high vocational 
training or academically educated). Mild knee symptoms were defined as having any knee pain in the past 
12 months.
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time than the 345 participants that showed little change in physical activity over time. 
These 42 participants more than doubled their physical activity, up to 160% above their 
baseline score 18 months after randomization, before remaining quite stable after that. 
Their physical activity level at baseline was in fact more than two times lower than the 
reference group. After these 42 participants increased their physical activity level up to 
the level of the reference group in the first year, no significant differences in physical 
activity between the two identified subgroups were observed. It turned out that the 
participants in the group that started lower and increased their physical activity had 
less favorable baseline characteristics: they had, on average, a lower baseline SQUASH 
score, a lower quality of life, a lower social participation and a lower educational level. 
The proportion of participants that complied with the Dutch Activity Guideline and the 
proportion that had a paid job were both lower in the group with the more advanta-
geous evolution of change in physical activity over time.
The significant interactions of the intervention effect of the original study with 
two baseline characteristics, namely baseline SQUASH score and social participation, 
showed that participants who scored high on these variables, were less likely to show 
the more favorable evolution of change in physical activity over time due to the inter-
vention. These findings indicate that a lifestyle intervention such as the diet and exercise 
intervention of the described original study, most likely has the greatest effects in those 
participants that are less physically and socially active. These findings could help when 
conducting future trials, to specifically target a population in which the probability of 
success of a particular intervention is high. In addition, these findings could be useful in 
clinical practice, to guide general practitioners in decision making, knowing which pa-
tients are more likely to increase their physical activity. It also showed that participants 
who report on their own physical activity as being high, are very unlikely to increase 
their physical activity, as shown in Figure 2. The intervention aimed to increase physi-
cal activity in all participants randomized to the intervention group. Perhaps it is more 
sensible to offer coaching on increasing physical activity only to those participants who 
report low physical activity at baseline. Additionally, the intervention was designed to 
encourage social interaction between participants: dieticians and sports activities were 
offered close to participants’ homes and physical activity classes were given in groups. 
This approach seems  most successful in participants with low social participation, as is 
shown by the significant interaction effect.
A limitation of this study is the fact that participants randomized to the intervention 
group were equally distributed over the two identified groups. Apart from the found 
interaction effects with the intervention effect, this makes our conclusions based on ob-
servational data. As a result, the baseline characteristics that were found to increase the 
odds of following a favorable pattern of change in physical activity over time, increase 
these odds regardless of any intervention. Only the two variables with a significant 
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interaction with the intervention effect are success factors that increase the odds to 
benefit from a lifestyle intervention. Another limitation of the present study is the low 
amount of participants that followed a favorable pattern of change in physical activity 
over time, limiting the power of all applied tests. Therefore, found associations with a 
p-value between 0.01 and 0.05 should be interpreted with caution.
The findings of the effects of different longitudinal evolutions of change in physical 
activity on the incidence of knee OA are to be interpreted with caution. Although an 
increase in the odds of developing ACR knee OA was found in group 1, this finding could 
not be confirmed when looking at radiographic evaluations. Available evidence on the 
effect of increased physical activity on incident knee OA is not uniform. Some trials sug-
gest no effect, some report a similar effect as found in the present study, while other 
trials suggest an effect opposite to the effect found in present study, although these 
findings are mostly based on cross sectional data29-32. A possible explanation for the fact 
that the present study found increased physical activity to be associated with a higher 
odds of developing knee OA could be that in this high risk population with up to 29% 
mild knee symptoms at baseline, an increase in physical activity in those participants 
that were not used to higher levels of physical activity, could have led to pain, which 
is a key factor in the ACR definition of knee OA. This finding has been found before in 
other populations33. Since no effect of the change in physical activity on K&L grades 
was found, no structural damage seems to have occurred in this group. However, MRI 
findings could provide more sensitive information on this matter. Nonetheless, these 
findings emphasize the importance of good supervision during a lifestyle intervention. 
When starting to encourage overweight participants who report low physical activity to 
increase their physical activity, an increase in knee complaints is to be expected. There-
fore, in future trials but also in clinical practice, these patients should be supervised 
closely and informed accurately about the expected consequences.
The findings of an effect of the different longitudinal patterns of change in physical 
activity on incident knee OA could be biased by different a priori chances of develop-
ing knee OA. As shown in Figure 2, group 1 started at a much lower level of physical 
activity than the reference group. It is possible that the a priori chance of developing 
knee OA was higher for this group, because of limited physical activity and other found 
less favorable baseline characteristics. However, this analysis was adjusted for baseline 
physical activity and all other possible measured confounders. However, unmeasured 
confounding could still have biased these results.
In conclusion, this is the first study to report on longitudinal evolutions of change 
in physical activity over time and successfully identified two subgroups with different 
trajectories over time during and after a lifestyle intervention. Participants with low 
physical activity and low social participation at baseline were more likely to increase 
their physical activity due to the intervention. Therefore, in future studies, but also in 
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clinical practice, lifestyle interventions aimed to increase physical activity should target 
these patients in particular. In addition, this study showed that in a population at high 
risk for knee OA, increased physical activity may lead to increased pain of the knees, but 
fortunately not to structural changes, a finding which has been found before in other 
populations. Therefore, careful supervision and education about this problem should be 
considered when promoting increased physical activity in this population. These con-
clusions emphasize the need to personalize lifestyle interventions to patients’ individual 
characteristics, as recommended in literature before34.
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Chapter 9 General Discussion
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Therapeutic options in knee osteoarthritis which are applicable to and cost-effective 
for large groups of patients are unfortunately still limited and fall short in alleviating 
the high and increasing global burden of this disease1-3. Current evidence emphasizes 
the need for preventive strategies in knee osteoarthritis, both primary and secondary3 4. 
However, despite literature recommendations to shift focus from therapy to prevention, 
trials investigating primary prevention of clinical knee osteoarthritis are still scarce5 6. 
In order to effectively prevent a disease, to lower its incidence, a modifiable risk factor 
needs to be identified. Trials investigating risk factors for knee osteoarthritis identified 
obesity as an important and prevalent factor in the etiology and a promising target for 
primary prevention3 7 8. This thesis evolves around the relationship between obesity and 
knee osteoarthritis, the role of this relationship in primary prevention and the translation 
of this concept into clinical practice. Data from the PROOF study, the first randomized 
controlled trial in the prevention of clinical knee osteoarthritis, was used to investigate 
these concepts. To recapitulate, the main aims of this thesis were to describe:
1. The effectiveness of a tailor-made lifestyle intervention in achieving a clinically 
significant amount of weight loss in middle-aged, overweight women
2. The effect of this achieved weight loss on the incidence of knee osteoarthritis
3. The long-term intervention effects of the PROOF study on both health outcomes and 
incident knee osteoarthritis
main FinDings
The tailor-made lifestyle intervention of the PROOF study, consisting of diet and exer-
cise and aimed to reduce body weight, proved to be effective in achieving a clinically 
significant amount of weight loss in the short term, with twice as many participants in 
the intervention group that achieved the goal of losing 5 kg or 5% baseline body weight 
after 6 months. However, as reported in Chapter 2, at the end of the intervention, 2.5 
years after randomization, no significant differences between the randomized groups 
were found. Secondary outcome measures, such as physical activity and nutritional 
habits, showed the same response pattern. Low compliance to the intervention and 
unexpectedly high figures of weight loss in the control group may have contributed to 
the absence of a significant difference in weight loss between the randomized groups 
at the end of the intervention. Secondary analyses of all body weight data collected in 
these first 2.5 years showed that weight that was lost during this period, was in fact, to 
a large extent, recently gained weight. Chapter 3 shows that weight gain in the year 
preceding randomization and a low body weight around the fortieth life year of the 
participants was predictive of higher odds to lose weight during the intervention. No 
factors were found that increased the odds to benefit from the lifestyle intervention. As 
134
an exploratory analysis, Chapter 4 shows that the group of participants that reached the 
goal of losing 5 kg or 5% or their baseline body weight at the end of the intervention, in 
fact had a significantly lower incidence of knee osteoarthritis 2.5 years after randomiza-
tion (15% versus 20%, adjusted odds ratio: 0.5, 95% CI: 0.3, 0.9). Despite limitations of 
this analysis, a proof-of-concept is provided that the association between weight loss 
in a high risk, overweight population and the development of knee osteoarthritis is at 
least plausible. However, this finding could not be confirmed by a secondary analysis 
using the subgroups identified in Chapter 3. The analysis described in Chapter 5 could 
not find a significant association between weight change trajectories and progression 
of MRI features of knee osteoarthritis, such as bone marrow lesions, meniscal extrusion 
and osteophytes. A possible explanation for the absence of such an association is the 
finding that at baseline, prevalence of the above mentioned MRI features were already 
very high, possibly indicating that these participants already passed a ‘point of no return’ 
regarding articular damage assessed by MRI, which continued to deteriorate despite 
changes in body weight. Additionally, the period of 2.5 years could be too short to bring 
about changes in the ongoing process of structural decline in knee osteoarthritis. In 
the long-term, the PROOF study did prove to have an effect on behavioral changes. As 
described in Chapter 6, the intervention group showed a significant increase in daily 
physical activity, a sustainable effect that even increased over time. However, changes in 
body weight decreased over time and were not significant at the end of the total follow-
up time, 6.5 years after randomization. Per protocol analyses showed greater effects for 
weight changes, but not for changes in physical activity, giving rise to the question as to 
how participants were motivated to increase their physical activity. Unfortunately, long-
term intervention effects on incident knee osteoarthritis were not found. Chapter 7 
shows no significant intervention effects on incident knee osteoarthritis after 6.5 years, 
despite the fact per protocol effects were greater than intention-to-treat effects for the 
lifestyle intervention. Such a trend was not seen for the glucosamine intervention. As a 
proof-of-concept, the incidence of knee osteoarthritis was compared between partici-
pants that lost 5 kg or 5% of their baseline body weight after the first year of follow-up 
and participants that did not reach this goal, indicating again beneficial effects of reach-
ing this goal on incident knee osteoarthritis, as found in Chapter 4. Lastly, Chapter 8 
studies in detail the evolutions over time of change in physical activity, using the same 
technique as used in Chapter 3. A group of 42 participants was identified with a favor-
able evolution of change in physical activity over the total follow-up time, compared 
to the other participants, that showed little change in physical activity over time. The 
group with the favorable changes was a group with less favorable baseline characteris-
tics, such as baseline physical activity, social participation and educational level. These 
findings suggest that careful selection of participants for specific interventions could 
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contribute to efficiency and cost-effectiveness of such interventions, yielding highest 
benefits in specifically targeted populations, i.e.  to apply personalized medicine.
health anD liFestyle OutCOmes
For centuries, weight loss has been the subject of many studies in virtually all cultures 
around the world. The last few decades many systematic reviews were published 
reporting on the efficacy and effectiveness of interventions aimed to lose weight in 
overweight and obese populations9 10. Many of these lifestyle interventions took place 
in primary care, which is often considered the most apt environment to study such inter-
ventions11 12. For an intervention to have an impact on the worldwide burden of obesity, 
it needs to be applicable on a very large scale13. Conducting trials in primary practice 
makes the translation from study results to clinical practice easiest, since populations 
in primary practice are more representative for the general population than specialist 
settings. In order for the results of the weight loss intervention of the PROOF study to 
be easily translated to clinical practice, it was important to minimize dropout rates. The 
tailor-made character of the lifestyle intervention and the motivational interviewing 
techniques of the dieticians were expected to contribute to low dropout rates, high 
compliance rates and sustainability of the achieved behavioral changes14. A recently 
published review identified these two factors, a tailored intervention and motivational 
interviewing, as predictors of success in achieving long-term obesity-related lifestyle 
changes15. Dropout rates after one and after 2.5 years of follow-up were indeed markedly 
lower than average dropout rates reported in obesity trials: Chapter 2 reports a dropout 
rate of 9.6% after one year and 11.3% after 2.5 years. Reviews estimate average dropout 
rates in obesity trials to be as high as approximately 40% in the first twelve months16 17. 
However, as described in Chapter 6, after 6.5 years of follow-up, data was available for 
just 60.7% of all participants. 2.5 years after randomization, at the end of the interven-
tion, all participants were requested permission to contact them 4 years later for these 
additional measurements. Despite the fact such a ‘post-intervention’ follow-up time was 
recommended in literature18, in order to take weight regain after the end of the inter-
vention into account, very few trials reported this in their results14 19. In fact, very few 
trials reported follow-up times beyond 30 months altogether. Therefore, it is difficult to 
compare this dropout rate with other lifestyle interventions. Based on the low dropout 
rates in the first 2.5 years of follow-up, we expect this rate not to be among the high-
est of dropout rates, when more lifestyle trials would follow their participants for such 
a long time, including follow-up time after the end of the intervention. Nonetheless, 
such high amounts of missing data cause high uncertainty and make it difficult to draw 
conclusions, as best illustrated in Chapter 7. Therefore, it is of the utmost importance 
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to consider additional means to minimize dropouts, when designing lifestyle interven-
tion trials with long follow-up periods. We expect electronic tools could be of assistance 
here, such as mobile apps and online questionnaires.
Compliance rates were expected to be higher than in comparable trials, because of 
the pragmatic design with the tailor-made intervention and the motivational interview-
ing skills all dieticians were trained in. For the diet and exercise intervention, compliance 
was difficult to determine, because every participant had different goals. However, as 
described in Chapter 6, there were few participants with high compliance figures for 
both diet and exercise. A proposed reason for these low compliance rates despite efforts 
in the design to maximize these, is the high level of motivation at baseline: 88% of all 
participants preferred to be randomized to the intervention group. Possibly motivational 
interviewing would have greater effects in a less motivated population. Moreover, the 
intervention could have been tailored to the individual needs more. In the PROOF study, 
all participants were offered counselling on both nutritional habits and physical exercise, 
as recommended in literature. However, as illustrated in Chapter 8, participants that 
reported a high baseline physical activity, showed very little changes in physical activity 
over time. Perhaps higher effectiveness could be achieved when participants were only 
offered counselling in what they need, in their own opinion. As said before, personalized 
medicine seems to be the key here.
Sustainable behavioral changes were expected when designing the PROOF study. Re-
garding physical activity, Chapter 6 shows long-term effects indeed. However, the sec-
ondary analysis described in Chapter 8 shows the group of participants that increased 
their physical activity significantly was in fact a small group. Also, these long-term 
behavioral changes did not seem to have a large effect on body weight, as illustrated 
by small changes in weight change over time that seemed to decrease over time as 
well. Furthermore, the changes in physical activity over time were not attributable to 
compliance to the intervention. In Chapter 6 this is shown by the fact that per protocol 
analyses showed no greater effects on change in physical activity than intention-to-treat 
effects. For weight change, per protocol effects were greater than intention-to-treat 
effects. Additionally, the proportion of participants randomized to the intervention 
group was not significantly different in the two groups identified in Chapter 8, which 
represented different longitudinal evolutions of change in physical activity. Taking this 
into consideration, the question come to mind as to what caused the participants in the 
intervention group to increase, on average, their physical activity markedly more than 
the participants in the control group did. In Chapter 8, it is shown that participants 
with a low baseline physical activity level and a low social participation were more likely 
to benefit from the intervention, regarding their physical activity. The relatively small 
group of participants that increased their physical activity accordingly, caused for a large 
part the mean differences between the randomized groups. Possibly, when targeting 
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participants with particular characteristics such as these, lifestyle interventions could 
yield more benefits and be more efficient in improving health.
An additional argument to specifically target participants for a lifestyle intervention, 
is to be found in the findings of Chapter 3. Here, it becomes clear that a large part 
of the relatively small group of participants that lost a clinically significant amount of 
weight during the trial, were in fact participants that were lower in body weight earlier 
in life, than they were at commencement of the intervention. Naturally, when address-
ing obesity as a whole, an intervention is needed that achieves weight loss in as large a 
group of individuals as possible. But when the aim of an intervention is to prevent knee 
osteoarthritis, highest yields are to be expected when selecting those individuals that 
were not high in body weight their entire lives, thus creating a group with high prob-
ability of successfully losing weight. The disadvantage of such an approach is that such 
an intervention would not be applicable to all overweight individuals or to all patients at 
high risk of knee osteoarthritis, but the upside would be that with less resources, weight 
loss in more individuals could be achieved, thus achieving higher cost-effectiveness. 
Maybe one lifestyle intervention that is applicable to large groups of individuals is a 
utopian endeavor and a more realistic picture of the future would be a variety of avail-
able interventions from which a general practitioner for instance, could choose the 
most appropriate for each individual. This approach seems successful in other areas of 
behavioral changes, such as smoking cessation20 21.
In conclusion, the lifestyle intervention of the PROOF study was capable of achieving 
long-term behavioral changes, however only in a small proportion of participants. More-
over, these changes did not result in significant changes in body weight in the long-
term. Compliance and dropout rates remain difficult issues and careful consideration 
of minimizing these problems is essential. Personalized medicine seems promising in 
contributing to successful lifestyle interventions and in achieving a clinically significant 
amount of weight loss in an as large as possible proportion of participants, lowering the 
numbers needed to treat and improving cost-effectiveness.
PreVentiOn OF Knee OsteOarthritis
The PROOF study was the first randomized controlled trial in the prevention of clinical 
knee osteoarthritis22. Previously published studies on the prevention of knee osteoar-
thritis often reported promising results on intermediate outcome measures, such as 
cartilage thickness or knee pain23 24. In the PROOF study, no significant intervention 
effects on incident knee osteoarthritis were found after 2.5 years of both the diet and 
exercise program and the glucosamine22.  Prolonging the follow-up time was expected 
to result in greater effects. However, as described in Chapter 7, the high dropout rate 
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impeded straightforward interpretation of the results. A completers’ analysis showed 
no significant intervention effects, but was undoubtedly biased, since this analysis only 
results in accurate estimates when the missing mechanism is missing at random, which 
is very rare in clinical trials25. According to literature recommendations, multiple impu-
tation was performed. However, unrealistically high estimates of knee osteoarthritis 
incidence and reversed effects for participants with missing data led to questions about 
the reliability of the results of the multiple imputation. Reports from literature confirm 
that high amounts of missing data, especially on the outcome, and the mechanism of 
missing data, especially missing not at random, can cause biased results from multiple 
imputation and even introduce bias that was not present in the completers’ analysis26 27. 
A third analysis was performed in Chapter 7, estimating the effects when no interven-
tion effect at all would be present in all participants with missing data. This analysis 
showed similar results as the completers’ analysis: no significant intervention effects, but 
greater effects for the diet and exercise intervention in the per protocol analysis than 
in the intention-to-treat analysis, indicating a possible effect, would compliance have 
been higher. For glucosamine, such a trend was not found. Which of these three analyses 
provided reliable estimates, remains a difficult issue. Probably, all three analyses were 
biased. However, assuming that reversed intervention effects in participants with miss-
ing data with respect to participants with complete follow-up data are very unlikely 
to occur, the third analysis shows the most pessimistic results. Assuming that it is very 
unlikely that intervention effects in participants with missing data were more favorable 
than in participants with complete follow-up data, the completers’ analysis shows the 
most optimistic results. Under these assumptions, the true estimates lie somewhere in 
between estimates from the completers’ analysis and the third analysis, the sensitivity 
analysis. Since these two analyses lead to the same conclusions, these conclusions seem 
reliable, provided that the aforementioned assumptions are met.
Regardless of the intervention effects, we wanted to investigate whether weight loss 
in itself could prevent incident knee osteoarthritis. Because actual differences in weight 
loss between the randomized groups were smaller than expected, we concluded that 
above described analyses did not answer this question. For this reason, the exploratory 
analysis in Chapter 7 was performed where all participants that achieved the goal of 
losing 5 kg or 5% of their body weight in the first year of the study were compared 
with all participants that did not reach this goal. Losing this amount in the period of 
one year seemed like an achievable goal and possibly a goal that can be used in clinical 
practice as recommendation to individuals at high risk for knee osteoarthritis. All three 
analyses showed preventive effects of achieving this goal, the completers’ analysis and 
the worst case analysis showing significant results. However, this group of participants 
had different baseline characteristics than participants that did not reach this goal and 
therefore, not the same a priori odds of developing knee osteoarthritis. Adjustment 
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of confounding variables obviated this problem to a certain extent, but unmeasured 
confounding could have still caused bias.
The association between actual weight loss and incident knee osteoarthritis has been 
studied in several ways using data from the PROOF study. In Chapter 4 an association 
was found using cross-sectional data from 2.5 years after randomization. The same 
conclusion was reached: the results suggest a preventive effect of losing 5 kg or 5% 
body weight on incident knee osteoarthritis, however, unmeasured confounding could 
have biased these results. No significant association could be found when comparing 
incidence numbers of MRI features of knee osteoarthritis between the identified latent 
classes representing different evolutions of weight change over time, as described in 
Chapter 5. Here, it is found that incidence of these MRI features was already very high 
at baseline, and it was suggested that in order for weight loss to have an effect on these 
features, an intervention should aim at younger individuals at risk of knee osteoarthritis.
In summary, no long-term preventive effects on incident knee osteoarthritis of both 
the diet and exercise intervention or the glucosamine were found. Indications of an ef-
fect of the diet and exercise program were found, but not for the glucosamine. To study 
the direct effect of weight loss on incident knee osteoarthritis proved to be difficult, 
since randomization is broken that way. Two studies found a preventive effect of losing 
5 kg or 5% baseline weight on incident knee osteoarthritis, but this was not confirmed 
by a third study, investigating the association between longitudinal weight changes and 
incidence of MRI features of knee osteoarthritis. To truly investigate the effect of weight 
loss on incident knee osteoarthritis, greater differences in weight change between the 
randomized groups would be needed, or perhaps propensity score matching could 
provide better controlling of confounding variables28.
imPliCatiOns FOr CliniCal PraCtiCe anD Future stuDies
The findings presented in this thesis could be of assistance in clinical practice to the 
general practitioner in a number of ways. First of all, it is illustrated that achieving a 
moderate amount of weight loss in a substantial proportion of a group of overweight 
women aged 50 to 60 seems to be a Herculean task. 88% of all participants enrolled in 
the study indicated to prefer being randomized to the diet and exercise intervention, all 
participants randomized to the lifestyle intervention were offered dietician counselling 
and physiotherapist guidance for free, goals were moderate and determined in dialogue 
and all participants were offered the additional incentive of preventing knee osteoar-
thritis, next to other well-known incentives for weight loss, regarding cardiovascular, 
malignant and degenerative diseases. Despite all these facts, average weight loss figures 
and proportions of participants that achieved the goal of losing 5 kg or 5% baseline 
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weight, were disappointing. The latter is illustrated in Figure 1, a Venn diagram show-
ing all participants who were 5 kg or 5% below their baseline body weight at a given 
time point and the overlap of the groups of participants that had achieved this goal 
at the indicated time points. It becomes very clear that overlap is low, indicating that 
very few participants that achieved this goal at some point during the study, actually 
maintained their lower body weight from that point on. The PROOF study is the first 
interventional study showing weight changes over a period of more than 30 months14. 
What this means for the general practitioner, and for his or her patient with a request 
for help with their overweight, is that they both realize the chance of success is low and 
the required dedication should be high. The proportions of participants that succeeded 
in achieving the goal of losing 5 kg or 5% baseline weight in the PROOF study were 
comparable to proportions of people that generally succeed in the cessation of smoking 
(approximately 15-20%)29. Maybe an approach used commonly in smoking cessation, 
the stages of change model, could be of assistance in guiding the general practitioner 
to advice and coach his or her overweight patients, as has been suggested in literature30. 
Taking into consideration the level of motivation of the patient, in addition to the low 
chance of success, could aid the general practitioner in counselling and in targeting spe-
cific patients for specific interventions, what brings us back to personalized medicine.
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Figure 1 Venn diagram showing groups of participants that achieved the goal of losing 5 kg or 5% of their 
baseline body weight at each given time point after baseline and their overlap
Venn diagram made using a web-based tool from Heberle et al31.
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As mentioned earlier in this chapter, subgroup analyses show that specific targeting 
of participants for specific interventions could increase efficacy and cost-effectiveness 
of lifestyle interventions. Personally, I believe that the upside of this approach, higher 
yields of weight loss in groups of overweight individuals, outweighs the downside of 
interventions not being applicable to all overweight individuals. This way, the largest 
group of overweight individuals could be helped with the smallest amount of required 
resources. Searching for an intervention that yields high success rates in large, hetero-
geneous groups of individuals seems inefficient, even if the intervention is tailor-made, 
as was the case in the PROOF study. A tailor-made intervention still offers the same key 
ingredients of a lifestyle intervention to all participants, namely diet and exercise. Rapid 
developments in genetic mapping and molecular epidemiology could make it possible 
to offer personalized advice about what specific approaches should be considered by 
every specific patient32. Different types of diet and different physical activity schemes 
would expand the tool kit of the general practitioner. Additionally, specialist interven-
tions such as bariatric surgery or pharmacological intervention should be considered33 34. 
Therefore, in future studies on the prevention of osteoarthritis through weight loss, we 
recommend to offer a highly personalized intervention strategy, with a wide range of 
interventional options or specialist referral available, in order to achieve sustainable life-
style changes. Another strategy could be to offer a less personalized intervention, but to 
select eligible participants with a high chance of benefit from that specific intervention. 
Naturally, this would be a choice at the expense of generalizability. However, the true 
preventive effects of weight loss on incident knee osteoarthritis could be studied more 
reliably this way.
The recommendation of increased physical activity in lifestyle interventions involves 
certain difficulties. As shown in Chapter 8, increased physical activity can lead to an in-
crease of knee complaints. Findings in earlier research on increased physical activity and 
knee osteoarthritis were not uniform, were often based on cross-sectional data and often 
involved patients already suffering from osteoarthritis, as opposed to the participants in 
the PROOF study35-37. Therefore, based on the findings in this thesis, it is recommended 
to inform overweight patients without knee osteoarthritis, of this possibility, when they 
want to increase their physical activity. Since no effect of increased physical activity on 
structural damage was found, and because such an effect has not been found before in 
literature, it seems justifiable to inform patients that this increase in pain does not neces-
sarily indicate damage or progression of osteoarthritis. Consequently, education could 
motivate participants to maintain their increased physical activity, resulting in all known 
benefits, when they would cease otherwise. Naturally, careful accompaniment should 
be offered in lifestyle intervention studies in the prevention of knee osteoarthritis, thus 
increasing compliance.
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The recruitment of participants in the PROOF study took place in primary care and 
implications consequently also concern primary care. However, the method used for 
inclusion was actually similar to open population inclusion. Cooperating general prac-
titioners sent all women aged 50-60 registered at their practices a letter to inform them 
about the study and to consider participation when the self-reported BMI was 27 or 
higher. In contrast to inclusion during consultation, the initiative to make contact lay 
with the general practitioner, resulting in a population of participants that might not 
have consulted the general practitioner for their overweight on their own initiative. Data 
from the NIVEL Primary Care Database show registered prevalence numbers of 5.8% for 
overweight and 7.9% for obesity38.
Estimates of prevalence numbers are much higher than that, indicating that a large 
number of overweight patients do not consult their general practitioner for this reason39. 
Therefore, careful consideration is warranted before translating the conclusions in this 
thesis to the patient consulting the general practitioner for their overweight. The group 
of patients that actually consults the general practitioner for this reason, might be a 
selective sample of the population the participants of the PROOF study represent. Logi-
cally, these patients would be more motivated and possibly already have some health 
complaints due to their overweight. It seems plausible to assume this higher motivation 
would lead to higher odds of benefit from a diet and exercise intervention. However, 
as is shown in Chapter 3 and Chapter 8, participants’ characteristics highly influence 
their odds of achieving sustainable behavioral changes. Taking all these factors into ac-
count, I believe long-term behavioral changes are attainable for a large group of these 
patients. Certainly, when applying personalized medicine, a higher chance of success is 
to be expected than the chance of 15%-20% to achieve a clinically significant amount of 
weight loss that was found in the PROOF study.
In conclusion, findings of this thesis warrant more research on the preventive effect 
of weight loss on incident knee osteoarthritis, emphasizing the difficulties associated 
with achieving a significant amount of weight loss in a group of overweight individuals. 
Accomplishing higher efficiency of lifestyle interventions asks for a paradigm shift from 
designing interventions applicable to as many overweight individuals as possible to a 
strategy where the choice of intervention is dependent on certain characteristics of the 
individual, that determine the individual’s chance of success of a particular intervention.
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Knee osteoarthritis (OA) is a degenerative condition which is characterized by knee pain, 
morning stiffness, functional limitation and bony enlargement. The cause of osteoarthri-
tis is not yet entirely clear, but probably mechanical loading and metabolic processes are 
the most important factors. Knee OA is a very common and disabling disease, resulting 
in a high burden worldwide. Unfortunately, therapeutic options for knee osteoarthritis 
are limited. Non-surgical management can contribute to less pain and better manage-
ment of the disease, but surgery is the only option in which the disease is removed 
altogether. However, surgery remains only available for a subset of patients, and is only 
effective in those patients with advanced osteoarthritis. Moreover, knee replacement 
surgery often does not result in a totally pain free and disability free situation.
When therapeutic options are limited and the burden of a disease is high, highest 
benefits are to be expected from primary prevention. In order to prevent a disease, risk 
factors need to be identified that can be modified before the disease starts to manifest. 
The main risk factors for knee OA are ageing, obesity, female gender, knee injury in the 
past and heredity. Obviously, obesity and knee injury are the only modifiable risk fac-
tors. To investigate the effect of decreasing knee injury on the development of knee 
OA would require following participants of a study for as long as 30-40 years, because 
knee OA develops later in life and most knee injuries occur early on in life. Obesity on 
the other hand, can be modified at any given moment in a participant’s life. Therefore, 
modifying obesity seems the most eligible choice when studying the prevention of knee 
OA.
Obesity of course, is very common in developed countries and there are ample strate-
gies to lower its incidence. The combination of diet and exercise often proved to be 
more effective than the sum of its components. The most important problem in losing 
weight is regain of the weight that was lost. In order to modify obesity as a strategy to 
prevent knee OA, long-term behavioural changes and sustainable weight loss should be 
accomplished.
The PROOF study (PRevention of knee Osteoarthritis in Overweight Females) was the 
first randomized controlled trial in the prevention of knee OA. The aim of this trial was to 
study the preventive effects of a diet and exercise intervention and of oral glucosamine 
sulfate. The diet and exercise intervention consisted of frequent appointments with a 
dietician and attendance of physical activity lessons, supervised by a physiotherapist. 
Participants were women aged 50-60 with a BMI ≥ 27 kg/m2 without knee OA. These cri-
teria were chosen, because the incidence of knee OA peaks around the fiftieth life year 
and is highest in women. Half of all participants were randomized to a tailor-made diet 
and exercise program, the other half did not receive this active intervention. Indepen-
dently of this lifestyle intervention, half of all participants were randomized to receive 
oral glucosamine sulfate, while the other half received placebo, without knowledge of 
what they received. This way, four different groups of participants were created, as il-
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lustrated in Figure 1. The outcome of the PROOF study was incidence of knee OA, which 
was assessed 2.5 years after randomization and 6.5 years after randomization.
Chapter 2 focusses on the diet and exercise intervention and its effectiveness in achiev-
ing a clinically significant amount of weight loss in the first 2.5 years of follow-up. The 
intervention proved to be effective in achieving weight loss in the short term, resulting 
in twice as many participants in the intervention group that achieved the goal of losing 
5 kg or 5% of their baseline weight than in the control group six months after random-
ization. The amount of weight loss achieved was comparable to that achieved in other 
studies dictating stricter, more intensive regimes of diet and exercise. However, mean 
weight changes were small and after 2.5 years, no significant differences were found 
between both groups. Probably, low compliance to the intervention contributed to the 
lack of any significant differences after 2.5 years. Participants attended the dietician and 
the offered physical activity lessons in low numbers and few of them achieved the goal 
of losing 5 kg or 5% of their baseline body weight.
When presenting mean weight changes, a common problem is that the proportion 
of participants that lost weight are leveled out by a proportion of participants that 
actually gained weight during the intervention. As a result, mean weight changes are 
often very low. To investigate the group of participants that did lose weight, a secondary 
analysis was performed on the weight data of the first 2.5 year. This analysis is described 
in Chapter 3. A technique called latent class growth analysis revealed three groups with 
distinctly different trajectories of weight change over time. It was found that assignment 
to the diet and exercise intervention lowered the chance to show a trajectory of weight 
gain over time. Moreover, the participants that showed a trajectory of weight loss over 
randomization. 
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time, were more likely to be high in baseline weight, low in body weight around their 
40th life year and high in weight gain in the year preceding the study. Consequently, it 
was concluded that a large part of the weight change that was observed during the 
intervention, was in fact recently put on weight.
To further investigate the direct effect of weight loss on incident knee OA, a secondary 
analysis on the 2.5 year data was performed. In Chapter 4 the group of participants that 
achieved the goal of losing 5 kg or 5% baseline weight after 2.5 years was compared 
with all participants that did not achieve this amount of weight loss, regarding their 
incidence of knee OA. The primary outcome in this analysis consisted of three com-
ponents: ACR (American College of Rheumatology) criteria, K&L (Kellgren & Lawrence) 
grades and joint space narrowing. ACR criteria are internationally regarded as standard 
in diagnosing clinical knee OA and make use of both clinical and radiographic data, K&L 
grades are radiographic evaluations and joint space narrowing was measured on plain 
radiographs. This composed outcome was used in order to make an analysis on incident 
knee OA over a relative short period of time feasible, since knee OA is a very slowly 
progressing disease. It was found that the group of participants that lost the defined 
amount of weight had a significantly lower incidence of knee OA. Additionally, blood 
glucose level, fat percentage and blood pressure were favorable in this group.
In Chapter 5 a different approach is used to investigate the direct relationship be-
tween weight loss and knee OA. Progression of MRI features of knee OA was compared 
between participants with different weight changes during the first 2.5 years. For this 
analysis, the three groups that were identified in Chapter 3 were used. No differences 
in progression of MRI features were found between the groups. At baseline, prevalence 
of MRI features was very high in all groups. Possibly this high prevalence indicates that 
these high-risk participants were already at a point beyond salvation regarding articular 
damage assessed by MRI. Apparently the changes in body weight over 2.5 years were 
not enough to bring about noticeable changes in MRI features, which were probably 
already progressing for a long period of time.
The long-term effects of the PROOF Study were assessed 6.5 years after randomization. 
In Chapter 6 and Chapter 7 these results are presented and discussed. It was found that 
in the long-term, the difference in weight change between both randomized groups 
declined over time to no significant difference. Changes in physical activity however, 
increased over time, proving the effectiveness of the intervention to bring about long-
term behavioural changes. However, these changes in behavioural patterns did not 
result in decreased incidence of knee OA. For both the diet and exercise intervention 
and the glucosamine intervention, no significant long-term intervention effects were 
found. For the diet and exercise intervention a trend was found that indicates a possible 
preventive effect on incident knee OA, that would be more noticeable when compliance 
would have been higher. For the glucosamine intervention, no such trend was found. 
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The group of participants that achieved the goal of losing 5 kg or 5% of their baseline 
body weight in the first year of the study did have a lower odds of developing knee OA. 
This finding served as a proof of principle that prevention of knee OA through weight 
loss is viable.
Finally, to further investigate the changes in physical activity during and after the 
lifestyle intervention, Chapter 8 reports on subgroups with different longitudinal evolu-
tions of change in physical activity over time. The same technique was used as described 
in Chapter 3. It was found that a group of 42 participants showed a distinctly different 
pattern of physical activity than the remaining 345 participants. These 42 participants 
started at a considerably lower level of physical activity, showed a steep increase in the 
first 12 months, up to the level of the remaining participants, and remained quite stable 
after that. Low physical activity and low social participation at baseline increased the 
odds to show this pattern of change in physical activity. Therefore, it was concluded 
that an intervention aimed at increasing participants’ physical activity, is best offered to 
those individuals with low physical activity and social participation. Additionally, it was 
found that an increase in physical activity in this group can cause an increase in knee 
complaints. Therefore, careful supervision and education should be considered when 
promoting increased physical activity in this population. Chapter 9 discusses all main 
findings in the light of existing research and reports on recommendations for clinical 
practice and future research. In short, the difficulties of achieving a significant amount 
of weight loss in a population of overweight, middle-aged women are discussed, em-
phasizing the need for higher efficiency of lifestyle interventions. A paradigm shift from 
interventions that are effective in as many overweight individuals as possible to a strat-
egy where a number of different interventions could create an extensive toolkit to the 
general practitioner and where the choice of a particular intervention is dependent on 
certain individual characteristics could heighten overall efficiency of lifestyle interven-
tions. This way, the search for the most effective lifestyle intervention in the treatment of 
obesity transforms in a search for which particular individuals benefit most from which 
intervention. Consequently, prevention of knee OA through weight loss could come one 
step closer through personalized medicine.
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Knie artrose is een degeneratieve aandoening die wordt gekenmerkt door knie pijn, 
ochtendstijfheid, functionele beperking en benige verdikking. De precieze oorzaak is 
nog niet helemaal duidelijk, maar mechanische belasting en metabole processen zijn 
waarschijnlijk de meest belangrijke factoren. Knie artrose is een zeer vaak voorkomende 
en invaliderende aandoening, wat resulteert in een hoge ziektelast wereldwijd. Helaas 
zijn de therapeutische opties voor knie artrose nog steeds beperkt. Conservatieve be-
handeling kan bijdragen aan minder pijn en beter leren leven met de aandoening, maar 
chirurgie is de enige optie waarbij de ziekte echt wordt verwijderd. Chirurgie is echter al-
leen een optie voor een beperkte groep patiënten en is alleen effectief bij patiënten met 
ver gevorderde artrose. Bovendien resulteert knie vervanging vaak niet in een pijnvrij en 
volledig functionerend gewricht.
Als therapeutische opties beperkt zijn en de ziektelast van een aandoening hoog 
is, resulteert primaire preventie vaak in de hoogste opbrengst. Om een aandoening 
te voorkomen, moeten risicofactoren geïdentificeerd worden die aangepast kunnen 
worden voordat de aandoening zich manifesteert. De belangrijkste risicofactoren voor 
het ontwikkelen van knie artrose zijn: hoge leeftijd, overgewicht, vrouwelijk geslacht, 
knieletsel in het verleden en erfelijke belasting. Overgewicht en knieletsel in het ver-
leden zijn duidelijk de enige risicofactoren die zijn aan te passen. Om het preventieve 
effect te onderzoeken van een vermindering van knieletsel op het ontwikkelen van knie 
artrose, zou een onderzoek nodig zijn die de deelnemers 30 tot 40 jaar volgt, omdat 
knie artrose zich pas op latere leeftijd openbaart, terwijl de meeste knie letsels zich op 
jonge leeftijd voordoen. Overgewicht echter kan op elk willekeurig moment aangepast 
worden. Daarom is overgewicht de meest geschikte risicofactor bij onderzoek naar de 
preventie van knie artrose.
Het is alom bekend dat overgewicht zeer veel voorkomt in ontwikkelde landen en dat 
er veel strategieën ontwikkeld zijn om hier iets aan te doen. De combinatie van dieet en 
beweging blijkt vaak effectiever dan de som van zijn delen. Het belangrijkste probleem 
bij gewichtsverlies is het jojo-effect: gewicht dat verloren is, komt vaak snel weer terug. 
Om knie artrose te voorkomen door gewichtsverlies, zijn echter duurzame gedragsver-
anderingen nodig en gewichtsverlies dat op de lange termijn volgehouden wordt.
De PROOF studie (PRevention of knee Osteoarthritis in Overweight Females) was 
de eerste gerandomiseerde gecontroleerde studie naar de preventie van knie artrose. 
Het doel van deze studie was om de preventieve effecten van een dieet en beweeg 
interventie en van oraal glucosamine sulfaat op de incidentie van knie artrose te onder-
zoeken. De dieet en beweeg interventie bestond uit frequente afspraken bij een diëtiste 
en het bijwonen van fysieke activiteit lessen, gesuperviseerd door een fysiotherapeut. 
De interventie was in het bijzonder gericht op het bereiken van lange termijn gedrags-
veranderingen en behoud van gewichtsverlies. Deelneemsters waren vrouwen van 50 
tot 60 jaar met een BMI van 27 of hoger zonder knie artrose. Deze criteria zijn gekozen, 
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omdat de incidentie van knie artrose op zijn hoogst is rond het 50ste levensjaar en hoger 
is bij vrouwen dan bij mannen. Na randomisatie werd de helft van alle deelneemsters 
ingedeeld in de dieet en beweeg groep, de andere helft ontving geen actieve leefstijl-
interventie. Onafhankelijk van deze randomisatie, werd nogmaals gerandomiseerd over 
het ontvangen van glucosamine of placebo. De deelneemsters en onderzoekers waren 
tijdens de studie niet op de hoogte wie glucosamine of placebo ontving. Op deze ma-
nier ontstonden 4 groepen, zoals weergegeven in Figuur 1. De uitkomst van de PROOF 
studie was incidentie van knie artrose, wat werd bepaald na 2.5 jaar en na 6.5 jaar.
hoofstuk 2 evalueert specifiek de effectiviteit van de leefstijl interventie in het bereiken 
van een klinisch significante hoeveelheid gewichtsverlies in de eerste 2.5 jaar na rando-
misatie. De interventie bleek effectief in het bereiken van gewichtsverlies op de korte 
termijn, wat resulteerde in twee keer zoveel deelneemsters in de interventiegroep dan 
in de controlegroep die het doel haalden om 5 kg of 5% van hun startgewicht af te vallen 
na 6 maanden. De hoeveelheid gewichtsverlies die werd bereikt was vergelijkbaar met 
vele andere studies die striktere, intensievere dieet en beweeg interventies voorschre-
ven. De gemiddelde gewichtsveranderingen waren echter klein en na één jaar follow-up 
werden er geen significante verschillen meer gevonden tussen beide groepen. Waar-
schijnlijk heeft een lage compliantie aan de interventie bijgedragen aan het ontbreken 
van significante verschillen na één jaar follow-up. De deelneemsters hebben de diëtiste 
maar weinig bezocht en weinig fysieke activiteit lessen bijgewoond. Bovendien heeft 
slechts een klein deel het doel bereikt om 5 kg of 5% van hun uitgangsgewicht af te 
vallen.
Figuur 1. Randomisatie van deelneemsters over beide interventies 
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Een veel voorkomend probleem bij studies naar gewichtsverlies is dat groepsgemid-
delden vaak erg klein zijn, doordat het effect van de deelnemers die afvallen vaak teniet 
wordt gedaan door deelnemers die juist aankomen tijdens de studie. Om de groep 
deelneemsters van de PROOF studie die wel zijn afgevallen tijdens de studie nader te 
onderzoeken, is een secundaire analyse gedaan op de gewichtsdata van de eerste 2.5 
jaar. Deze analyse is in hoofdstuk 3 beschreven. Een techniek genaamd ‘Latent Class 
Growth Analysis’ heeft drie subgroepen geïdentificeerd die een duidelijk van elkaar te 
onderscheiden beloop van gewichtsverandering in de tijd lieten zien. Deelneemsters 
gerandomiseerd in de leefstijl interventie hadden een lagere kans om een beloop van 
gewichtstoename te laten zien. De deelneemsters die een beloop van gewichtsafname 
lieten zien hadden een hogere kans om een hoog uitgangsgewicht te hebben, een 
relatief laag gewicht rond het veertigste levensjaar en gewichtstoename in het jaar 
voorafgaande aan de studie. Hieruit bleek dat een groot deel van het gewichtsverlies 
dat was geobserveerd tijdens de studie, in feite recent aangekomen gewicht was.
Om het directe effect van gewichtsverlies op de incidentie van knie artrose nader 
te onderzoeken, is een secundaire analyse gedaan met de data die in de eerste 2.5 
jaar zijn verzameld. In hoofdstuk 4 worden alle deelneemsters die aan het eind van 
2.5 jaar follow-up het doel hadden bereikt om 5 kg of 5% af te vallen vergeleken met 
alle deelneemsters die dit doel niet hadden bereikt. De incidentie van knie artrose na 
2.5 jaar werd vergeleken tussen deze groepen. Omdat 2.5 jaar relatief kort is om de 
langzaam progressieve ziekte knie artrose te bestuderen, werd een samengestelde 
uitkomstmaat gebruikt in deze analyse. Deze uitkomstmaat bestond uit drie com-
ponenten: ACR criteria (American College of Rheumatology), K&L scores (Kellgren & 
Lawrence) en gewrichtsspleet versmalling. ACR criteria worden internationaal gezien 
as standaard in het diagnosticeren van klinische knie artrose en maken gebruik van 
klinische en radiografische gegevens, K&L scores zijn radiografische beoordelingen en 
gewrichtsspleetversmalling werd gemeten op röntgen foto’s. De groep deelneemsters 
die waren afgevallen hadden een significant lagere incidentie van knie artrose. Ook had 
deze groep een lagere bloeddruk en glucose gehalte en een lager vetpercentage.
In hoofdstuk 5 wordt een andere benadering gebruikt om de relatie tussen gewichts-
verlies en de incidentie van knie artrose te bestuderen. Progressie van kenmerken van 
knie artrose op MRI scans werd vergeleken tussen groepen met een verschillend beloop 
in gewichtsverandering tijdens de eerste 2.5 jaar. Voor deze analyse werden de drie 
groepen gebruikt die waren geïdentificeerd in hoofdstuk 3. Er werden geen signifi-
cante verschillen in kenmerken van knie artrose gevonden tussen deze drie groepen. Bij 
de aanvang van de studie, was de prevalentie van eerder genoemde kenmerken op MRI 
scans al zeer hoog in alle groepen. Deze hoge prevalentie bij aanvang betekent mogelijk 
dat deze populatie van vrouwen met een hoog risico op knie artrose al op een ‘point of 
no return’ waren, wat betreft gewrichtsschade op MRI. Het blijkt dat de veranderingen 
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in lichaamsgewicht in 2.5 jaar niet genoeg waren om meetbare veranderingen in MRI 
kenmerken teweeg te brengen. Waarschijnlijk waren deze kenmerken al lang aanwezig.
De lange termijn resultaten van de PROOF studie zijn 6.5 jaar na aanvang van de 
studie geëvalueerd. Deze resultaten worden besproken in hoofdstuk 6 en hoofdstuk 
7. Op de lange termijn blijkt het verschil tussen beide gerandomiseerde groepen in 
gewichtsverandering af te nemen tot geen significant verschil. Het verschil tussen beide 
groepen in verandering in fysieke activiteit neemt echter toe in de tijd. De leefstijlin-
terventie bleek dus wel duurzame gedragsveranderingen teweeg te kunnen brengen. 
Deze gedragsveranderingen hebben echter niet geleid tot een lagere incidentie van 
knie artrose. Voor beide interventies, de leefstijl interventie en de glucosamine, werden 
geen significante interventie effecten gevonden. Voor de leefstijl interventie werd wel 
een trend gevonden, wat indiceert dat er mogelijk wel een significant effect zou kun-
nen zijn gevonden, wanneer de compliantie hoger was geweest. Voor de glucosamine 
interventie werd een dergelijke trend niet gevonden. De groep deelneemsters die in 
het eerste jaar van de studie het doel bereikten om 5 kg of 5% af te vallen, had wel 
een lagere kans op het ontwikkelen van knie artrose. Deze bevinding toont aan dat het 
voorkomen van knie artrose door gewichtsverlies in principe wel mogelijk is.
Tot slot worden de veranderingen in fysieke activiteit tijdens en na de interventie 
bestudeerd in hoofdstuk 8. Voor deze analyse werd dezelfde techniek gebruikt als in 
hoofdstuk 3. Een groep van 42 deelneemsters werd geïdentificeerd die een duidelijk 
ander beloop in verandering van fysieke activiteit in de tijd liet zien dan de overige 345 
deelneemsters. Deze 42 deelneemsters hadden een aanzienlijk lager niveau van fysieke 
activiteit bij aanvang van de studie, stegen snel in de eerste twaalf maanden tot het 
niveau van de overige deelneemsters, om daarna stabiel te blijven. Een laag niveau van 
fysieke activiteit en een laag niveau van sociale participatie verhoogde de kans om dit 
beloop in de tijd te volgen. Daarom werd geconcludeerd dat een leefstijl interventie, 
gericht op het verhogen van fysieke activiteit, het beste aangeboden kan worden aan 
mensen met een lage fysieke activiteit en sociale participatie. Daarnaast bleek uit deze 
analyse dat een verhoging van fysieke activiteit in deze groep kan leiden tot een toe-
name van knie klachten. Daarom is het belangrijk om vrouwen van deze leeftijd met 
overgewicht die hun fysieke activiteit willen gaan verhogen, goed te begeleiden en te 
informeren over dit mogelijke effect.
In hoofdstuk 9 worden alle bevindingen in dit proefschrift besproken in het licht van 
bestaande literatuur en worden aanbevelingen gedaan voor de kliniek en onderzoek in 
de toekomst. Kort samengevat worden de obstakels besproken in het bereiken van een 
klinisch significante hoeveelheid gewichtsverlies in een populatie vrouwen van mid-
delbare leeftijd met overgewicht, waarbij benadrukt wordt dat er efficiëntere leefstijl 
interventies nodig zijn. Er is een paradigmaverschuiving nodig van leefstijl interventies 
die effectief zijn bij zoveel mogelijk mensen naar een uitgebreid arsenaal van verschil-
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lende interventies waarbij de keuze voor de meest geschikte interventie wordt genomen 
op basis van individuele persoonskenmerken, die de kans op succes zo groot mogelijk 
maken. Op deze manier wordt niet gezocht naar de meest effectieve interventie voor 
een grote groep mensen met overgewicht, maar wordt gezocht naar welke mensen de 
hoogste kans op succes hebben van welke interventie. Op deze manier komt de preven-
tie van knie artrose door gewichtsverlies een stap dichterbij.
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Rond december 2009 mocht ik mij oriënteren op het keuze-onderzoek waarmee het 
eerste deel van mijn geneeskunde opleiding zou worden afgesloten, voordat ik aan 
mijn coschappen zou gaan beginnen. Een fase waarin ik getrokken werd naar de spe-
cialistische opleidingen, deed mij een plan opstellen bij de afdeling maag- darm- en 
leverziekten. Onderzoek leek mij saai, maar ik hoopte mijn opleidingskansen hiermee 
te vergroten.
Er werd echter anders voor mij besloten. Ik moest eerst mijn coschappen gaan lopen, 
voordat ik toestemming kreeg om aan mijn keuze-onderzoek te beginnen. Dit besluit 
heeft mij gedwongen wat tijd ter bezinning te nemen over het onderzoek, wat heeft 
geleid tot een zeer bewuste switch naar de huisartsgeneeskunde. Als gevolg hiervan 
mocht ik in de periode van oktober 2011 tot maart 2012 een glimp opvangen van wat 
het was om onderzoek te doen bij de huisartsafdeling van het Erasmus MC. In deze 
periode begon ik onderzoek onverwachts erg leuk te vinden…
Donderdag 15 maart 2012, ‘des ochtends te 10:30 uur’, woonde ik een openbare 
verdediging van een proefschrift bij in Utrecht. Het was niet de eerste promotie die 
ik bijwoonde. Desalniettemin was het wel een plechtigheid die veel indruk op mij 
maakte. Het betrof namelijk de promotie van mijn zwager Bart, die promoveerde op het 
onderwerp ‘Ontaardingen van kubische viervouden en holomorfe symplectische meet-
kunde.’ Na de plechtigheid was mijn begrip van het onderwerp niet noemenswaardig 
gegroeid, wat mijn fascinatie voor het fenomeen promotieonderzoek alleen maar deed 
toenemen. De timing van deze promotie was wat mij betreft perfect; ik rondde juist 
mijn keuze-onderzoek af, had er onverwachts heel veel plezier in gehad en begon mij 
te verdiepen in wat promotieonderzoek precies inhield. Bart, hartelijk dank voor deze 
uitstekende timing van het afronden van jouw promotietraject waarmee je, wellicht 
ten dele onbewust, mij hebt gestimuleerd tot wetenschappelijke vorming. Ik ben nog 
steeds diep onder de indruk.
Jos, jij was er vanaf het allereerste begin bij. Jij hebt mij op een heel leuke en leerzame 
manier wegwijs gemaakt in de wereld van onderzoek. Ik was onder de indruk van je ken-
nis en kunde en had er plezier in hier zoveel mogelijk van te leren. Hartelijk dank voor de 
intensieve begeleiding tijdens mijn keuze-onderzoek, maar ook voor het onderhouden 
van contact daarna, wat uiteindelijk heeft geleid tot dit proefschrift. Ook in de periode 
van mijn promotieonderzoek ben ik onder de indruk gebleven en heb je me op een zeer 
prettige manier begeleid. Je creatieve ideeën over wat er allemaal wel niet mogelijk was 
met de data van de PROOF studie, je zeer laagdrempelige, bijna 24/7 bereikbaarheid 
en je stimulerende vragen hebben de fundering gevormd van mijn wetenschappelijke 
vorming. Zeer veel dank daarvoor.
Sita, ook jij hebt me vanaf het begin al gesteund met je advies en ideeën. Jouw cre-
ativiteit heeft aan de basis van de PROOF studie en dus van dit proefschrift gestaan. 
Al gauw bleek jij onmisbaar bij het onderzoek wat ik deed; niet zelden was mijn to do 
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lijstje volledig op zijn kop gekeerd na overleg en gevuld met nieuwe ideeën waar ik zelf 
nooit op was gekomen. Deze verrijkende ideeën hebben samen met jouw persoonlijke 
betrokkenheid mijn wetenschappelijke vorming verdiept en daarmee dit proefschrift 
tot een hoger niveau getild. Hartelijk dank hiervoor.
Ik wil graag alle deelneemsters, huisartsen, fysiotherapeuten, diëtisten en onderzoek 
medewerkers van de PROOF studie bedanken. Jullie inspanningen hebben geleid tot 
een prachtig resultaat, wat heeft geleid tot nieuwe inzichten op het gebied van preven-
tie van knie artrose.
In het bijzonder wil ik Diana bedanken voor al het harde werk dat zij in de PROOF 
studie heeft gestoken. Diana, vanaf het begin was mij al duidelijk dat jij een niet te 
verwaarlozen bijdrage aan de PROOF studie hebt geleverd. Op een recent congres in 
Amerika ontving ik nog complimenten over de uitstekende follow-up van de PROOF 
studie. Deze complimenten komen geheel toe aan jou.
Op de afdeling huisartsgeneeskunde heb ik mij zeer thuis gevoeld. De prettige, open 
sfeer heeft ervoor gezorgd dat ik met veel plezier naar mijn werk ging. Ik wil iedereen die 
aan deze sfeer heeft bijgedragen bedanken, maar in het bijzonder mijn kamergenoten: 
Carolien, Nynke, Marieke, Nadine, Anke, Toke, Marco, Kevin, Helen, Mirthe, Yvonne, 
Mohammed, Jos, Dieke, Wendy, Kelly en Rianne. Bijzondere dank gaat ook uit naar 
Saskia, dankjewel dat je mij hebt geleerd om Mplus te gebruiken. Ahlam, bedankt voor 
je bijdrage aan het onderzoek middels je keuze-onderzoek, ik vond het erg leuk om van 
elkaar te leren. Hanneke, dank voor je begeleiding bij het geven van onderwijs. Adinda, 
Carolien en Patrick, veel dank voor de gezellige trip naar Colorado Springs. Ik ben zeer 
dankbaar dat mij de kans is gegeven om een jaar lang op deze prachtige afdeling rond 
te lopen. Iedereen hartelijk bedankt daarvoor en voor de fijne sfeer!
Mijn familie en mijn vrienden ben ik ook veel dank verschuldigd. Dank jullie allemaal 
voor de getoonde interesse, maar vooral voor de nodige afleiding en relativering. Ik voel 
me oprecht heel gezegend en kan me geen fijnere familie en vriendenkring voorstellen!
Lieve Marieke, allereerst heel veel dank voor je eeuwige geduld met mij. Je hebt 
jarenlang alle verhalen aangehoord over analyses, artikelen en publicaties. Je hebt mijn 
zenuwen voor congressen en andere dingen verdragen, mijn getwijfel over wat ik wilde, 
je hebt het allemaal liefdevol ondergaan. Maar wat heb je dat goed gedaan, ik heb me 
oprecht gesteund gevoeld door jou, je hebt me altijd gestimuleerd, maar ook afleiding 
geboden in de perfecte verhouding. Marieke, ik hou van jou, ik heb je nodig en ben 
vereerd dat ik de rol van man in jouw leven op me heb mogen nemen!
167
1
2
3
4
5
6
7
8
9
10
11

12
3
4
5
6
7
8
9
10
11
Curriculum vitae

171
1
2
3
4
5
6
7
8
9
10
11
Bastiaan de Vos is geboren op 2 mei 1988 te Sliedrecht. In 2006 behaalde hij zijn gymna-
sium diploma aan het Lyceum Oudehoven te Gorinchem. Daaropvolgend begon hij aan 
de Erasmus universiteit aan de opleiding geneeskunde, die hij in 2012 afrondde. Tijdens 
zijn afstudeerproject maakte hij kennis met de onderzoeksafdeling van de huisartsge-
neeskunde en met de PROOF studie, waarover ook zijn afstudeerscriptie ging.
Na het behalen van zijn artsdiploma in 2012 heeft Bastiaan een jaar gewerkt als arts 
op de kinderafdeling van het Sint Franciscus Gasthuis te Rotterdam. Vervolgens is hij in 
2013 gestart aan de huisartsopleiding te Rotterdam. Tijdens zijn huisartsopleiding bleef 
hij betrokken bij de onderzoeksafdeling en de PROOF studie en volgde de mogelijkheid 
om de huisartsopleiding te combineren met een promotietraject.
Op dit moment werkt Bastiaan in Waddinxveen als huisarts in opleiding. Hij hoopt 
in de zomer van 2017 zijn huisartsopleiding af te ronden. In de toekomst hoopt hij zijn 
huisarts carrière te kunnen combineren met betrokken blijven bij de onderzoeksafdel-
ing van de huisartsgeneeskunde.
Bastiaan is in 2015 getrouwd met Marieke en zij wonen in Berkel en Rodenrijs.
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PhD POrtFOliO
name PhD student: Bastiaan de Vos Promotor: Prof. dr. S.M.A. Bierma-Zeinstra
erasmus mC Department: General Practice supervisor: Dr. Jos Runhaar
research school: NIHES PhD period: 2013-2016
1. Vocational training year
GP Training, Department of General Practice, Erasmus MC, 
Rotterdam
2013-present
2. PhD training year workload (eCts)
Courses / training
Courses for the quantitative researcher 2016 1.4 ECTS
Biostatistics for clinicians 2016 0.7 ECTS
Principles of epidemiologic data-analysis 2016 0.7 ECTS
Repeated measurements 2016 1.4 ECTS
Missing values in clinical research 2016 0.7 ECTS
Scientific integrity 2016 0.3 ECTS
Oral presentations
NHG Wetenschapsdag, Rotterdam 2015 1 ECTS
NHG Wetenschapsdag, Amsterdam (two presentations) 2016 2 ECTS
RCGP Annual Primary Care Conference, Harrogate, UK 2016 1 ECTS
NAPCRG Annual Meeting, Colorado, USA (two presentations) 2016 2 ECTS
Poster presentations
Osteoarthritis Research Society International (OARSI) World 
Congress, Amsterdam
2016 1 ECTS
RCGP Annual Primary Care Conference, Harrogate, UK 2016 1 ECTS
3. teaching year workload (hours)
Lecturing
Lecturing basic statistics to general practitioners in training, 
development of teaching programme
2015-2016 80 hours
Lecturing principles of evidence based medicine to medical 
specialists
2016 40 hours
Lecturing principles of evidence based medicine to general 
practitioners in training
2016 16 hours
Lecturing basic statistics to medical students 2016 16 hours
Supervising practicals and excursions, Tutoring
Supervising writing and publication of letter to the editor by 
medical students
2016 16 hours
Supervising Master’s theses
Supervising medical student 2016 80 hours
Other
Oral presentation at weekly work discussion meetings 2016 8 hours
Oral presentation at monthly interdisciplinary research group 
meetings
2016 8 hours
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Reviewing article for PLOS ONE 2016 8 hours
Reviewing article for BMC Musculoskeletal Disorders 2016 8 hours
Reviewing article for Arthritis Care & Research 2016 8 hours
Reviewing article for Osteoarthritis and Cartilage 2016 8 hours
Writing “Practical Evidence About Real Life Situations” for general 
practitioners attending staff training
2016 8 hours
total (28 hours = 1 eCts) 24.1 eCts
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